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Abstract 
The reprogramming of epigenetic marks is a genomewide process and yet CpG 
islands escape the overall trend. In addition, not all CpG islands behave in the same way. 
While the majority of CpG islands resist the de novo DNA methylation establishment in 
the germ lines, ~1600 CpG islands acquire methylation during oogenesis. The majority 
of these oocyte-methylated CpG islands remain un-methylated during spermatogenesis, 
that is, they are maternal germ line differentially methylated regions (maternal gDMRs). 
All but 25 (permanent) maternal gDMRs lose their methylation post fertilisation and 
pre-implantation. 
The DNA sequences of CpG islands was investigated - in the context of transcription 
in the oocyte - to identify targeting signals for either establishing and/or maintaining, or 
altogether escaping DNA methylation during oogenesis and in the pre-implantation 
embryo. The methylation of CpG islands in the oocyte was found to be significantly 
associated with transcription through CpG islands, as previously observed. However, 
the sequences of oocyte-methylated CpG islands do not contain a characteristic DNA 
sequence motif, and neither do the upstream promoters from which transcription 
through oocyte-methylated CpG islands originates. An analogous de novo motif search 
successfully identifies TGCCGC, the recognition site of the Zfp57/Kap1 imprint 
maintenance complex, as a DNA sequence motif that is characteristic for PPM-DMRs. 
Analysis of the incidence of TGCCGC indicates that not just its presence but also 
multiple occurrences within a sequence may be required for imprint maintenance. 
Furthermore, the lack of additional characteristic motifs suggests the absence of 
additional DNA-binding factors that specifically interact with PPM-DMRs. 
A period of 8-10bp in the spacing of CpGs in PPM-DMRs was previously observed 
and proposed as a targeting signal for de novo methylation in the germ line. This 
observation was reproduced, and the property of the average was found to be 
representative to only less than the half of the PPM-DMRs. Moreover, the pairs of 
CpGs 8-10bp apart are in fact depleted in oocyte-methylated CpG islands, consistent 
with the consequence of accidental deamination over time. The absence of a DNA 
sequence motif or CpG spacing characteristic of oocyte-methylated CpG islands 
(including PPM-DMRs) supports a sequence-independent model of de novo methylation 
establishment during oogenesis. 
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However, the CpG islands that escape this mechanism contain a characteristic CG-
rich motif that is highly similar to the recognition site of E2F1/2, DNA-binding protein 
involved in chromatin remodelling that is expressed in oocytes. Logistic-linear 
regression analyses indicate that the presence of the motif independently conveys 
significant protection from methylation, regardless of, for example, whether the CpG 
island is an active promoter. Therefore, the following is proposed: E2F1/2 are part of a 
mechanism for the active protection of specific CpG islands from de novo methylation 
in the oocyte.  
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1. Chapter 1: Introduction 
 
1.1. Preliminaries and background 
This section introduces the main concepts and terms that are relevant to this study. It 
starts with a brief discussion of the definition of epigenetics and the two main 
epigenetic modifications of chromatin: post-translational histone modifications and 
DNA methylation. This is followed by a brief description of the mammalian epigenetic 
reprogramming cycle during embryogenesis and germ cell development, including its 
association with genomic imprinting and the special status of CpG islands in this 
context. Finally, the computational tools to identify DNA sequence motifs and next-
generation sequencing approaches to genomewide epigenetic data generation are 
introduced. 
 
1.1.1. Epigenetics 
Epigenetics in general encompasses reversible biochemical modifications of DNA 
and chromatin that do not change the underlying DNA sequence but influence its 
interpretation by the cellular machinery. These modifications are stable and heritable 
through cell division and serve in the regulation of gene expression (Blomen and 
Boonstra, 2010). Epigenetic marks control the fate of cells during differentiation and 
play an important role in organism development (Morgan et al., 2005). These marks 
are affected by environmental insults/challenges, including nutrition (Verma, 2013). 
Epigenetics is controlled by two major mechanisms: DNA methylation and histone 
modifications. Each cell type in an organism has a distinct methylation and histone 
pattern (Morgan et al., 2005). 
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1.1.1.1. Epigenetic Modifications 
1.1.1.1.1. Histone Modification 
Histones are the component proteins of nucleosomes which are the basic unit in 
DNA packaging (Figure 1.1) around which ~ 150bp of chromosomal DNA are 
wrapped at semi-regular and variable intervals, resulting in a “beads-on-a-string” 
structure (Kouzarides, 2007). There are two main classes of histone: core histones 
(H2A, H2B, H3 and H4) which form the core particle of the nucleosome and 
linker histones (H1) which lock the DNA ends that are wrapped around the 
nucleosome (Luger et al., 1997; Kouzarides, 2007). 
 
 
Figure 1.1: Cartoon anatomy of nucleosome structure. The nucleosome, the basic unit 
of chromatin, has an octameric structure, termed core particle, which consists of two 
each of the core histones (blue balls): H2A, H2B, H3 and H4 around which 146/7 base 
pairs of DNA (red) are wrapped. Histones have tails (black curves) that undergo several 
post-translational modifications that have the potential to influence the chromatin 
structure, thereby regulate the functions of the genome. H1 (light blue) is the linker 
histone that binds the linker DNA region and stabilizes the structure by keeping the 
wrapped DNA in place. 
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Several epigenetic post-translational modifications of histone proteins are 
directly involved in gene regulation. These modifications occur along the tails of 
histones, for example, methylation/de-methylation and acetylation/deacetylation. 
In the case of acetylation, a histone acetyl transferase (HAT) enzyme adds an 
acetyl group (COCH3) to a lysine amino acid in a histone tail, resulting, with the 
contribution of other processes, in euchromatin (‘lightly packed’ / open chromatin 
structure, Figure 1.2) that makes the DNA accessible for transcription factors and 
leads to gene activation (Grunstein, 1997; Shahbazian and Grunstein, 2007). In 
the case of deacetylation, a histone deacetylase (HDAC) enzyme removes these 
acetyl groups forming, with the contribution of other additional processes, 
heterochromatin (‘tightly packed’ / closed chromatin structure, Figure 1.2). The 
condensed DNA is less accessible to proteins, in particular transcription factors, 
which decreases the ability of genes to be expressed (Grunstein, 1997; Shahbazian 
and Grunstein, 2007). 
 
 
Figure 1.2: Histone acetylation/deacetylation and gene regulation. Histone acetylation 
(green) and deacetylation (purple) are complementary epigenetic modifications that 
affect gene expression. While acetylation by a HAT enzyme opens the chromatin 
structure for transcription factors and RNA polymerase, allowing gene transcription, an 
HDAC enzyme removes acetylation and closes the chromatin, making the DNA 
inaccessible, which results in gene silencing. HAT: histone acetyl transferase, HDAC: 
histone deacetylase, RNA pol II: RNA polymerase II. 
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The term 'histone code' was proposed by Strahl and Allis (2000) to indicate a 
set of histone modifications that work independently or in combination to enable 
downstream DNA functions. Histone modifications can act as attractors to recruit 
other protein complexes, which in turn influence DNA-based local as well as 
genomewide functions like gene transcription and DNA replication, respectively. 
These modifications are mediated by specific enzymes (histone modifying 
enzymes), which modify histones at multiple sites leading to specific chromatin 
structure that is associated to a biological event (Kouzarides, 2007). Lysine 
methyltransferases, for example, have high specificity in that they target single 
lysine residues on a single histone. Figure 1.3 shows the core histones along with 
the corresponding modifications and their specific targeted enzymes. 
Genomewide studies uncover the overall associations between sets of these 
modifications and the transcriptional status of the genome (Roh et al., 2006; 
Barski et al., 2007). For instance, H3K9me3 and H3K27me3 are implicated in 
heterochromatin formation, gene silencing (Bannister et al., 2001) and gene 
repression (Roh et al., 2006), while tri-methylation of histone H3 lysine 4 
(H3K4me3) and acetylation of histone H3 lysine 9 (H3K9ac) have been identified 
as marks of active transcription (Barski et al., 2007). Particularly, H3K4me3 is 
highly enriched near the transcription start sites (TSS) of active genes as well as at 
a high proportion of silent promoters (Ruthenburg et al., 2007). Conversely, 
H3K36me3 signals are highly enriched within the body of actively transcribed 
genes (Bannister et al., 2005). 
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Figure 1.3: Histone-modifying enzymes. The top left box contains a colour-coded list 
of the main histone modifications. The targeted sites for each modification, along the 
amino acid chain of the histone tail, are marked in matching colours. For example, 
lysine (K) 4 (numbering starts at the end of the tail) of histone H3 is methylated by 
histone methyltransferases (HMTs) like MLL1 that, with other modifications, can lead 
to gene activation. Figure is from Wikipedia, created by 'Kosi Gramatikoff', 
http://en.wikipedia.org/wiki/File:NucleosomeKG.jpg. 
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1.1.1.1.2. DNA Methylation 
In mammals, DNA methylation typically refers to the addition of a methyl 
group (CH3) to the fifth carbon atom of the cytosine ring in a CpG dinucleotide 
(Figure 1.4). DNA methylation is heritable in that it can be propagated through 
DNA replication and cell division (Wigler et al., 1981). Studies of the nucleotide 
composition of the genome revealed a relative depletion of CpGs. The overall 
observed frequency of CpGs is approximately 25% of what is expected (Bird, 
1986). This is due to the high rate conversion of methylated cytosine into thymine 
(and ammonia) via deamination, resulting in TpGs (Bird, 1986). 
DNA methylation has a critical role in developmental gene regulation (Li et al., 
1992) and it is one of the mechanisms used to silence the promoter of a gene and 
thereby control its transcription, like in the cases of imprinted genes (Genomic 
imprinting, section 1.1.1.3) and retrotransposons, (Goll and Bestor, 2005). It is 
also necessary for the stabilisation of some repetitive elements, like satellite repeat 
sequences, and for X-chromosome inactivation in female (Ooi et al., 2009). 
 
Figure 1.4: DNA Methylation, from cytosine to 5-methylcytosine (5mC). This 
epigenetic modification requires certain enzymes (of the DNA methyltransferase or 
DNMT family) to recognise the cytosine base in a CpG dinucleotide and to replace the 
hydrogen atom on the fifth carbon atom of cytosine with a methyl group (CH3). This 
requires the transfer of a methyl group from a donor molecule like SAM (S-Adenosyl 
methionine) in a transmethylation reaction. 
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 5-Hydroxymethylcytosine, a different type of DNA methylation 
5-hydroxymethylcytosine (5hmC) is a form of DNA methylation that has 
been recently identified in neurons (Kriaucionis and Heintz, 2009). It is the 
result of 5-methylcytosine oxidation by members of the ten-eleven 
translocation (TET) enzyme family, e.g., TET1 (Figure 1.5, Tahiliani et al., 
2009). TET1 contains domains for iron and oxoglutarate binding, a cysteine-
rich domain for DNA binding and a CXXC zinc finger domain that allows it to 
bind un-methylated, methylated and hydroxy-methylated DNA (Branco et al., 
2011). Recent genomewide sequencing showed high association of 5hmC with 
euchromatin and increased levels of transcription (Ficz et al., 2011). Studies of 
the chemical structure of cytosine, 5mC and 5hmC, in addition to their 
genomic distribution, provided evidence that 5hmC is an intermediate form 
during the transformation of 5mC into cytosine (Branco et al., 2011). There is 
strong evidence that the TET enzymes are part of an 'active' DNA de-
methylation pathway, with a role in controlling gene expression (Branco et al., 
2011). 
 
Figure 1.5: 5-methylcytosine oxidation by a TET enzyme forms 5-
hydroxymethylcytosine (5hmC). The methyl group (CH3) is replaced by hydroxide 
(OH). 5hmC provides a mechanism for reversing the methylation of 5mC into plain 
cytosine, detailed proposed de-methylation pathways which include 5hmC are 
discussed in (Branco et al., 2011). 
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 Mammalian DNA methylation enzymes 
DNA methylation is mediated by members of the DNA methyltransferase 
(Dnmt) enzyme super-family. Each sub-family is controlled by specific 
regulatory signals, which correspond to specific biological functions, reviewed 
in Goll and Bestor (2005) and Ooi et al., (2009). Depending on their functions, 
they can be classified into two groups: maintenance and de novo DNA 
methyltransferases. Maintenance methyltransferases preserve the methylation 
after DNA replication by methylating the newly produced daughter strand 
based on the methylation pattern of the template strand, while de novo 
methyltransferases establish DNA methylation patterns on a completely un-
methylated DNA sequence, which occurs genomewide during, for example, 
gametogenesis and in the pre-implantation embryo (Epigenetic reprogramming; 
section 1.1.1.4). 
 
 Dnmt1 
DNA methyltransferase 1 (Dnmt1) is mainly responsible for DNA 
methylation maintenance. It has the ability to methylate both hemi-
methylated and un-methylated sequences, though its methylation activity on 
hemi-methylated sequences is greater than on un-methylated sequences 
(Yoder et al., 1997). Homozygous Dnmt1-null mutant mouse embryos show 
delay in development and mid-gestation lethality as well as a reduction in 
global DNA methylation levels (Li et al., 1992). 
Alternative splicing of Dnmt1 controls the production and localisation of 
the protein within the cell at specific stages of gametogenesis, specifically in 
oocytes (Figure 1.6). Large amounts of Dnmt1 are located in the nuclei of 
growing oocytes, at approximately the time of de novo methylation during 
oogenesis (Epigenetic reprogramming; section 1.1.1.4). However, during a 
later stage of oocyte growth (germinal vesicle “GV” oocytes), an 
alternatively spliced transcript with a distinct 5' exon, termed Dnmt1o, is 
translated to provide a maternal store of DNA methyltransferase for early 
development (Mertineit et al., 1998). 
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This oocyte-specific isoform is exclusively cytoplasmic during the 2- and 
4-cell stages until the 8-cell stage when it enters the nuclei to maintain 
methylation patterns specifically at imprinted genes (Genomic imprinting, 
section 1.1.1.3) during the fourth embryonic S phase, then it again become 
cytoplasmic at 16-cell stage until the implantation (Howell et al., 2001). 
 
Figure 1.6:  Levels and locations of Dnmt1 in germ cells and early mouse embryos. In 
early growing oocytes, Dnmt1 is localised in the nuclei at high levels (concurrently with 
the de novo methylation wave). At a later oocyte growth stage, specifically the GV 
stage, a distinct cytoplasmic variant of Dnmt1 (Dnmt1o) becomes active. This isoform 
persists in the cytoplasm throughout the early cell divisions and until implantation, 
except for the 8-cell stage when it enters the nuclei. Later on in development, all 
somatic cell types produce the nuclear-located Dnmt1 variant (Dnmt1s; that maintain 
the methylation patterns in post-implantation embryos). Dnmt1 levels and location is 
shown in red, while blue indicates the nucleus when it is free of Dnmt1. Figure is from 
(Mertineit et al., 1998). 
 Dnmt2 
Dnmt2 is similar in sequence to other DNA methyltransferases; however 
it does not show any DNA methyltransferase de novo or maintenance 
activity (Okano et al., 1998.a) but rather a high RNA methylating capability, 
specifically with regards to the C38 position of tRNA-Asp (Goll et al., 
2006). Therefore, the name of this methyltransferase has recently been 
changed to TRDMT1 (tRNA aspartic acid methyltransferase 1). 
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 The Dnmt3 Family 
The Dnmt3 family comprises Dnmt3a, Dnmt3b and Dnmt3L, but only 
the former two have catalytic activity, while Dnmt3L acts as a co-factor. 
Dnmt3a and Dnmt3b are de novo methyltransferases that are essential for 
establishing DNA methylation at CpG dinucleotides. They were first 
identified while searching for novel DNA methyltransferases, similar to 
Dnmt1, via screening expression sequence tag (EST) databases (Okano et 
al., 1998.b). 
Okano et al., (1999) investigated the biological implications of Dnmt3a 
and Dnmt3b, specifically on de novo methylation in germ cells and during 
early mouse embryonic development. They observe lack of de novo 
methylation activity in the embryonic stem cells (ESCs) and mouse embryos 
with homozygous mutant for both Dnmt3a and Dnmt3b, demonstrating their 
essential role in de novo methylation after fertilisation. However, their 
absence did not affect the maintenance of methylation patterns at some 
imprinted loci (Genomic imprinting, section 1.1.1.3). They also show that 
Dnmt3a and Dnmt3b are vital for normal embryonic development since 
Dnmt3a
-/-
 mice died at about four weeks old and Dnmt3b
-/-
 mice died before 
birth. 
A distinct isoform of Dnmt3a, termed Dnmt3a2, shows a different sub-
cellular localisation pattern compared to the canonical isoform. While 
Dnmt3a preferentially methylates heterochromatic domains, Dnmt3a2 
targets euchromatic domains (Chen et al., 2002). Dnmt3a/b work in concert 
to methylate the genome; for example, Dnmt3a is required for the 
methylation of imprinting control regions in the germ line (Kaneda et al., 
2004), while minor satellite repeats are a specific target of Dnmt3b (Okano 
et al., 1999). Both enzymes have no innate sequence preferences beyond 
CpG dinucleotides. Hence, establishing as well as maintaining DNA 
methylation patterns at specific loci requires regulatory cofactors such as 
Dnmt3L. 
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Sequence similarity with Dnmt3a/b led to the identification of DNA 
methyltransferase 3-like, Dnmt3L (Aapola et al., 2000). However, despite 
this similarity, it lacks the catalytic activity that is needed for being an 
active DNA methyltransferase. Instead, it works as a cofactor with 
Dnmt3a/b by enhancing and stimulating their DNA methylation activity 
(Suetake et al., 2004; Wienholz et al., 2010). Dnmt3L plays a key role in 
establishing DNA methylation at maternally methylated regions in the 
oocyte (Bourc’his et al., 2001). Loss of methylation occurs at these regions 
in heterozygous embryos derived from homozygous mutant oocytes, leading 
to embryonic death at the stage of implantation at 9.5 days post coitum (dpc) 
(Bourc’his et al., 2001). 
 
 Dnmts and histone modifications 
Although DNA methyltransferases are responsible for establishing and 
maintaining DNA methylation, there are other complementary cofactors that 
play an essential role in regulating and controlling these processes. Recent 
studies provide evidence for the direct interaction between these cofactors 
and the methyltransferases. 
The N-terminal domain of Dnmt3L binds the N-terminal tail of histone 
H3, provided lysine 4 is unmodified (Ooi et al., 2007). Binding is disrupted 
when lysine 4 is modified by either mono-, di- or tri-methylation, but is 
unaffected by modifications at other positions (Figure 1.7). Thus, Dnmt3L 
specifically recognises and binds to un-methylated H3K4. More generally, 
the result provides strong evidence for a direct link between the DNA 
methylation machinery and the modification state of histone tails. 
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Figure 1.7: Dnmt3L specifically recognises the unmodified state of H3K4. 
Peptide interaction assays with full-length human DNMT3L and the unmodified 
state of histone H3. (a) DNMT3L specifically interacts with histone H3 (left) and 
this interaction depends on the first 6 amino acids (right). (b) The DNMT3L-H3 
interaction depends on the methylation state of lysine 4: DNMT3L only 
recognises and binds to unmodified H3K4. Figure is from (Ooi et al., 2007). 
 
 
Dnmt3a has two sub-domains at its N-terminus: a PWWP domain and an 
ADD domain. Using peptide arrays, Dhayalan et al. (2010) showed that the 
PWWP domain of Dnmt3a2 specifically recognises tri-methylation of lysine 
36 on histone H3 and that this interaction is essential for its catalytic activity 
on native chromatin. H3K36me3 histone mark is enriched in the body of 
transcribed genes, which suggest a high correlation between gene body 
methylation and transcription initiated from upstream promoters (Section 
2.7). The interaction between Dnmt3L/Dnmt3a2 and their preferential 
histone marks induces de novo methylation (Figure 1.8). 
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Figure 1.8: Methylation state interaction model. The N-terminal of Dnmt3L recognises 
unmodified lysine 4 on histone H3 N-terminal tail and its C-terminal interacts with 
Dnmt3a2. Similarly the ADD domain of Dnmt3a2 interacts with H3K4me0 while its 
PWWP domain specifically recognises H3K36me3. 
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1.1.1.2. CpG islands and chromatin structure 
In mammals, most DNA methylation takes place at cytosines in 5' -CG- 3' 
dinucleotides (CpGs) where p refers to the phosphate group that links cytosine and 
guanine. Approximately 60% - 90% of the CpGs in the mammalian genome are 
methylated (Bird, 1986). However, there are GC rich regions with a relatively high 
density of CpGs, called CpG islands, that account for ~1% of the genome and in 
most cases, are un-methylated (Bird, 1986 and 2011). CpG islands can be identified 
experimentally or defined computationally based on a set of sequence features. The 
most commonly used definition requires a sequence of at least 200bp with a GC 
content of at least 50% and an observed over expected ratio of CpG occurrences of at 
least 0.6 (Gardiner-Garden and Frommer, 1987). CpG islands are mainly located 
near the TSSs of mammalian genes, and for example in human, 60-70% of genes 
have a CpG island associated with their TSSs (Bird, 2002; Illingworth and Bird., 
2009). 
Typically, CpG islands are associated with promoter-like features (Illingworth et 
al., 2008 and 2010), even if they are not near an annotated TSS. Thus, they help to 
identify promoter regions. Other sequence features like transcription factor binding 
sites (TFBS) are too evenly distributed throughout the genome to be reliable 
predictors of promoters on their own. 
Un-methylated CpG islands at gene TSSs has a specific chromatin signature 
(characteristic set of epigenetic features) that is distinct from the rest of the genome 
(Figure 1.9), including histone acetylation, a lack of histone H1, a nucleosome 
depleted region (NDR) that is often occupied by transcription factors (TFs) and 
chromatin remodelling factors, and flanking nucleosomes that include the histone 
variant H2A.Z and carry the H3K4me3 histone mark (Singal and Ginder., 1999; 
Jones., 2012). CpG island promoters differ from non-CpG island promoters in that 
transcription can be initiated from multiple positions (Illingworth and Bird, 2009). 
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Figure 1.9: Cartoon anatomy of the chromatin structure at a simple gene locus. An un-
methylated CpG island is nucleosome-free at the TSS, allowing TFs to bind. The TSS-
flanking nucleosomes are marked with H3K4me3 and contain the H2A.Z histone 
variant. However, intragenic CpGs tend to be methylated. Consequently, overall and 
genomewide, one observes anti-correlation between H3K4me3 and DNA methylation 
and correlation of the latter with H3K36me3 (Dhayalan et al., 2010). NDR: Nucleosome 
depletion region. TF: Transcription factor. Figure adapted from (Jones, 2012). 
 
 
Although CpG islands are typically un-methylated, they can be methylated. 
Methylation of a CpG island promoter prevents transcription initiation and is usually 
associated with stable (though not irreversible) gene silencing. Therefore, methylated 
CpG island promoters are mainly observed in somatic tissues at germ cell-
specifically expressed genes, in imprinted regions (Genomic imprinting, section 
1.1.1.3), and at genes on the inactive X-chromosome (Jones, 2012). Improper CpG 
island methylation can lead to in appropriate gene silencing and consequently, 
various types of disorders and cancer (Baylin et al., 2000). 
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In contrast, CpG islands in gene bodies are typically methylated, marked by 
repressive histone marks (repressive when present at a TSS) such as H3K9/36me3, 
and bound by methyl-CpG-binding protein 2 (MECP2). They do not block 
transcriptional elongation. On the contrary, they stimulate elongation and may also 
have an impact on transcript splicing (Jones, 2012). Illingworth et al., (2010) 
proposed that distal CpG islands (either within the genes body [intragenic] or within 
gene deserts ‘without annotated gene’ [intergenic]) may serve as promoters at early 
stages in development. Therefore, methylation of CpG islands probably plays a 
major role in regulating the activity of early development-specific promoters 
(Maunakea et al., 2010). 
In the majority of cases, the methylation state of a CpG island is the same on both 
parental alleles. However, a special set of CpG islands does not follow this rule, but 
rather are differentially methylated in a parental allele-specific manner, i.e., on either 
only the paternally or only the maternally inherited allele, a phenomenon called 
genomic imprinting. 
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1.1.1.3. Genomic Imprinting 
Genomic imprinting is restricted to placental mammals, marsupials (Killian el at., 
2000; Renfree et al., 2008) and flowering plants. It is a form of epigenetic control of 
gene expression resulting in genes being expressed in a parent-of-origin-dependent 
manner, independent of genetic differences between the parental alleles. 
Both alleles of most mammalian genes are functionally equivalent and equally 
expressed (biallelic). However, a small number of genes do not follow this ‘rule’. 
These genes, of which only either the maternal (e.g., H19) or the paternal (e.g., IGF2) 
allele is expressed, are called imprinted genes (Figure 1.10). Imprinted gene 
expression is due to DNA methylation and histone modification differences between 
the parental alleles. These differences are due to differences in the epigenetic 
reprogramming of the genome between the parental germ lines that are maintained in 
the somatic cells of the offspring (Epigenetic reprogramming, section 1.1.1.4). Like 
other genes, the expression of imprinted genes can be tissue and/or developmental 
stage-specific. However, in addition, whether or not parental allele-specific versus 
biallelic expression occurs can also depend on the cell type and/or developmental 
stage (Prickett and Oakey, 2012).  
 
Figure 1.10: Imprinted gene expression: allele-specific gene expression in a parent-of-
origin-specific manner. The maternal allele is shown in pink, the paternal allele in dark 
blue. Gene expression is indicated by an arrow, while a vertical line symbolises gene 
silencing. (A) Expression of non-imprinted gene from both parental alleles (biallelic 
expression). (B) An imprinted gene that is only expressed from the paternal allele. (C) 
An imprinted gene with maternal allele-specific expression.  
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Genomic imprinting is necessary for normal development (Figure 1.11, A). This 
was demonstrated by experiments investigating the effect of having either only two 
maternal or only two paternal genomes on mouse embryonic development (Surani et 
al., 1986). In both cases, the embryo is not viable. In the case of parthenogenesis 
(two maternal genomes), the placenta is under-developed and the embryo is 
significantly smaller than normal (Figure 1.11, B). In the case of androgenesis (two 
paternal genomes), the placenta over-proliferates, while the embryo hardly develops 
at all (Figure 1.11, C). This reflects what is now known about the opposing functions 
of maternally- and paternally-imprinted genes in the regulation of growth and 
development. 
 
Figure 1.11: The effect of parthenogenesis and androgenesis on mammalian embryonic 
development. (A) Normal development of a mouse embryo and the extra-embryonic 
tissues with two genetically identical genomes, one inherited from the mother and the 
other inherited from the father. (B) Parthenogenic embryo and extra-embryonic tissues 
with two genetically identical genomes but both inherited from the mother: at 10 dpc, 
the placenta (trophoblast-derived) is poorly developed, and the embryo is relatively 
small. (C) Androgenic conception with two genetically identical paternally inherited 
genomes at 10 dpc: the trophoblasts have over-proliferated, while the embryo has hardly 
developed. TB: trophoblast, YS: yolk sac. Figure adapted from Surani et al., (1986). 
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1.1.1.3.1. Genomic imprinting and disease 
Loss of imprinting (LOI) and/or aberrant expression of particular imprinted 
genes plays a major role in multiple developmental disorders. For example, LOI 
of IGF2 is associated with cancer, e.g., colorectal, liver, esophageal, 
adrenocortical and breast tumours (Kaneda and Feinberg, 2005; Chao and 
D'Amore, 2008). Biallelic expression of H19 and down-regulation of IGF2 also is 
associated with the growth restriction disorder Silver Russell Syndrome (SRS) 
(Gicquel et al., 2005), while the over-growth Beckwith-Wiedemann Syndrome 
(BWS) is associated with the opposite molecular phenotype (Adams, 2008; Chao 
and D'Amore, 2008). 
Angelman syndrome (AS) is a neuro-genetic disorder characterized by severe 
intellectual disability, ataxia, speech impairment, jerky movements of limbs and 
bouts of laughter/smiling (Adams, 2008; Chamberlain and Lalande, 2010). The 
molecular cause underlying this disease is the inactivation (mutation) or the 
absence (deletion) of the maternally expressed imprinted gene UBE3A on human 
chromosome 15 in neurons (Chamberlain and Lalande, 2010). 
Prader-Willi syndrome (PWS) is a complex condition that is associated with 
multiple symptoms including, but not limited to, feeding difficulties and poor 
growth in infancy, hyperphagia and sleep abnormalities in childhood, obesity and 
anxiety in adulthood (Adams, 2008). PWS is caused by loss of expression of 
several paternally expressed imprinted genes near the UBE3A locus. 
Understanding the molecular basis of genomic imprinting is critical for 
understanding these and other numerous imprinting-related disorders and various 
types of cancers. 
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1.1.1.3.2. Imprinted gene clusters and imprinting control regions 
The first imprinted gene, Insulin-like growth factor type-2 (Igf2), was 
identified in 1991 on mouse chromosome 7. Igf2 is a paternally expressed gene 
that plays an essential role in growth and development (Barlow et al., 1991; 
DeChiara et al., 1991). Since the identification of Igf2, around 150 imprinted 
genes in mice and around 80 in human have been identified (Morison et al., 2001; 
Schulz et al., 2008; MRC, 2013). Most of these imprinted genes are located in 
coordinately regulated imprinted gene clusters like, for example, the H19 and 
KCNQ1 clusters on mouse chromosome 7 and human chromosome 11, 
respectively (Verona et al., 2003; O’Neill, 2005; Edwards and Ferguson-Smith, 
2007). Figure 1.12 illustrates the uneven, clustered distribution of imprinted genes 
in the mouse genome (MRC, 2013). Each cluster can contain both paternally and 
maternally expressed genes as well as interspersed non-imprinted genes (Pauler 
and Barlow, 2006; Bartolomei, 2009). However, not all imprinted genes are part 
of large clusters (e.g., Impact). 
Imprinting control regions (ICRs) are DNA sequences that are responsible for 
regulating the expression of imprinted genes. Loss of function of an ICR results in 
LOI of the genes under its control. In mammals, the two parental genomes differ 
at ICRs in that the DNA of either only the maternally (maternal ICRs) or only the 
paternally (paternal ICRs) inherited ICR allele is methylated. The parental allele-
specific methylation of an ICR can either be established in one of the parental 
germ lines (germ line/primary ICR), or subsequently during embryonic 
development (somatic or secondary ICR) as a consequence of the action of a 
primary ICR. 
There are two distinct known mechanisms of imprinted gene regulation by 
ICRs in imprinted gene clusters: either the ICR functions as an insulator, for 
example, at the H19/IGF2 locus (Ideraabdullah et al., 2008), or the ICR is at the 
promoter of a regulatory non-coding RNA (ncRNA), for example, at the KCNQ1 
locus (Ideraabdullah et al., 2008). 
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1.1.1.4. Epigenetic reprogramming during early embryogenesis and 
in the germ line 
Epigenetic reprogramming is required to generate the totipotent zygote from 
which all other different cells will be generated (Morgan et al., 2005). Totipotency is 
achieved by erasing the accumulative parental epigenetic marks and establishing new 
base-line marks during early embryogenesis (Morgan et al., 2005). Epigenetic 
reprogramming is also required during gametogenesis to reset (global de-methylation 
and de novo sex-specific methylation) the parental genomic imprints, in each 
generation, to epigenetically reflect the sex of the embryo (Morgan et al., 2005; 
Surani and Hajkova., 2010). Although this epigenetic marks resetting is genomewide, 
CpG islands are an exception to this overall trend. Moreover, specific sets of CpG 
islands act differently than the rest of CpG islands. 
 
1.1.1.4.1 Overall DNA methylation dynamics during early 
embryogenesis 
During early embryonic development (Figure 1.13), the genome is 
epigenetically reprogrammed (modified) on a large scale. Studies of epigenetic 
modifications at the zygote, morula and blastocyst stages have detected global 
differences in the kinetics of especially DNA methylation changes (de-
methylation and re-methylation) between the parental genomes and between 
embryonic and extra-embryonic tissues. 
 
Figure 1.13: Normal early human embryonic development. (A) The fertilised egg 
(zygote) at E1. (B) The 8-cell stage. (C) The 32-cell stage (morula) at E3. (D) The 
blastocyst stage at E5. E refers to embryonic day. Figure adapted from: 
http://www.sjfert.com/index.php/ivf/program/ 
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Immediately after fertilisation and when the parental genomes are still separate 
in the pronuclei, active genomewide de-methylation (probably through oxidation 
of 5mC, Wossidlo et al., 2011) erases the methylation from the sperm/paternal 
genome, although a few specific regions, for example, paternally methylated ICRs 
(Figure 1.14), maintain their methylation (Reik et al., 2001; Seisenberger et al., 
2012). On the other hand, the oocyte/maternal genome is protected from this 
global oxidation/de-methylation that is suggested to be triggered by sperm 
chromatin remodelling, via PGC7/Dppa3/Stella (Wossidlo et al., 2011).  
However, during subsequent cleavage divisions the maternal genome is de-
methylated passively, mainly due to the exclusion of DNMT1 from the nucleus, 
again except for a few specific regions, for example, maternal ICRs, that remain 
methylated (Reik et al., 2001). Around the time of implantation, methylation of 
both genomes will be re-established by de novo DNA methylation. Yet some 
regions resist this wave of de novo methylation, for example, most CpG islands 
and the un-methylated alleles of ICRs (section 1.1.1.4.3). 
 
1.1.1.4.2 Overall DNA methylation dynamics in the germ line 
In the germ line, DNA methylation and in particular parental genomic imprints 
are reset so that the mature gametes epigenetically reflect the sex of the individual. 
The resetting comprises two steps, erasure and establishment (Figure 1.14). In 
erasure, the DNA methylation of primordial germ cells (PGCs) is removed via the 
conversion of 5mC into 5hmC (Hackett et al., 2013) in two distinct stages. Most 
DNA methylation is removed early, prior to E9.5. However, the DNA methylation 
at some specific sites, including maternal ICRs, is removed later, between E10.5 
and E13.5 (Seisenberger et al., 2012). 
The de novo “re-methylation” of male germ cells completes prior to birth (at 
late fetal stages) and before germ cell meiosis, while in female gametes, this 
process does not complete until after puberty, during the final oocyte growth 
phase prior to ovulation (Bourc’his and Proudhon, 2008). Still some regions 
maintain their default un-methylated state, for example, most CpG islands (section 
1.1.1.4.3). 
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1.1.1.4.3 CpG islands and parental imprints during epigenetic 
reprogramming 
CpG islands and imprinted regions constitute an exception relative to much of 
the rest of the genome because of when and how their DNA methylation levels 
change during epigenetic reprogramming, motivating distinct terms when 
referring to specific reprogramming stages during development (Figure 1.15). 
Methylation imprints erasure occurs in primordial germ cells as a consequence 
of genomewide de-methylation, though imprinted regions tend to resist this 
process for longer than most of the rest of the genome (Figure 1.14 and 
Seisenberger et al., 2012). 
Methylation imprints establishment coincides with the wave of de novo 
genomewide methylation during gametogenesis, however most CpG islands resist 
methylation establishment and remain un-methylated (CpG islands, section 
1.1.1.2). An exception to the majority of CpG islands are the imprinted regions 
(most of them are CpG islands) that become methylated only during either 
spermatogenesis or oogenesis, resulting in germ line differentially methylated 
regions (gDMRs). There are around 1000 oocyte-methylated CpG islands 
(Smallwood et al., 2011) most of them are un-methylated in sperm (maternal 
gDMRs). 
Methylation imprints maintenance refers to the mechanisms by which a subset 
of gDMRs firstly resists the genomewide de-methylation post fertilisation. After 
the development of the blastocyst, a wave of de novo methylation occurs that is 
resisted by most CpG islands. Again, a subset of the still intact gDMRs 
(permanent gDMRs) resists methylation of their respectively un-methylated allele. 
The subset of gDMRs that completely resist post fertilisation reprogramming and 
are therefore maintained in the post-implantation embryo are the set of (primary) 
ICRs (Reik and Walter, 2001; Bourc’his and Proudhon, 2008; Seisenberger et al., 
2012). 
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The maintenance of the DNA methylation at ICRs is carried out by the 
Zfp57/Kap1 protein complex that has been recently identified (Quenneville et al., 
2011). Chapter 4 discusses the maintenance of the DNA methylation at imprinted 
loci and associated DNA sequence signals in detail. 
In 2008, Mackay et al. reported an association between mutations in ZFP57, 
hypo-methylation of multiple imprinted loci, and transient neonatal diabetes 
mellitus 1 (TNDM1) (Mackay et al., 2008). TNDM1 is a common form of 
diabetes that presents at birth with variable additional phenotypes, sometimes 
including birth defects, growth retardation inside the womb and developmental 
delay (Boonen et al., 2013). Till date, ZFP57 has not linked to any other 
imprinting-associated disorder other than TNDM1 (Spengler et al., 2009; Boonen 
et al., 2012; Court et al., 2013). 
 
 
Figure 1.15: The parental DNA methylation imprints cycle. Blue indicates the 
paternal genome, while pink symbolises the maternal genome. A filled small oval 
indicates the methylated allele of an ICR, while an un-filled oval represents the un-
methylated allele. As examples, one maternally methylated ICR, and one paternally 
methylated ICR are shown. Arrows stand for gene transcription from the respectively 
un-methylated allele. PGCs: primordial germ cells. Figure adapted from (Reik and 
Walter, 2001). 
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1.1.2. DNA sequence motif discovery tools 
To better understand the mechanisms that regulate gene expression, one strategy is 
to identify regulatory elements, e.g., transcription factor binding sites, in the DNA 
sequence. Motif discovery is a challenging problem in both molecular biology and 
computer science. Many computational algorithms have been developed to identify 
and analyse motif sequences. Some depend on counting the frequencies of motif 
occurrences (exhaustive enumeration) and others apply probabilistic models to 
decompose the input sequences into informative sequence that may contain motif(s), 
and non-informative background sequence (Das and Dai, 2007). 
 
1.1.2.1. The MEME suite 
MEME contains several modules that perform different types of motif analyses, 
starting from motif discovery to assigning a biological function (Figure 1.16 and 
Bailey et al., 2009). The following is a brief description of the main modules: 
 MEME (Multiple Expectation-maximization for Motif Elicitation): a 
probabilistic model-based motif discovery tool used to search in a set of 
input sequences for motifs that have a significantly higher than expected 
frequency of occurrence relative to random sequences. Significance is 
expressed as an E-value, “an estimate of the expected number of motifs with the given log 
likelihood ratio (or higher), and with the same width and site count, that one would find in a 
similarly sized set of random sequences”. The E-value is a Bonferroni corrected p-
value (p-value * number of possible similar motifs). 
 MAST (Motif Alignment and Search Tool): a search tool used to find the 
best matches for an input set of motifs in a set of sequences (Bailey and 
Gribskov, 1998). 
 FIMO (Find Individual Motif Occurrences): like MAST, but finds all motif 
occurrences meeting a significance threshold (Grant et al., 2011). 
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 DREME (Discriminative Regular Expression Motif Elicitation): an 
exhaustive enumeration-based motif discovery tool that identifies 
relatively short sequence motifs that are enriched in a given set of 
sequences compared to a control set (Bailey, 2011). 
 TOMTOM (Motif Comparison Tool): a search tool used to analyse 
discovered motifs by finding similar known regulatory motifs in databases 
such as JASPAR, TRANSFAC and UNIPROBE (Gupta et al., 2007). 
 GOMO (Gene Ontology for Motifs): finds the GO terms/categories that 
contain a significantly larger than expected number of genes with a given 
motif in their promoter sequence (Buske et al., 2010). 
 
Figure 1.16: MEME suite architecture model. Starting from input sequences, MEME 
provides different modules for identifying significant motifs and their potential function. 
The modules on the left target different types of input sequences, in terms of either the 
input size or certain other characteristics like the existence of gaps in the sequences. 
After identifying a set of motifs, further analyses can be performed using motif and GO 
databases. Each of these modules answers a different type of question, e.g., is a motif 
novel or known (TOMTOM), what potentially is the function of a motif (GOMO) and 
what is the degree of enrichment of a motif in a given set of sequences that is potentially 
distinct from the set in which the motif was found (FIMO). The box in the bottom left 
corner contains a very brief description for each module. Figure is from (Bailey et al., 
2009).  
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1.1.2.1.1. Multiple Expectation-maximization for Motif 
Elicitation (MEME) 
Recent releases of MEME introduced a new approach for motif discovery 
that involves the use of two datasets. The input sequences that are believed to 
contain interesting motifs are the (positive set), and they are evaluated relative 
to another set of sequences thought not to contain these motifs, the (negative 
set). This approach is called discriminative motif discovery (Bailey et al., 2010). 
It is vital to carefully select the suitable negative set that contain sequences 
similar in characteristic to the positive set, except for the feature that is being 
searched for. Failure in selecting the adequate negative set may result in 
inaccurate outcomes. 
The idea is to find the motifs that are significantly over-represented in the 
positive set compared to the negative set. The discriminative approach 
calculates Position-Specific Priors (PSP) for the positive and negative sets that 
are then provided as an additional input to MEME. For each sequence and 
position within the sequence, the PSP file contains the prior probability of 
finding any motif starting at that position (Bailey et al., 2010). MEME depends 
on these probabilities to guide the search toward the positions with a higher 
prior probability of finding a motif in the positive versus the negative set. 
MEME uses a background model of randomly evolving sequence (random 
relative to the input sequence sets). The background model depends on the 
observed frequencies of k-mers in the input sequences and is used to estimate 
the probability of finding a particular motif by chance in a randomly evolving 
input sequence set of the same size and k-mer composition as the actual set. 
The default background model used by MEME is of 0
th
 order (k= 1): the 
nucleotide frequencies for each position are independent of the nucleotides at 
prior positions. The experiments in this study used a 1
st
 order (k= 2) 
background model, which is more appropriate given the essential role of 
dinucleotides, especially CpGs, in the context of DNA methylation. 
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 MEME parameters 
MEME, probabilistic motif discovery tool, finds un-gapped motifs in a set 
of DNA sequences. It supports searching assuming any one of three motif 
distribution models: only one [motif occurrence] per sequence (OOPS), zero or 
one [motif occurrences] per sequence (ZOOPS) and any number of [motif] 
repetitions [per sequence] (ANR) (Figure 1.17). The different assumptions 
regarding motif distribution among the sequences affect the calculation of 
motif significance (e-value) and hence, the composition of the output list of 
motifs and their rankings. Specifically, only the number of motif occurrences 
consistent with the chosen model is taken into consideration for the e-value 
calculations.  Other basic parameters of MEME are summarised in Table 1.1. 
Table 1.1: Other MEME parameters and advanced features. Providing a negative set 
and a background model is optional (Bailey et al., 2009). n: the total number of 
sequences in the positive set. 
Parameter / 
Feature 
Description Default Values 
Training set 
Set of DNA sequences, also called 
the positive set 
/ 
Minimum motif 
width MEME will find the optimal motif 
width within these boundaries 
6 
Maximum motif 
width 
50 
Number of motifs 
Maximum number of reported 
motifs 
3 
Minimum number 
of sites 
Bounds on the number of motif 
occurrences in the training set 
OOPS: n 
ZOOPS: sqrt(n) 
ANR: sqrt(n) 
Maximum number 
of sites 
OOPS: n 
ZOOPS: n 
ANR: Min(5*n, 50) 
Negative Sequences 
Perform discriminative motif 
discovery. For more details, please 
refer to section 1.1.2.1. 
No negative set 
Background 
Markov model 
The degree of the generative model 
for random sequences. For more 
details, please refer to section 
1.1.2.1.1 
0-order Markov model, 
based on single letter 
frequencies of the 
training set 
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Figure 1.17: MEME motif distribution models. The OOPS model allows exactly one 
motif occurrence per sequence to be taken into account when calculating the motif e-
value. It is the most stringent, yet computationally most efficient and most sensitive 
model. ANR, on the other hand, permits any number of non-overlapping motif 
occurrence including zero. Although it is useful when the repetition of motif 
occurrences per sequence is significant, it is less sensitive to weak (motifs with low 
information content, expressed by average bits per position) motifs that do not occur 
multiple times in a single sequence and is computationally costly since all motif 
occurrences are evaluated. ZOOPS (the default) permits at most one motif occurrence 
per sequence to contribute to the e-value calculation, even if there are multiple 
occurrences. It is computationally more complex than OOPS and less sensitive to weak 
motifs that are present in all sequences. It is a good model when motifs are thought to 
be missing from some sequences (Bailey et al., 2009). Black lines represent the DNA 
sequences. The filled rectangles indicate the motif occurrences and their different 
colours reflect the different models.  
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1.1.2.1.2. Discriminative Regular Expression Motif Elicitation 
(DREME) 
This discriminative DNA motif discovery tool is specially designed to 
identify short motif that are enriched in the positive set when compared to a 
negative set. It follows an enumeration approach that exhaustively explores all 
occurrences of all possible k-mer sequences in the provided sets where k 
ranges between 3 and 8. DREME has been optimised for the discovery of all 
short, non-redundant motifs that significantly discriminate the potentially large 
sets of sequences, e.g., ChIP-seq data (NGS, section 1.1.3). DREME uses the 
Beam search algorithm that initially identifies a set of significantly enriched 
motifs and then attempts to create more general yet still significant forms of 
them (Bailey, 2011). 
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1.1.3. Next Generation Sequencing 
Next generation sequencing (NGS), the massive parallelisation of molecular 
methods of DNA sequencing, has enabled cost-effective, high throughput sequencing 
of DNA. Different platforms each optimising different aspects of DNA sequencing 
like, for example, read length, error rate, number of reads or total amount of 
sequence generated per run have been developed (Figure 1.18). NGS applications 
include the genomewide profiling of DNA methylation (BS-seq, RRBS-seq and 
MeDIP-seq), transcriptome sequencing (RNA-seq), and the identification of protein 
binding sites and histone modifications across the genome (ChIP-seq). 
 
Figure 1.18: Next generation sequencing platforms. Sample preparation of both 454 GS 
FLX pyrosequencing (a) and SOLiD (b) is similar; it involves ligating adaptors to DNA, 
immobilising the ligated products on beads, and then clonally amplifying them by PCR 
to boost the eventual output signal generated by fluorescence. Solexa GA or Illumina (c) 
uses ligated DNA immobilised on a glass slide and clonally amplified in place (cluster 
generation). The Heliscope (d) and Pacific Biosciences (e) platforms sequence single 
molecules, but are not widely deployed. For more details about each platform refer to 
(MacLean et al., 2009). Figure is from (MacLean et al., 2009). 
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There are many molecular tools for detecting DNA methylation patterns, reviewed 
in Zilberman and Henikoff (2007), for instance, bisulphite conversion, methylation-
sensitive restriction enzymes, methyl-binding proteins and monoclonal 5(h)mC-
specific antibodies. The integration of these tools with DNA microarrays or NGS 
provides high throughput techniques for genomewide, quantitative and high-
resolution DNA methylation profiling. The former and the later mechanisms 
(bisulphite conversion and monoclonal antibodies) are discussed in details in the next 
sections since some of the data used in this study were generated using them. 
 
 
1.1.3.1  MeDIP-seq 
Methylated DNA immunoprecipitation (MeDIP) is a technique for purifying 
methylated DNA fragments from a DNA sample via a monoclonal antibody that 
specifically recognises 5mC (Weber et al., 2005; Mohn et al., 2009). The 
monoclonal antibody will target methylated cytosine in any context. 
MeDIP is normally followed by either array hybridisation (MeDIP-Chip) or 
high-throughput sequencing (MeDIP-seq, Down et al., 2008). Data generated with 
DNA microarrays is limited to the regions of the genome that are represented by 
probes on the array, and the DNA methylation measurements are relative to a 
control (e.g., un-purified input DNA). In contrast, MeDIP-seq provides 
genomewide, quantitative measurements of methylation abundance (Zilberman 
and Henikoff, 2007), specifically the density of 5mC in a region. Therefore, a 
sparsely methylated, CpG-rich site yields similar measurements when compared 
with a fully methylated CpG-poor region. Down et al., (2008) develop a statistical 
tool for analysing MeDIP-seq data that can estimate absolute percent DNA 
methylation levels, across different CpG densities. 
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1.1.3.2  BS-seq and RRBS-seq 
 Our understanding of the distinct forms, patterns and functions of DNA 
methylation, in various cell contexts, has been refined recently by experiments 
employing techniques that allow genomewide, quantitative and single base-
resolution DNA methylation profiling. The standard sequencing techniques cannot 
distinguish methylated from un-methylated cytosine. However, via bisulphite 
conversion of DNA, specifically the conversion of un-methylated cytosines to 
uracil, the methylation state of cytosines can subsequently be determined by DNA 
sequencing (Figure 1.19). Current research efforts are focused on overcoming the 
fact that this technique cannot distinguish methylated from hydroxymethylated 
cytosine (Section 1.1.1.1.2). 
 
 
Figure 1.19: Bisulphite Conversion of DNA. The two strands of a DNA fragment are 
separated (denaturation) and then treated with sodium bisulphite, which converts un-
methylated cytosine into uracil. Performing polymerase chain reaction (PCR) will 
convert the uracil into thymine. After the bisulphite conversion, the DNA strands are no 
longer reverse-complementary. 
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After the bisulphite conversion, the nucleotide distribution is changed. There 
are more thymines (original thymines and converted un-methylated cytosines) and 
fewer cytosines (only the ones that were methylated remain). Sequencing a 
sufficiently large number of treated DNA fragments (Bisulphite Sequencing: BS-
seq) enables the quantification of methylation for a large fraction of the cytosines 
in the genome. One critical factor of the bisulphite conversion is the conversion 
efficiency. Low conversion efficiency has a consequence of an increase in false 
positive methylation calls in the downstream analyses, (Zilberman and Henikoff, 
2007). 
 Dedicated bisulphite-based protocols were developed to target specific 
sequences in the genome, particularly RRBS-seq (Reduced Representation 
Bisulphite sequencing), which results in data enriched for CpG-rich regions 
(Meissner et al., 2005). This protocol reduces the amount of sequencing required 
to, for example, determine the methylation levels of CpGs in CpG islands (and 
hence, cost), but read coverage outside CpG-rich regions, i.e., in most of the rest 
of the genome, is low. 
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1.1.3.3 RNA-seq 
Transcribed regions of the genome are not restricted to annotated genes as was 
previously thought. Transcription occurs throughout the genome and is linked to 
many other functional elements of the genome. Actually, recent studies suggest 
that 76% of the human genome is transcribed (Pennisi, 2012). Hybridisation-
based methods (reviewed in Wang et al., 2009) were initially used to quantify the 
transcriptome. However, low sensitivity due to high background noise levels and 
genome sequence knowledge-dependency are limitations of these methods that 
have motivated other approaches. 
Sequence-based approaches were developed to overcome some of these 
limitations. These approaches include Sanger sequencing of cDNA (reverse 
transcribed mRNA) or ESTs, serial analysis of gene expression (SAGE, 
Velculescu et al., 1995), cap analysis of gene expression (CAGE, Kodzius et al., 
2006), and massively parallel signature sequencing (MPSS, Brenner et al., 2000). 
Nevertheless, due to limited throughput, these methods could only be used to 
analyse a small portion of all transcripts, and it was difficult to distinguish 
different isoforms (Wang et al., 2009). 
The use of high-throughput sequencing provides an effective way to map and 
quantify the transcriptome on a genomewide level, a technique called whole 
transcriptome shotgun sequencing (WTSS or simply RNA-seq, Morin et al., 2008). 
RNA-seq (Figure 1.20) helps to reveal transcript information on multiple levels 
such as the expression level, transcript structure and occurrences of alternative 
splicing. RNA-seq can also be used to sequence the transcriptome of non-model 
organisms for which microarrays are not available (Wang et al., 2009). 
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Figure 1.20: Basics of RNA-seq. The mRNA sequence is converted into cDNA and 
sheared into fragments to which sequencing adaptor sequences are ligated. The 
fragments are sequenced from one or both ends, resulting in short sequence reads that 
can be aligned to a reference genome or transcriptome. Based on their alignment,  reads 
can be classified as either spanning a splice junction, being exonic or belonging to the 
poly(A) tail of a mature mRNA. The aligned reads can be used to generate a base-
resolution, quantitative gene expression profile. Figure is from (Wang et al., 2009). 
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1.1.3.4  ChIP-seq 
Owing to the rapid advance in sequencing technology, DNA-protein 
interactions have attracted major attention during the past few years. Uncovering 
the binding sites for specific DNA-binding proteins and the various histone marks 
on a genomewide scale has become more and more achievable. Chromatin 
immunoprecipitation followed by sequencing (ChIP-seq, Barski et al., 2007) is the 
whole-genome profiling of sequence-specific interactions between DNA and 
proteins that constitute the chromatin including DNA-binding proteins (non-
histone ChIP) and histone modifications (histone-ChIP). Figure 1.21 provides an 
overview of a ChIP-seq experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.21: Basics of ChIP-seq. ChIP-seq is used to identify sequences bound by 
DNA-binding proteins (non-histone ChIP) or in contact with particularly modified 
histones (histone ChIP). Treating cells with formaldehyde cross-links DNA-binding 
protein to DNA. The chromatin is split up into small fragments by, for example, 
sonication. The DNA-protein complex or the targeted histone mark is 
immunoprecipitated by specific antibodies, and the DNA is purified from the antibody-
bound chromatin fraction. The DNA fragments can be sequenced using any platform to 
identify the binding sites sequences. Figure is from (Park, 2009). 
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1.2. Study aims and objectives 
The reprogramming of epigenetic marks is a genomewide process and yet CpG 
islands (among a few other sequence classes, such as intracisternal A particle [IAP] 
elements) escape this overall trend. Nevertheless, not all CpG islands respond similarly; 
while the majority of them resist the global de novo DNA methylation establishment, 
around 1000 CpG islands acquire methylation in oocyte. What drives the methylation 
machinery to specifically these CpG islands remains poorly understood and what role 
the DNA sequence plays remain yet to be determined. This study concentrates on the 
latter, in an attempt to search for DNA sequence signals (such as short motifs) that may 
attract DNA binding proteins which in turn play specific roles in the epigenetic 
reprogramming at CpG islands during oogenesis and early embryogenesis. 
1.2.1. Oocyte transcription and de novo DNA methylation 
Recently, several whole-genome sequencing studies generated DNA methylome 
and transcriptome maps for different stages of mouse oogenesis and early 
embryogenesis. These and other data (BS-seq, RRBS-seq, RNA-seq and ChIP-seq) 
will be re-analysed and then used to classify the CpG islands into different classes 
according to their methylation state and transcriptional context. The correlation 
between gene-body DNA methylation and transcription initiated from upstream 
promoters will then be examined. 
1.2.2. Maintenance of the DNA methylation post fertilisation 
Immediately after fertilisation the genome undergoes rapid global de-methylation 
that is resisted by a subset of gDMRs (oocyte specifically-methylated regions) that 
maintain their DNA methylation during early development and in the somatic cells. 
At the same time, the respective un-methylated allele of the still intact gDMRs 
(permanent gDMRs) resists the genomewide de novo methylation wave at the time of 
implantation. The maintenance is performed by Zfp57/Kap1 protein complex that 
recognises and binds a methylated hexanucleotide (TGCC
m
GC) that has been 
recently identified by a ChIP-seq. A de novo motif search for TGCCGC will be 
performed along with other analyses of its coverage and density at permanent 
gDMRs. Moreover, the existence of a second (TGCCGC-like) player will also be 
explored. 
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1.2.3. DNA methylation establishment during oogenesis 
Only 4.5% of CpG islands become methylated during oogenesis, most of them are 
also un-methylated in sperm (maternal gDMRs). Whether the DNA sequence of this 
special set of CpG islands differs from other (un-methylated) CpG islands will be 
discussed. A DNA methylation establishment model for oocyte-methylated CpG 
islands via a specific DNA-binding protein is proposed and will be validated using 
two different motif finding tools; MEME and DREME. Another model that is 
specific to intragenic oocyte-methylated CpG island methylation establishment via a 
specific transcription factor driving the upstream promoter is also proposed and 
validated. 
CpG periodicity had been suggested as a DNA sequence feature that attracts the 
methylation machinery, represented by Dnmt3a and Dnmt3L, to specifically 
permanent gDMRs. This suggestion will be investigated through permutation testing 
and a generated CpG spacing distribution for each of the three CpG islands groups; 
permanent gDMRs, oocyte-methylated and oocyte un-methylated CpG islands. 
 
1.2.4. Protection against DNA methylation during oogenesis 
Previous studies discussed and proposed mechanisms through which the majority 
of CpG islands are protected from the genomewide changes during oogenesis and 
pre-implantation embryos. A comprehensive analysis will be performed on the DNA 
sequence of oocyte un-methylated CpG islands with the aim of identifying a 
discriminative ‘protection signal’ in their DNA sequence that may attract a specific 
protein complex that then protects the DNA sequence of the region, in cis, from 
acquiring methylation. 
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2. Chapter 2: Data Collection, Analysis, Classification, 
Annotation and Integration 
 
DNA methylation levels change dynamically during the epigenetic reprogramming in 
early embryogenesis and gametogenesis. While these marks will be reset in early 
embryo development to erase the methylation marks acquired in the parental germ-cells 
and to generate a totipotency state that is essential for producing all the different cell 
types in an organism, they will be reprogrammed during germ-cells development to 
reflect the sex of the embryo. 
Although these changes are genomewide, studying the CpG islands, in particular, is 
interested since they are exceptional case to the overall trend. Most of the CpG islands 
preserve their default un-methylated state and are not affected by either the erasure or 
the establishment of the DNA methylation. However, around 1000 CpG islands act 
differently than the rest of the CpG islands such that they acquire DNA methylation 
during oogenesis (most of them are gDMRs). Furthermore, among these 1000, around 
25 regions, all of them are gDMRs, resist post fertilisation changes and maintain the 
germ line acquired DNA methylation marks. The Smallwood et al., (2011) set of CpG 
islands (23,020) was used in this study. It was originally described in Illingworth et al., 
(2010). The coordinates of the Smallwood set of CpG islands are derived from the 
Illingworth set so that Smallwood CpG islands are smaller by 100bp at both ends, to 
have more precise coordinates. 
New sequencing techniques have resulted in the accumulation of large amounts of 
CpG islands-focused and genomewide data on DNA methylation, histone modifications 
and transcription at different stages of mouse oogenesis and early embryogenesis. These 
data provide valuable and comprehensive profiles to study the dynamic changes of 
DNA methylation and its association with transcription and histone marks, in particular 
at CpG islands, during the epigenetic reprogramming. Based on these data in the public 
domain, temporal profiles of epigenetic modifications and transcription at CpG islands 
were generated. 
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2.1 Calling the methylation state of CpG islands in the oocyte 
Recent genomewide high throughput sequencing studies assessed the DNA 
methylation levels of CpG islands during mouse oogenesis and in E8.5 embryos. 
Different techniques were applied, including BS-seq of DNA from fully grown oocytes 
(Kobayashi et al., 2012), RRBS-seq of DNA from growing oocyte (at d20 postnatal) 
Smallwood et al., 2011) and MeDIP-seq using whole E8.5 embryos derived from 
Dnmt3L-deficient oocytes (Proudhon et al., 2012). Based on the data for oogenesis, 
each CpG island with sufficient sequencing coverage was annotated as either 
methylated (methylation level >= 75%) or un-methylated (methylation level <= 25%), 
as detailed below and in Figures 2.1-2.3. Only 37% (8,567) of total CpG islands (23,020) 
have methylation data, due to the limited number of starting material (oocytes), and 
hence, only these were used in this study. The rest of the CpG islands were excluded. 
CpG island is considered with sufficient sequencing coverage if the data coverage 
exceeds 5 informative CpGs in total and 10% informative CpGs, where a CpG is 
informative if it is covered by more than 4 reads (Figure 2.1). 
 
 Methylated CpG islands: 
A CpG island was labeled as ‘oocyte methylated’ if its methylation level >= 75% 
in at least one of the two replicates of the GV stage oocyte paying attention, at the 
same time, that the CpG island is also not un-methylated (methylation level > 25%) 
in both of the two replicates. If there is no enough data at the GV stage to make the 
call, the CpG island at MII stage is checked, if its methylation level >= 75% then it is 
methylated, since methylation establishment completed at around the MII stage 
(Figure 1.14). To confirm the methylation call, and only keep the CpG islands with 
consistent methylation state, the CpG island should not be un-methylated 
(methylation percentage > 25%) according to Kobayashi et al., (2012) data (Figure 
2.2). Following these criteria, 1,031 oocyte-methylated CpG islands were identified, 
18 of them were permanent gDMRs. 
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 Un-methylated CpG islands: 
A CpG island was labeled as ‘oocyte un-methylated’ if its percentage of DNA 
methylation <= 25% in both GV stage oocyte replicates as well as the MII stage 
oocyte from Smallwood et al., (2011) data. It is important to check both time points 
(GV and MII) because if the CpG island is not methylated in GV it is not guaranteed 
that it is also un-methylated in MII (Figure 1.14). In addition, the CpG island should 
not be methylated (methylation percentage < 75%) according to Kobayashi et al., 
(2012) data for extra confirmation and consistency (Figure 2.3). 7,526 un-methylated 
CpG islands satisfy these stringent conditions. 
 
 
Figure 2.1: CpG island quality control for the RRBS-seq experiment by Smallwood et 
al. ICG (Informative CpG): covered by a minimum of five reads. ICG%: percentage of 
ICGs relative to the total number of CpGs in the island. QC: quality control. 
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Figure 2.2: Criteria for calling a CpG island methylated. CpG islands QC is determined 
as shown in Figure 2.1. MP: methylation percentage. WT: wild type. GV: germinal 
vesicle, MII: metaphase II. GV and MII samples from Smallwood et al., (2011), while 
the WT oocyte sample is from Kobayashi et al., (2012). 
  
  
68 
 
 
 
Figure 2.3: Criteria for calling a CpG island un-methylated. Abbreviations like in 
Figure 2.2. 
 
 
Methylation state in other tissues / developmental stages were also collected, 
including: sperm (Smallwood et al., 2011; Kobayashi et al., 2012), blastocyst 
(Smallwood et al., 2011; Kobayashi et al., 2012), ESCs (Kobayashi et al., 2012) and 
adult liver (Proudhon et al., 2012). Although, these data were not used in this study, 
they provide rich resource for further analyses (Table A.1). 
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2.2 Oocyte Transcriptome: mRNA-seq data analysis 
A recent study has demonstrated that transcription initiating upstream of a gene 
body-associated (intragenic) CpG island can cause the CpG island to become 
methylated in the oocyte (Chotalia et al., 2009). A subsequent genomewide study found 
a significant positive association between DNA methylation and CpG islands within 
transcriptionally active loci (Smallwood et al., 2011). To investigate this association in 
more detail, two mRNA-seq data sets for growing (d10, Smallwood et al., 2011) and 
fully grown (d35, Smallwood et al., 2011; 7-8 week wild type and 7-15 week Dnmt3L-
deficient Kobayashi et al., 2012) oocytes were re-analysed together, using the Tuxedo 
protocol as described in Trapnell et al. (2012). The tools that were used to analyse the 
mRNA-seq data are presented in Table A.2. 
The six samples from the two experiments (Table 2.1) were divided into two groups 
(early and late) to reflect the temporal association of gene activity with DNA 
methylation. The early group (d10 oocytes) represents transcription at the onset of the 
methylation establishment phase during oogenesis, while the late group (d35 and >7 
week oocytes) reflects transcription after the establishment of methylation. This division 
allows for comparisons of gene activity between the pre and post methylation 
establishment stages of oogenesis, though mRNA levels in the late samples are 
cumulative, i.e., a transcript may be present late in oogenesis even though the promoter 
has become inactive. Finally, a third, merged super-group was created from all samples 
to maximise data completeness, independent of the stage of oogenesis. Figures 2.4 and 
2.5 show detailed flow diagrams for the analysis protocol, which results in Oocyte 
transcriptome maps for three groups of mRNA-transcript data samples; pre and post 
methylation establishment and a combination of the two stages. 
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Table 2.1: Oocyte mRNA-seq data samples. PE: paired end. SE: single end. The 
number between parentheses in the ‘Trimmed bad bases’ column refers to the sequence 
length after trimming. 
Experiment Samples 
Total 
number 
of 
sequences 
Sequence 
length 
Trimmed 
bad bases 
Percent 
duplication 
Filter 
of bad 
reads 
Smallwood 
et al., 2011 
d10 PE 24421407 40 1-12 (28) 
71.17 % 
69.36 % 
/ 
d10 SE 19706072 40 1-12 (28) 63.91 % / 
d 35 SE 19398792 40 1-12 (28) 60.4 % / 
Kobayashi 
et al., 2012 
WT-1 SE 24838186 36 1-12 (24) 53.18 % 
<16 
quality 
score 
WT-2 SE 49612304 36 1-12 (24) 1 % 
<16 
quality 
score 
Dnmt3L-
deficient 
SE 
44529344 36 1-12 (24) 63.93 % 
<16 
quality 
score 
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Figure 2.4: mRNA-seq read data pre-processing and filtering. After checking the 
quality of the data, the first 12 bases were trimmed from each sequence in all samples. 
Kobayashi et al., (2012) data had to undergo another round of quality check to filter out 
the reads with < 16 quality score. The Fastx tool was used for both trimming and 
filtering the reads (Hannon Lab, http://hannonlab.cshl.edu/fastx_toolkit/). Average DNA 
fragment size for the PE data was estimated using Novoalign to be used as an input 
parameter by TopHat for proper read alignment. The orange cylinders represent the pre-
processed oocyte samples. 
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Figure 2.5: Summary work flow for mRNA-seq data analysis. The main tools that were 
used to analyse the mRNA-seq reads are TopHat (Trapnell et al., 2009), Cufflinks 
(Trapnell et al., 2010) and Cuffmerge (Trapnell et al., 2012). Dashed lines indicate 
applying the step for each data sample independently. TopHat (a tool that align reads to 
a reference genome to identify exon-exon splice junction) with specific parameters 
(Table 2.2) was used to align the pre-processed reads to the mouse reference genome 
(NCBI build 37), independently for each sample. Duplicates (identical alignments 
generated by distinct reads) were removed from d10 PE data but were kept for other SE 
data. Generally, it is difficult to distinguish PCR copies from valid, high coverage 
generated reads (biological duplicates), specifically if the read length was relatively 
small (theoretically, the maximum read depth at any point is twice the read length); 
hence keeping all the duplicates (including PCR’s) for a SE is better than removing 
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valid reads. However, in the case of PE reads most of the duplication percent comes 
from PCR and hence removing them will purify the reads. Transcripts were then 
assembled from the aligned reads, independently for each sample, using Cufflinks. The 
main outputs of Cufflinks are assembled transcripts in GTF format 
(http://mblab.wustl.edu/GTF22.html). No reference transcriptome was used at this stage. 
Hence, the assembled transcripts are pure reconstructions from the mRNA-seq reads. To 
generate the oocyte transcriptome for each of the early, late and merged sample groups, 
Cuffmerge was applied to the Cufflinks outputs for the respective samples, generating a 
single set of assembled transcripts per group of samples. The reference that was used is 
University of California Santa Cruz (UCSC, http://genome.ucsc.edu/) refFlat for NCBI 
mouse build 37. 
 
 
Table 2.2: TopHat alignment parameters for each mRNA-seq sample. Fragment size for 
PE data was estimated to be 88 using Novoalign, and was used, by TopHat, to calculate 
the mean inner distance between mate pairs (mate-inner-dist). Default values were used 
for the other parameters. 
Tool Parameter d10 PE d10/35 SE WT1/2/Dnmt3L-- 
TopHat 
Bowtie 1 1 1 
mate-inner-dist (88-28*2)=32 / / 
segment-length (28/2)=14 (28/2)=14 (24/2)=12 
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2.3 Promoter Region identification 
Determining the transcription start site (TSS) of the transcripts reconstructed from 
the mRNA-seq data is essential to the identification of oocyte-active promoters and the 
classification of CpG islands with respect to their location relative to transcripts (e.g., 
promoter-associated, intragenic etc.). The promoter region was defined as +/- 1kbp 
around the TSS of a stranded transcript for which Cufflinks was able to determine the 
strand of origin and hence, the direction of transcription (Figure 2.6). Cufflinks can 
assign strand information for multi-exonic transcripts by determining the donor/acceptor 
sites at a splice junction. However, for many mono-exonic transcripts, Cufflinks could 
not determine the strand. Therefore, both start and end of un-stranded transcripts were 
considered potential promoters (Figure 2.6). Only promoters with TSS label (belong to 
stranded transcripts) were used in the downstream analysis. 
 
 
 
Figure 2.6: Cartoon representation for the promoter region for both stranded and un-
stranded transcripts. Solid blue lines represent the transcripts. The region +/-1kbp 
around the TSS (bounded by vertical dashed light blue line) is the promoter. Horizontal 
dashed grey lines mark the extended region around the transcript. Vertical dashed 
orange lines mark the ends of the transcripts.  
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2.4 H3K4me3 ChIP-seq analysis 
As an additional confirmation of the activation state for oocyte genes, genomewide 
chromatin immunoprecipitation (ChIP) data for histone 3 lysine 4 tri-methylation 
(H3K4me3) in growing oocyte (d15) were re-analysed (Figure 2.7 and Smallwood et al., 
2011). Table 2.3 summarises the H3K4me3 samples. Although the number of starting 
cells/oocytes obtained was limited, the ChIP-seq data are good enough to investigate the 
overall association of the H3K4me3 mark with CpG island methylation as well as gain 
confidence when identifying the promoters of transcripts. 
 
Table 2.3: Oocyte H3K4me3 ChIP-seq samples. IP: H3K4me3 immunoprecipitation. 
Although the duplication levels were very high in the two IP samples, duplicates were 
retained when identifying H3K4me3 signals (Figure 2.7, second approach) since the 
data are single end, making it hard to distinguish PCR from biological duplicates. 
Experiment Samples 
Total number 
of sequences 
Sequence 
length 
Duplication level 
Smallwood 
et al., 2011 
Input 20,704,436 40 43.75 % 
IP1 24,436,914 40 91.77 % 
IP2 26,168,956 40 93.87 % 
 
Two analysis approaches were followed: one for assessing the quality of the 
H3K4me3 data, approach 1 in Figure 2.7, the other for identifying H3K4me3 signals, 
approach 2 in Figure 2.7. In approach 1, the USeq (Figure 2.8 and Nix et al., 2008) peak 
calling tool identified 31,865 peaks genomewide after filtering the mapped reads that 
overlap >= 50% with repeats, using a <50% false discovery rate (FDR) threshold, and a 
1kbp sliding window. The reason for using USeq because it exceeds other peak calling 
tools (http://seqanswers.com/forums/showthread.php?t=1039), in addition to prior positive 
experience when applying it to the MeDIP-seq data (Proudhon et al., 2012). 
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Figure 2.7: H3K4me3 ChIP-seq analysis work flow. Starting from the raw ChIP data 
(two IP samples and one input) several pre-processing steps were then applied to align 
(Novoalign) the reads, sort (Picard) and filter (SAM tools) the alignments. The selected 
minimum mapping quality was 10. The numbers 1 and 2 indicate the two analysis 
approaches that were followed. Duplicates were removed before applying USeq (1) for 
assessing the quality of the data genomewide, while duplicates were retained before 
applying HTSeq, DESeq and Limma (2) when identifying the H3K4me3 enrichment at 
specific regions (CpG islands and promoters). The diagram is colour-coded depending 
on the tools used. 
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Figure 2.8: Peak calling with USeq. Bed files (input, IP1 and 2) of mapped reads 
(output from pre-processing, Figure 2.7) are the main inputs (dashed grey boxes) to 
USeq. USeq functions are shown in blue. The outputs are bounded by dashed red lines. 
Tag2Point converts the bed files into binary mid-point format (PointData.bar). 
FilterPointData filters from PointData those reads that contain >=50% repeats (UCSC 
repeat masker track). ReadCoverage calculates per base coverage statistics and also 
generates a graph (bar files) for visualisation in the integrated genome browser (IGB; 
Nicol et al., 2009). PeakShiftFinder estimates the base pair difference between the 
sense and antisense ChIP-seq peaks. MultipleReplicaScanSeqs (MRSS) identifies 
enriched regions in the genome, using a sliding window. A peak shift of 150bp, a 
1000bp sliding window, and a <50% FDR thresholds were used. 
EnrichedRegionMaker combines neighbouring enriched windows identified by MRSS 
into larger enriched regions. Red arrows refer to the main functions that produce outputs. 
The red filled box contains the identified peaks and is used as input for the validation 
step. 
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2.4.1 Quality assessment based on USeq peaks 
Due to the low quantity of starting material, and the technical difficulties of 
applying ChIP-seq for H3K4em3 on limited number of oocytes, it was necessary to 
check the quality of these data genomewide before identifying the enrichment of 
H3K4em3 signals at specific regions (CpG islands). USeq identified peaks (Figure 
2.8) were validated using ENCODE/LICR (Bing Ren's laboratory at the Ludwig 
Institute for Cancer Research) H3K4me3 ChIP-seq data for mouse ESCs (GEO 
sample accession: GSM1000124). H3K4me3 in ESCs is the closest data found in the 
public domain, in terms of the cell type, for the validation of H3K4em3 in oocytes. 
The overlapping regions of these two data sets were determined using Galaxy 
(Blankenberg et al., 2010; Goecks et al., 2010). 
28% of USeq peaks with <50% FDR overlap with LICR peaks, while 63% of 
USeq peaks with <5% FDR overlapped with LICR peaks. Figure 2.9 illustrates the 
work flow diagram of the validation step. Next, the distribution of USeq peaks 
relative to the distance from the closest RefSeq gene was calculated (bar chart in the 
right bottom corner in Figure 2.9). 31% of the peaks lie within 5kbp of a gene. 54% 
of them were located within 0.5kbp of the TSS, and 74% within 1kbp. 
A 1000x permutation test was conducted to determine whether the observed 
distribution (bar chart in the right bottom corner in Figure 2.9) of USeq peaks 
relative to the distance from the nearest gene is significantly different from what is 
expected by chance. The positions of the 31,865 peaks identified by USeq were 
randomised using MATLAB
®
 (The MathWorks, 2011b), maintaining the same 
chromosomes and peak sizes. As for the actual (non-random) peaks, the number of 
randomised peaks that lie within a specific window (0.5kbp non-overlapping 
windows from 0 to 5kbp from the TSS) from the nearest gene was calculated, for 
each of the 1000 permutations. For each window, the counts were averaged over the 
1000 permutations. Comparing this average empirical null distribution with the 
distribution for the actual peaks revealed a significant difference specifically for the 
0-0.5 kbp and 0.5-1 kbp windows (Figure 2.10). This implies that H3K4me3 peaks 
identified by USeq (genomewide) are significantly enriched near the TSS of 
annotated genes relative to what is expected by chance. 
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Figure 2.9: Validation of USeq peaks. Light blue boxes represent USeq and LICR 
H3K4me3 peaks. The red filled box “Output/X_MRSS” is the output from the USeq 
EnrichedRegionMaker function (Figure 2.8), while the blue filled box is another 
function in USeq FindNeighboingGenes used to find the closest RefSeq gene within 
100kbp of USeq peaks. 
 
 
Taking all together, the high correlation between the high confidence USeq peaks 
(63% with <5% FDR) and LICR dataset despite the different cell types, and the 
relatively high co-localisation of H3K4me3 USeq peaks with the TSS of annotated 
genes provide more confidence in the quality of these data. Therefore, these data 
were used to analyse the overall association of H3K4em3 histone mark and the 
methylation state of CpG islands, in addition of using it as an additional confidence 
of promoter region identification. 
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Figure 2.10: Comparison between the observed and the expected number of peaks near 
RefSeq annotated genes. The light blue bars represent the actual number of USeq peaks 
while the purple bars represent the average number across 1000 permutations of the 
peak positions. Peaks that lie within each 0.5kbp window at a particular distance from 
the nearest RefSeq TSS were determined using USeq function FindNeighboingGenes 
(X-axis). 
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2.4.2  Identifying H3K4me3 signals at CpG islands and 
promoters 
Knowing that the data are good enough genomewide, despite the technical 
limitations while conducting the experiment, encourages the identification of 
H3K4em3 enrichment at specific regions. Reads over CpG islands and promoters of 
oocyte-expressed transcripts were counted using HTSeq (HTSeq, 2013). DESeq was 
used to normalise read counts for differences in sequencing depth between samples, 
to robustly estimate the variance of read counts between samples, and to variance-
stabilise and log-transform the read count data (Anders and Huber, 2010). 
Subsequently, regions enriched for H3K4me3 in the IP samples compared to the 
input were identified using Limma linear modelling of one factor ‘treatment’ with 
two levels ‘treatment’ (IP) and ‘control’ (input) (Smyth, 2005 and Figure 2.11). 
HTSeq counts how many reads map to a certain region (CpG islands or 
promoters). HTSeq uses three modes to map reads that overlap with more than one 
region: union (the default), intersection-strict and intersection-nonempty. For 
H3K4me3 reads, the union mode was used since it handles partial overlapping (while 
intersection-strict does not) and it also discards the reads that overlap more than one 
region (while intersection-nonempty does not) (HTSeq, 2013). Because reads were 
not strand-specific, the ‘stranded’ option was set to ‘no’. Otherwise, HTSeq would 
discard about half of the reads prior to counting. 
The mapped read counts are used by DESeq to create a count dataset using the 
function newCountSataSetFromHTSeqCount. The effective sample size was 
estimated by calling the function estimateSizeFactors, in order to normalise the read 
counts according to the read depth. This moves the samples onto a common read 
count scale to make them comparable (Anders, 2013). After normalisation, 
estimateDispersions function estimates the dispersion of read counts from the mean 
using a pooling method and a parametric data model (fitType= parametric; default) 
(Anders, 2013). To log-transform the read counts while accounting for the high 
variance in the regions with low counts, the varianceStabilizingTransformation 
function was applied. Finally, a linear model with two treatment samples (IPs) and 
one control (input) aiming to find the regions that are enriched in the IPs relative to 
the input was fit to the normalised counts using Limma (Smyth, 2005). 
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None of the statistical tests applied (either using DESeq or Limma) produced 
significant results after multiple testing correction, which was somewhat expected 
due to the large noise in the data. The enriched regions with H3K4me3 were defined 
as the regions having positive log-fold change for the IPs relative to the input based 
on the Limma analysis, which might produce high false positive rate. However, these 
false positives will not affect the subsequent analyses since H3K4me3 data were only 
used to study the overall association with the CpG islands methylation state and as an 
additional confirmation of the active state of genes in oocyte. 
 
 
Figure 2.11: Work flow for the identification of H3K4me3-enriched regions. Mapped 
reads were counted using HTSeq, in union mode and with the non-stranded option. 
Mapped reads (SAM format) for the H3K4me3 IP and input samples, the coordinates of 
CpG islands +/-1kbp, and promoter coordinates (separately for transcripts identified 
from the early, late and merged groups of RNA-seq samples) were the inputs to HTSeq. 
The normalisation and log-transformation of the counts was handled by DESeq. Finally, 
Limma was used to identify H3K4me3 enriched regions.  
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2.5 CpG island Classification 
CpG islands were classified according to their location relative to oocyte-expressed 
transcripts, and depending on H3K4me3 enrichment as defined above (Figure 2.12). 
 
2.5.1  Stranded transcripts: 
 Promoter associated (PA): CpG islands that overlap a 1kbp region (enriched in 
H3K4me3) around the TSS by at least 1bp, and H3K4me3 enrichment. 
 Intragenic (Intra): CpG islands that are located within a transcript, at least 1kbp 
distant from the TSS. 
 Distal intragenic (Dst-Intra): CpG islands that overlap the 1kbp region 
downstream from the end of the transcript. 
 
 
Figure 2.12: CpG island classification relative to a stranded transcript. PA: promoter-
associated in red. Intra: intragenic (gene body) in blue. Dst-Intra: distal intragenic in 
light green. Black lines represent the transcript, while grey dashed lines represent the 
extended region around the transcript. 
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Since the TSS of an un-stranded transcript (transcripts lacking information on the 
direction of transcription) is not well defined, most of the overlapping CpG islands were 
classified as end-associated (Figure 2.13). 
 
2.5.2 Un-Stranded transcripts: 
 Promoter associated (PA): CpG islands that overlap both ends of the transcript, 
and H3K4me3 enrichment. 
 Intragenic (Intra): CpG islands that are fully contained within a transcript, at 
least 1kbp distant from both ends. 
 End associated (EA): CpG islands that overlap +/- 1kbp region of either the start 
or end of the transcript. 
 
 
Figure 2.13: CpG island classification relative to an un-stranded transcript. EA: end-
associated. Other symbols have the same meaning as those in Figure 2.12.  
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2.6 CpG island and transcript database 
After analysing oocyte mRNA-seq and H3K4me3 ChIP-seq data, and classifying 
CpG islands according to their relative location to oocyte transcripts, these data were 
integrated into a database and used to create profiles for both CpG islands and oocyte 
transcripts. The following Figures (2.14-2.16) illustrate the database contents in 
simplified form, while the detailed class diagrams are presented in appendix B. 
 
Figure 2.14: Oocyte H3K4me3 database schema diagram (simplified). H3K4me3 
enrichments were identified using Limma (indicated by log fold change, raw and 
adjusted p-values, in purple) for the set of CpG islands (green), oocyte promoters (for 
the early, merged and the late groups of RNA-seq samples, in light blue) and UCSC 
known genes promoters (grey). The diagram was created using Creately online 
diagramming tool (http://creately.com/). 
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Figure 2.15: Oocyte-expressed transcripts database schema diagram (simplified). Using 
the Tuxedo protocol oocyte mRNA-seq data were analysed and oocyte-expressed 
transcripts were identified (light blue). Cufflinks produced several features, such as: 
Length: size of the transcripts. FPKM: isoform level relative abundance (Fragments per 
kilobase per million mapped fragments). Coverage: an estimation of read coverage 
depth. The overlapping CpG islands are shown in green and H3K4me3 enrichments that 
overlap the promoters of these transcripts are presented in purple. The diagram was 
created using Creately online diagramming tool (http://creately.com/). 
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Figure 2.16: CpG islands database schema diagram (simplified). ‘Promoter’: UCSC-
based classification of CpG islands according to Smallwood et al., (2011); Null: 
intergenic, 0: intragenic, 1 or more: promoter-associated CpG island. The set of CpG 
islands was overlapped with oocyte-expressed transcripts (light blue) and H3K4me3 
signals (purple). CpG islands were classified according to their methylation state (red) 
at different stages; oocytes, ESCs, E8.5 embryo and adult liver. Furthermore, they were 
also classified according to their location relative to oocyte-expressed transcripts into 
promoter-associated, intragenic, distal intragenic, intergenic and end associated (yellow). 
The diagram was created using Creately online diagramming tool (http://creately.com/). 
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2.7 Overall correlation patterns between CpG island 
methylation, transcription and H3K4me3 in oocytes 
Having created a database that integrates genomewide data sets from different 
sources on CpG island methylation, transcription and the H3K4me3 histone mark 
during oogenesis, overall patterns of correlation between these data sets were 
investigated, to check the data for consistency with previously reported observations, 
and to potentially refine these observations. H3K4me3 marks un-methylated CpG island 
promoters, in human ESCs, irrespective of the activation state of the gene (Deaton and 
Bird 2011). Analysing the correlation between the methylation state of CpG islands and 
the H3K4em3 histone mark in mouse oocytes shows that methylated CpG islands seem 
to be incompatible with H3K4me3, while being un-methylated has little predictive 
value in terms of H3K4me3, yet it is significant using Fishes’s exact test (p < 2.2 e-16, 
Figure 2.17) 
 
 
 
 
 
 
 
 
Figure 2.17: Negative correlation of the H3K4me3 mark and the CpG island 
methylation state in oocyte. 
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Previous studies reported associations of the CpG island methylation state and CpG 
island location relative to the 5’-end of a gene. Un-methylated CpG islands are 
associated with active gene promoters, while methylated CpG islands tend to occur in 
gene bodies (Deaton and Bird 2011; Smallwood et al., 2011). Figure 2.18 shows the 
association between the methylation state of CpG islands that overlap oocyte-expressed 
transcripts and their transcript-relative location. The majority (88%) of transcribed un-
methylated CpG islands (first bar) are promoter-associated (PA), while more than half 
(58%) of transcribed methylated CpG islands (third bar) are intragenic, which is 
consistent with what has been reported (Smallwood et al., 2011). Some CpG islands 
have an ambiguous classification (more than one label) such that a CpG island is PA as 
well as intragenic, relative to different transcripts (Figure 2.18 first and third bars). 
When purifying the groups of CpG islands by removing those with an ambiguous 
classification, PA un-methylated and intragenic methylated CpG islands gain an 
additional eight to nine percent share of the total, respectively (Figure 2.18 second and 
fourth bars). 
 
Figure 2.18: CpG island distinct classes; association between the methylation state of 
CpG islands and their transcript-relative location. PA: promoter-associated, Intra: 
intragenic, Dst-Intra: distal intragenic, EA: end-associated. T: transcribed. Unmethy, 
Methy: un-methylated and methylated CpG islands. Pure: there is no ambiguous 
classification. Number between parentheses shows the total number of CpG islands in 
the group. CpG island groups in second and forth bars are mutually exclusive ‘Pure’. 
  
90 
 
Introducing H3K4me3 marks in identifying PA CpG islands has a major effect 
specifically on methylated CpG islands. Most of the methylated CpG islands that 
overlap the TSS of a transcript do not co-localise with an H3K4me3 signal (Figure 2.17). 
Thus, adding H3K4me3 to the criteria for PA identification decreases the PA class share 
of methylated CpG islands, while the intragenic class increases its share by ~17%, 
Figure 2.19. 
These associations were also investigated in the context of the early and late oocyte 
transcriptome. The results overall were not significantly different (data not shown). 
Therefore, CpG island classifications based on the merged (early + late) oocyte 
transcriptome were used in downstream analyses. 
 
 
Figure 2.19: Distinct classes of CpG islands after adding H3K4me3 to the criteria for 
identifying PA CpG islands. Other symbols have the same meaning as those in Figure 
2.18. 
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The merged oocyte transcriptome does not cover all CpG islands; 34% of un-
methylated (total of 7,526) and 23% of methylated CpG islands (total of 1013) are not 
transcribed. These CpG islands were classified according to the UCSC Known Genes 
transcript annotation (Hsu et al., 2006). Figure 2.20 compares CpG islands that overlap 
with oocyte-expressed transcripts with those that do not. Note that CpG islands with 
ambiguous classifications as well as CpG islands that overlap promoters lacking an 
H3K4me3 signal in oocytes were excluded from the set of transcribed CpG islands. 
 
 
 
Figure 2.20: Oocyte transcriptome- and UCSC Known Genes-based CpG islands 
classification. U: un-transcribed. Inter: intergenic. Other symbols have the same 
meaning as those in Figure 2.18. 
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Depending on the data in the public domain for oocyte methylation (MeDIP-, BS- 
and RRBS-seq), transcription (mRNA-seq) and H3K4me3 histone mark (ChIP-seq), a 
comprehensive database (appendix B) that integrates these different factors was created 
allowing the investigation of the associations between these factors at CpG islands, in 
particular. Although the H3K4em3 data were noisy, the genomewide validation of USeq 
identified peaks suggests that the data are good enough to be used in overall association 
analyses. Indeed, adding the H3K4me3 mark to the criteria of identifying oocyte-
expressed promoters makes the association between being PA and un-methylated, and 
between being intragenic and methylated CpG island more significant (Figure 2.19). 
These associations highlight some exceptional cases of CpG islands, which their DNA 
sequence are being analysed looking for distinct characteristics, like sequence motifs, 
that can distinguish them from other CpG islands (Chapters 4, 5 and 6). To do so, an 
adequate motif finding tool needs to be selected (Chapter 3).  
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3. Chapter 3: Evaluation of Motif Discovery Tools 
The Zfp57/Kap1 protein complex was recently identified as being responsible for 
maintaining the DNA methylation at ICRs post fertilisation in mouse ESCs 
(Quenneville et al., 2011). TGCCGC is the consensus binding site for the Zfp57/Kap1 
protein complex. It was used as a positive control to evaluate different motif finding 
tools in terms of their ability to identify short DNA sequence motifs that are highly 
enriched but in a relatively small set of sequences. The successful tool, in identifying 
TGCCGC, will be used in searching for sequence motifs related to either DNA 
methylation establishment at oocyte-methylated CpG islands (Chapter 5) or protection 
from de novo methylation at un-methylated CpG islands (Chapter 6). Motif discovery 
tools vary in their initial assumptions and the underlying search methods (Section 1.1.2). 
MEME (Bailey et al., 2009) is one of the most commonly used motif discovery tools. 
Hence, it was the first choice to search for the TGCCGC motif in maternal ICR 
sequences. 
 
3.1  MEME fails to identify the Zfp57/Kap1 motif 
In an early attempt to detect the TGCCGC motif recognised by Zfp57/Kap1 de novo 
in the sequences of 21 maternal ICRs, the discriminative analysis feature of MEME was 
used. A set of 267 distinct CpG islands that like the ICRs become methylated in oocytes 
but lose methylation post fertilisation served as the negative set. While the MEME 
output contained Zfp57/Kap1-like motifs (Figure 3.1), none of them reached statistical 
significance, in contrast to homo-polymer (poly-A and poly-T) motifs that were 
reported as highly significant, even after repeat masking of the sequences. The figure 
also highlights the sensitivity of MEME towards repetitive elements hence, it is a good 
practice to mask these repeats before applying MEME. 
Different combinations of values for MEME search parameters were used in an 
attempt to identify Zfp57/Kap1 motif de novo, for example, with/without a background 
model derived from the negative set, with/without using the discriminative analysis, 
changing motif distribution model (ZOOPS, OOPS and ANR), changing the requested 
motif width, number of reported motifs and the E-value threshold (section 1.1.2.1.1). 
Despite these various trials, none was successful in detecting TGCCGC. 
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The subsequently identified small number of ICR sequences as well as the shortness 
of the Zfp57/Kap1 motif are likely reasons for MEME failing to report TGCCGC as a 
significant motif (see below). 
 
 
Figure 3.1: MEME results for comparing 21 ICRs with 267 oocyte-methylated CpG 
islands, either without (left) or with (right) repeat masking. Motifs with similarity to the 
Zfp57/Kap1 motif are highlighted. Used parameters are: Minimum motif width = 5, 
maximum = 25. Number of motifs = 20. Motif model distribution is ZOOPS. 
Background model is a first order model derived from the negative set. 
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3.1.1 CTCF Experiments 
During the early stages of this study, few experiments, using known CTCF 
consensus binding site (Martin et al., 2011), were conducted to evaluate the 
dependency of MEME reported motif E-value on its width (section 3.1.2), in addition 
to its correlation with the number of sequences in the positive input set (section 
3.1.3). Since these experiments were performed before having access to oocyte 
methylated CpG islands (Smallwood et al., 2011; Kobayashi et al., 2012) the input 
sequences were collected following different criteria. The positive set contained 19 
known ICRs while the negative set contained carefully selected sequences with 
similar characteristics to those in the positive set, but sequences that are not or are at 
least unlikely to be imprinted. Thus, the negative sequences (around 5000 sequences) 
were non-imprinted promoter-associated CpG islands that were extracted from the 
CpG islands identified in Illingworth et al., (2010). 
CTCF enriched sequences (19,921 * 20 bp) determined by ChIP-seq (Prickett et 
al., 2013) were used to evaluate MEME ability to find the CTCF binding motif using 
the OOPS or ZOOPS distribution model without a background model or a negative 
dataset. MEME found the known CTCF consensus motif (Martin et al., 2011) and 
reported it as a highly significant (Table 3.1).  These results raise a question about 
the ICR dataset: Given the small number of sequences and their relatively large sizes, 
can MEME at least in principle find a motif like the CTCF binding motif in the ICR 
dataset and under what conditions? 
To answer this question, ‘identical’ and ‘similar’ 20bp CTCF binding site 
sequences were inserted (one per sequence) randomly in 19 ICRs (excluding coding 
sequence; the rationale at the time of conducting this experiment was that coding 
sequence encodes proteins hence, it is less likely to also contain protein-binding 
motifs involved in the imprinting mechanism) which represents the positive set. Thus, 
only the positive set was manipulated, while the negative set and its 1
st
 order 
background model remained unchanged. The 20bp CTCF motif was found and 
reported as highly significant in two out of three experiments (Table 3.2 and Figure 
3.2), indicating that a small data set of large sequences does not in principle prevent 
MEME from finding a CTCF-like, relatively long motif. 
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Table 3.1: CTCF binding site experiments. (X_Y_Z_W) refers to parameters send to 
MEME per run; X: minimum motif width, Y: maximum motif width, Z: requested 
number of motifs to find, W: number of actual motifs found. The E-value of a motif 
indicates the number of expected occurrences of the motif in a random dataset of the 
same size and with the same background dinucleotide composition. 
Dataset Experiment Description MEME Result 
CTCF 
Binding 
Sites 
ZOOPS 
(6_20_10_1) 
Take the first 1,250 out 
of 19,921 CTCF 
enriched sequences 
E-value = 5.5e-7523 
OOPS 
(6_20_10_1) 
Take the first 300 CTCF 
enriched sequences * 
E-value = 4.7e-1970 
 
 
 
Table 3.2: CTCF binding site experiments for the 20bp identical or similar 
sequences. The number in parentheses indicates the width of the actual motif that 
was found. The terms are analogous to those in Table 3.1. 
Experiment Description 
Found 
Significant 
MEME Result 
OOPS 
(5_20_5_5) 
Identical 20bp CTCF 
Motif 
NO 
Motif 1: partial motif 
of width 9 with E-
value = 8.0 e-01 
(Figure 3.2, A) 
OOPS 
(5_30_5_5) 
Identical 20bp CTCF 
Motif 
Yes (20) 
Motif 1: 
E-value = 3.7 e-49 
OOPS 
(5_20_5_5) 
Similar 20bp CTCF 
Motif 
Yes (20) 
Motif 1: 
E-value = 4.8 e-30 
(Figure 3.2, B) 
  
 
 
 
 
 
* The maximum number of letters in the input sequence set using the OOPS distribution model on the MEME web 
site is 600 hence, 300 sequences is the maximum number of sequences that could be used in this experiment. 
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Figure 3.2: Sample set of identified planted CTCF motifs. (A) Nine bp motif found by 
MEME in OOPS (5_20_5_5) experiment with E-value 8.0e-001 instead of the full-
length 20bp CTCF motif. (B) Similar 20bp CTCF motif found in OOPS (5_20_5_5) 
with E-value 4.8e-030, from which different width prefixes were used to study the 
relationship between motif width and reported significance. 
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3.1.2 The effect of motif length on the E-value in MEME 
Prefixes of CTCF binding sites of different widths were randomly inserted in 19 
ICRs to study the relationship between the motif width and MEME ability to find the 
prefix and report it as significant (E-value < 1). The inserted motif prefixes widths 
ranging from 10bp to 19bp. The smallest motif that MEME could report with E-
value < 1 was 14bp (Table 3.3). 
Table 3.3: CTCF binding site experiments to study the relationship between motif 
width and E-value. The number in parentheses in the ‘Found with E-value <1’ column 
indicates the actual motif width found by MEME. The terms are analogous to those in 
Table 3.1. 
Dataset 
MEME 
parameters 
CTCF prefix 
length 
Found with 
E-value < 1 
Result details 
Positive set: 
known ICRs 
+ 
CTCF 
Binding 
Sites 
 
Negative set: 
non-imprinted 
promoter-
associated CpG 
islands 
 
OOPS 
(5_20_5_5) 
10bp NO 
Not among the 5 motifs 
reported by MEME. 
Smallest E-value = 
1.3e+011 
OOPS 
(5_20_30_30) 
10bp NO 
Reported by MEME as 
motif 6 of width 9bp with 
E-value = 2.3e+015 
OOPS 
(5_20_30_30) 
12bp NO 
Reported by MEME as 
motif 3 of width 13bp with 
E-value = 1.0e+010 
OOPS 
(5_20_30_30) 
13bp NO 
Reported by MEME as 
motif 3 of width 10bp with 
E-value = 1.1e+011 
OOPS 
(5_20_30_30) 
11 and 14bp 
(both of them were 
inserted to each 
ICR) 
11  NO 
 
Not among the 30 motifs 
reported by MEME 
14  Yes (13) 
Motif 2: 
E-value = 3.9e-001 
OOPS 
(5_20_5_5) 
15bp Yes (14) 
Motif 1: 
E-value = 2.1e-003 
 
OOPS 
(5_20_30_30) 
16, 17, 18 and 19 
bp (all of them 
were inserted to 
each ICR) 
16  Yes (15) E-value = 7.8e-017 
17  Yes (16) E-value = 4.0e-020 
18  Yes (17) E-value = 1.2e-022 
19  Yes (19) E-value = 1.2e-026 
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3.1.3  The effect of input sequence set size on the E-value in 
MEME 
To study the relationship between the size of the positive input set and motif E-
values, ‘similar’ 10bp (because this was the size that consistently not being detected) 
CTCF binding sites were inserted randomly in positive sets of different sizes. The 
additional sequences added to the positive set to increase its size were taken (and 
excluded) from the negative set. Therefore, for each experiment, new positive and 
negative sets as well as background models were created. In each time, 21 sequences 
were add to the positive set, and by increasing its size, the E-value for the inserted 
motif reported by MEME was decreasing (Table 3.4). 
 
Table 3.4: The impact of input dataset size on the motif E-value. The actual motif 
width found by MEME in all experiments was 9 instead of 10. This was due to the 
first base in the selected similar CTCF prefixes having low information content and 
hence, MEME did not include it as part of the motif. The terms are analogous to those 
in Table 3.1. 
MEME 
parameters 
Positive 
Set Size 
Negative 
Set Size 
Found with 
E-value<1 
Result details 
OOPS (5_20_30) 
19 5296 NO 
Reported by MEME as 
motif 6 of width 9 with E-
value = 2.3e+015 
40 5275 Yes (9) 
Motif 3: 
E-value = 1.0e-003 
61 5254 Yes (9) 
Motif 2: 
E-value = 4.1e-018 
82 5233 Yes (9) 
Motif 1: 
E-value = 3.2e-032 
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3.2  DREME successfully identifies the Zfp57/Kap1 motif 
Due to the inability of MEME in detecting short motifs in small dataset size, another 
motif finding tool was used. DREME (Bailey, 2011) module “Discriminative Regular 
Expression Motif Elicitation” was recently added to MEME suite (starting from MEME 
version 4.7.0). It follows exhaustive searching method to identify short enriched motifs 
and it has significantly identify TGCCGC, the next chapter will explain in details 
DREME trails in detecting the maintenance signal (Zfp57/Kap1 motif). 
 
3.3  Summary and Discussion 
Motif discovery tools differ in their ability of detecting DNA sequence motifs 
depending on motif width, input set size and repeats content. Zfp57 binds to small DNA 
sequence motif at a handful of CpG islands that maintain their DNA methylation post 
fertilisation and during early embryogenesis (Quenneville et al., 2011). The Zfp57/Kap1 
motif, TGCCGC, was used a positive control to assess the competence of different motif 
discovery tools to detect such a signal. The aim was to find a reliable tool that is capable 
of recognising short signals in a relatively small dataset of sequences. MEME was the 
first tool to be used due to its popularity. In several trials exploring different 
combinations of MEME parameter values, TGCCGC was not identified or reported as a 
significant motif in the set of ICR sequences for which TGCCGC is known to be a 
characteristic feature (Quenneville et al., 2011). 
Analysing the results of the two comparisons in Figure 3.1 indicates that MEME is 
sensitive to simple and low complexity repeats. Without repeat masking, most of the 
statistically significant identified motifs were repeats, while TGCCGC was reported as 
insignificant. Masking the repeats eliminated most of the repetitive motifs from the 
output and more incidents of TGCCGC-like motifs were reported, yet none as 
significant. 
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The length of the motif plays a major role, and also its homo-polymer content, but 
the exact criteria by which MEME assigns E-values are not clear. The CTCF 
experiments aimed to study the effect of motif width on MEME ability to identify the 
motif with a small E-value (< 1) in the context of the ICR data: small dataset size and 
long sequences. Only the OOPS motif distribution model was used since a single copy 
of the motif was inserted into each sequence in the dataset. Initially, identical 19 copies 
of the 20bp CTCF motif were inserted into the ICR set and then used as an input to 
MEME with a minimum motif length of 5bp and a maximum of 20bp. 
Unexpectedly, MEME could not find the inserted motif and instead found a motif of 
9bp with an E-value of 8.0e-001 (Table 3.2 and Figure 3.2.A). The experiment was 
repeated by changing the maximum motif width to 30 and this time, MEME found the 
motif with an E-value of 3.7e-49. There is no good explanation for this, since even if the 
motif width minimum and maximum boundaries were not inclusive, MEME should still 
find the 19bp motif instead of the full-length 20bp, but this was not the case. 
In reality, the instances of a motif would be similar instead of identical. Therefore, 
similar 20bp CTCF motifs were used and as expected, the E-value for these sequences 
was greater (less significant) than that for the identical motif instances (Table 3.2). In 
experiments using the artificially introduced known CTCF binding motif and prefixes of 
it of different widths, varying from 10bp to 19bp, an exponential relationship between 
planted motif width and MEME-reported statistical significance (E-value) was observed 
(Table 3.3). And yet, the minimum motif width that MEME could find with E-value < 1 
was 14bp. The conclusion from these experiments is that if there is a motif of 13bp or 
less in the ICR data, MEME will either not find it or it will not be considered significant. 
The study of the effect of the positive set size on motif significance showed that 
expanding the positive set size, even by a small number of sequences, significantly 
enhances MEME ability to detect relatively short motifs. The result in Table 3.4 
indicates an exponential dependency of reported significance on input dataset size. The 
CTCF protein is known to bind to 68% of the maternal ICRs (Prickett et al., 2013). 
However, since the known CTCF binding site motif was not found in the ICR set, unless 
it was artificially planted there, the explanation is either that the ICR sequences do not 
normally contain the canonical CTCF binding site motif, or the CTCF binding site motif 
does exist in the ICR set but due to its limited sensitivity, MEME did not find it. CTCF 
may also bind to maternal ICRs using a different, unknown motif.  
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4. Chapter 4: DNA Methylation Maintenance Post 
Fertilisation 
 
Immediately after fertilisation, the genome undergoes an active de-methylation 
process in which most of the DNA methylation is being erased. However, some regions, 
like ICRs, resist these genomewide changes. ICRs in particular retain their differential 
parental allele-specific methylation post fertilisation. DNA methylation marks at these 
regions are maintained by a specific protein complex called Zfp57/Kap1 that recognises 
a methylated hexanucleotide (TGCC
m
GC) in mouse ESCs (Quenneville et al., 2011). 
This sequence motif has been identified by overlapping then filtering ChIP-seq binding 
sites for three proteins: Zfp57, Kap1 and Setdb1 (Quenneville et al., 2011). As 
mentioned in section 3.2, the DREME de novo motif finding tool is able to detect the 
Zfp57/Kap1 consensus binding site. Here, DREME is applied systematically to compare 
the motif compositions of three distinct sets of CpG islands (including ICRs), each with 
a characteristic profile of DNA methylation during oogenesis and post fertilisation 
reprogramming. 
 
4.1 Dataset collection and comparisons 
The DNA sequences of oocyte-methylated regions that show differential, maternal 
allele-specific methylation post fertilisation and up to E8.5 mouse embryos were 
identified, utilising MeDIP-seq data (Proudhon et al., 2012). Throughout this study, 
these regions are being called primary permanent maternal-differentially methylated 
regions (PPM-DMRs) because their maternal methylation is established in the germ line 
and they remain imprinted post implantation. Table 4.1 contains the genomic 
coordinates of these regions. 
Three datasets of CpG island sequences were collected: a positive set of 28 CpG 
islands that overlap the permanent maternally imprinted regions (Table 4.1), a negative 
set of 1,013 oocyte-methylated CpG islands that lose their DNA methylation post 
fertilisation (Chapter 2 Figure 2.2), and another negative set of 7,526 oocyte un-
methylated CpG islands (Chapter 2 Figure 2.3). 
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Table 4.1: Genomic coordinates of the 23 primary permanent maternal-differentially 
methylated regions (PPM-DMRs). The coordinates are from Proudhon et al., (2012) 
(boundaries of significantly meC-enriched regions by MeDIP-seq). Kelsey ID: CpG 
island identifiers from (Smallwood et al., 2011). These CpG islands overlap the PPM-
DMRs and are methylated in at least one of the GV and MII oocyte samples from 
(Smallwood et al., 2011) or in the wildtype oocyte sample from (Kobayashi et al., 2012). 
Chromosome Start End Gene Name Kelsey ID 
chr10 12808823 12812542 Zac1 #10-56 
chr11 11924753 11927373 Grb10 #11-133 
chr11 22871199 22874744 U2af1-Rs1 #11-189 
chr13 47106262 47106763 AK008011 #13-310 
chr15 72638946 72641843 Peg13 #15-248 
chr15 96885270 96886284 Slc38a4 #15-703 
chr17 87524084 87525819 Socs5 #17-1073 
chr17 12933529 12936244 Igf2r/Air #17-72 
chr18 13130394 13133109 Impact #18-68 
chr2 152511620 152513915 Mcts2 #2-1310 
chr2 157384230 157387951 Nnat #2-1428 
chr2 157384230 157387951 Nnat #2-1429 
chr2 174119695 174127298 Nespas #2-1709 
chr2 174119695 174127298 Nespas #2-1710 
chr2 174119695 174127298 Nespas #2-1711 
chr2 174151206 174155152 Gnas-exon1a #2-1712 
chr6 30684874 30689459 Mest #6-140 
chr6 30684874 30689459 Mest #6-141 
chr6 30684874 30689459 Mest #6-142 
chr6 47974007 47975979 Zfp777 #6-242 
chr6 58855970 58857759 Nap1l5 #6-371 
chr6 4696114 4698664 Peg10 #6-8 
chr7 6681534 6684030 Zim2 #7-105 
chr7 135830911 135832795 Inpp5fv2 #7-1597 
chr7 150480004 150483196 Kcnq1ot1 #7-1779 
chr7 6083480 6084890 Zfp787 #7-86 
chr7 67148934 67150346 Snurf/Snrpn #7-980 
chr8 125387861 125390344 Cdh15 #8-1221 
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To find a DNA signal that is responsible for maintaining the DNA methylation at 
PPM-DMRs post fertilisation despite the active genomewide de-methylation process, 
discriminative motif finding analyses were performed. The first analysis compares 
PPM-DMRs with oocyte-methylated CpG islands. The second compares PPM-DMRs to 
oocyte un-methylated CpG islands. In principle, the enriched sequence signal in PPM-
DMRs compared to both negative sets should be the same. 
 
 
4.2 DREME significantly identifies TGCCGC in PPM-DMRs 
Comparing these sets with MEME produced similar results to those presented in 
section 3.1 (Table 4.2). However, applying DREME on the same sequence sets changed 
the results remarkably (Table 4.2). As shown in Figure 4.1, TGCCGC (first two motifs) 
is the most statistically significant motif identified by DREME (E-value = 2.0 e-16, 1.2 
e-10) when comparing PPM-DMRs with oocyte-methylated CpG islands. Notably, there 
are sharp drops in the significance level between the second and third motifs, that is, 
TGCCGC is an outlier when considering the distribution of e-values of the identified 
motifs (Figure 4.3, blue bars). DREME also succeeded in identifying TGCCGC in the 
other comparison of PPM-DMRs versus oocyte un-methylated CpG islands (Figure 4.2) 
with the same distinct E-value distribution (Figure 4.3, pink bars). 
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Figure 4.1: DREME results for the PPM-DMRs (28) versus oocyte-methylated CpG 
islands (1013) comparison. Motif: a regular expression representation of the motif in 
IUPAC format. Logo: continuous motif representation (y-axis is information content in 
bits) on the forward strand. RC: reverse complement. E-value: statistical significance 
measure. 
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Figure 4.2: DREME results for PPM-DMRs (28) versus oocyte un-methylated CpG 
islands (7526). Other terms are analogous to those in Figure 4.1. 
 
 
 
 
Table 4.2: MEME/DREME experiments for DNA methylation maintenance signal 
detection. Discriminative searching approach was used, in which positive and negative 
sets of DNA sequences were provided using two tools. Significant motif means E-value 
<= 0.05. The number between parentheses indicates the total number of sequences. The 
order of magnitude = - log10 (E-value). Results are summarised from Figures 4.1, 4.2 
and data not shown.  
Tool Positive Set Negative Set 
No. of 
significant 
motifs 
Smallest 
E-value 
Order of 
magnitude 
MEME 
PPM-DMRs 
(28) 
Oocyte-methylated 
CpG islands (1013) 
0 3.8 E-1 
1, -4, -5, -6,  
- 6, -7, -7 
DREME 
PPM-DMRs 
(28) 
Oocyte-methylated 
CpG islands (1013) 
12 2.0E-16 
16, 10, 4, 4, 
4, 4, 3 
Oocyte un-
methylated CpG 
islands (7526) 
3 3.0E-12 12, 4, 2 
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Figure 4.3: Distributions of DREME-identified motifs in PPM-DMRs versus oocyte-
methylated and oocyte un-methylated CpG islands. Results depend on Figures 4.1 and 
4.2. X-axis: E-value bins on a log10 scale, with text labels referring to the bin centres. Y-
axis: number of motifs with an E-value in the respective bin. PPM-DMRs: primary 
permanent maternal-differentially methylated regions (28). Methy: oocyte-methylated 
CpG islands (1013). Unmethy: oocyte un-methylated CpG islands (7526). 
 
 
 
Despite that TGCCGC is overrepresented in PPM-DMRs, it is present in (covers) a 
high proportion of oocyte methylated and un-methylated CpG islands (Table 4.3), 
which suggests that its mere presence is apparently insufficient for protection from de-
methylation post fertilisation. Nevertheless, the actual Zfp57/Kap1 binding sites (from 
Quenneville et al., 2011 ChIP-seq) specifically co-localise with PPM-DMRs (Table 4.3). 
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Table 4.3: Coverage of the Zfp57/Kap1 consensus binding site (TGCCGC) versus 
actual Zfp57/Kap1-binding events at CpG islands and their shores. The binding events 
were determined by ChIP-seq (Quenneville et al., 2011), and were counted if the centre 
of the ChIP-seq peak was <1 kbp distant from the centre of the CpG island. 
CpG islands Set TGCCGC Zfp57 ChIP-seq (distance < 1kbp) 
PPM-DMRs (28) 24 (86%) 22 (79%) 
PPM-DMRs_1kbp (28) 28 (100%) / 
Oocyte-methylated CpG 
islands (1013) 
440 (43%) 5 (0.5%) 
Oocyte-methylated CpG 
islands_1kbp (1013) 
593 (59%) / 
Oocyte un-methylated CpG 
islands (7526) 
4700 (62%) 1 (0.0%) 
Oocyte un-methylated CpG 
islands_1kbp (7526) 
5266 (70%) / 
 
 
 
Analysing the density of TGCCGC occurrences per 1kbp at PPM-DMRs, oocyte-
methylated and un-methylated CpG islands uncover a significant association with 
specifically the PPM-DMRs group (Figure 4.4). This indicates that the density of 
TGCCGC is indispensable discriminative feature that distinguishes PPM-DMRs from 
other CpG islands. 
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Figure 4.4: TGCCGC density per CpG island category with and without +/- 1kbp 
flanking sequences. The primary Y-axis represents density as occurrences per 1kbp, 
while the secondary Y-axis shows density relative to the background density in the 
whole mouse genome (NCBI build 37). 
 
 
 
 
4.3 Summary and Discussion 
Three datasets were collected and used to identify the Zfp57/Kap1 recognition site 
(TGCCGC). Applied to these sets, the MEME probabilistic motif finding tool could not 
identify TGCCGC as a significant motif (Table 4.2). The DREME motif discovery tool, 
on the other hand, successfully detected TGCCGC in PPM-DMR sequences (Table 4.2). 
This indicates that the Zfp57/Kap1 binding site can be found using de novo motif search. 
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DREME reported TGCCGC with notable E-value distribution (it is an outlier when 
considering the distribution of e-values of the identified motifs) in both comparisons; 
PPM-DMRs with other oocyte-methylated and un-methylated CpG islands (Figure 4.3). 
No other motifs were reported as significant as TGCCGC at PPM-DMRs, which 
suggests the absence of another (Zfp57/Kap1-like) DNA-binding protein (complex) that 
can also maintain the DNA methylation at PPM-DMRs post fertilisation. 
Although all the PPM-DMR regions with +/- 1kbp flanking sequences contain 
Zfp57/Kap1 motif, a large proportion of oocyte-methylated (59%) and un-methylated 
CpG islands (70%) also contain TGCCGC occurrences. TGCCGC needs to be 
methylated for the Zfp57/Kap1 protein complex to bind (Quenneville et al., 2011). This 
can explain why the protein complex does not bind to the motif occurrences in the un-
methylated CpG islands (given that the motif will not be methylated). Yet, it does not 
explain why the protein complex does not bind and/or maintain the DNA methylation of 
around 600 oocyte methylated CpG islands that also contain the recognition motif. 
Other than the coverage of different CpG island groups by the motif, its density 
(occurrences per 1kbp) was also analysed (Figure 4.4). TGCCGC density significantly 
distinguishes PPM-DMRs from other oocyte methylated and un-methylated CpG 
islands. These results propose that TGCCGC density is a distinctive feature for PPM-
DMRs and can play an essential role in attracting the Zfp57/Kap1 protein complex to 
the region which can explain the specific co-localisation of Zpf57/Kap1 actual binding 
sites and PPM-DMR regions (Table 4.3). 
Around 80% of the PPM-DMRs co-localise with Zfp57/Kap1 ChIP-seq peaks. 
However, there are some regions that do not overlap any peaks within a distance of up 
to 1kbp (Table 4.4), despite having a TGCCGC, and yet their DNA methylation is 
preserved. These cases can be easily explained by the incompleteness of the ChIP-seq 
experiments and/or differences due to cell types. 
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Table 4.4 shows other exceptional cases in which Zfp57/Kap1 binds to five oocyte-
methylated CpG islands and yet their DNA methylation is not maintained post 
fertilisation (Proudhon et al., 2012). In addition, an un-methylated CpG island at the 
Coro1c gene is bound by Zfp57/Kap1; the explanation might be that Coro1c is the 
parent gene of the imprinted retrogene AK008011 (Table 4.1). Therefore, probably the 
Zfp57/Kap1 peak at Coro1c is due to mis-aligned reads that actually originate from the 
methylated CpG island at AK008011. One possible explanation for all these cases is that 
the Zfp57/Kap1 ChIP-seq experiment was conducted in mouse ESCs rather than mouse 
oocytes (Quenneville et al., 2011). 
 
Table 4.4: Interesting cases of CpG islands that maintain their DNA methylation 
despite the absence of actual Zfp57/Kap1 binding and vice versa. 
CpG island Set 
Gene Name / CpG 
islands ID 
#TGCCGC 
#TGCCGC 
(+/- 1kb) 
Zfp57 ChIP-seq 
peak distance (bp) 
PPM-DMRs 
Commd1 0 2 825 
Slc38a4 0 1 N/A (2816360) 
Socs5 4 4 N/A (57783270) 
NNAT / #2-1429 1 2 N/A (1139) 
Nespas / #2-1710 0 5 987 
Nespas / #2-1711 7 8 N/A (3448) 
Gnas-exon1a 2 4 N/A (31419) 
Mest / #6-140 0 1 N/A (2062) 
Oocyte 
methylated 
N/A / #5-1460 2 2 109 
Gpr1 / #1-314 3 3 111 
Spred2 / #11-162 2 3 158 
Fkbp6 / #5-1239 2 3 182 
Zfp668 / #7-1575 0 3 953 
Oocyte un-
methylated 
Coro1c / #5-796 2 2 108 
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5. Chapter 5: DNA Methylation Establishment during 
Oogenesis 
 
5.1 Oocyte-methylated CpG islands lack characteristic DNA 
sequence motifs 
During the DNA methylation establishment in oogenesis, more than 1000 CpG 
islands become methylated (Smallwood et al., 2011; Kobayashi et al., 2012) during the 
de novo genomewide methylation wave, while other CpG islands remain un-methylated. 
What drives the DNA methylation machinery to these regions in particular, and what 
specifically the role of the DNA sequence is in the establishment of the methylation 
marks is incompletely understood. 
Quenneville et al., (2011) identified the consensus binding site of Zfp57/Kap1 
protein complex (TGCC
m
GC) that plays an essential role in maintaining the DNA 
methylation at PPM-DMRs post fertilisation (Chapter 4). The protein complex 
recognises and binds the TGCC
m
GC motif and maintains the methylation of the region 
in cis, a paradigm of the central role of a DNA sequence signal in epigenetic 
reprogramming. Therefore, the following hypothesis was proposed: the DNA sequence 
of oocyte methylated CpG islands contains a signal that, via, for example, signal-
specific DNA-binding of a protein, contributes to the establishment of DNA 
methylation in these regions (Figure 5.1). 
One aim was to identify DNA sequence motifs involved in DNA methylation 
establishment. To do so, the DNA sequence of 1,013 oocyte-methylated and 7,526 un-
methylated CpG islands were analysed, looking for potential recognition sites for DNA-
binding protein(s) in the methylated set of sequences. DREME motif finding tool 
(Bailey, 2011) successfully detected the TGCCGC motif de novo in PPM-DMRs, at 
levels of statistical significance (-log10 E-value) orders of magnitude higher than for any 
of the other identified motifs (Figure 4.3). Thus, DREME was used to specifically look 
for distinctive sequence motifs in methylated CpG islands with similarly extreme E-
values relative to the overall E-value distribution for all reported motifs. 
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Figure 5.1: DNA methylation establishment model at oocyte methylated CpG islands 
via recognition of a DNA sequence motif by a DNA-binding protein. Filled circles 
represent methylation, while the un-filled indicates methylation-free. CGI: CpG Island. 
 
This comparison of methylated versus un-methylated CpG islands did not uncover 
any significant (E-value <= 0.05) motifs in the DNA sequence of methylated CpG 
islands. However, a recent study has highlighted the importance of CpG island shores 
(Irizarry et al., 2009). In particular, the study reported that most of tissue-specifically 
methylated sequences were located outside the CpG islands and in their shores, 
suggesting that those sequences may play a role in targeting the methylation machinery 
to the region (Irizarry et al., 2009).  This motivated the expansion of the sequence motif 
search to include the +/- 1kbp flanking regions of the CpG islands. 
Including CpG island shores markedly changed the DREME results: 12 statistically 
significant motifs were identified, 11 of which contained TG dinucleotides and none 
contained a CG dinucleotide (Figure 5.2). However, the distribution of the E-values for 
the identified motifs (Figure 5.3, blue bars) was relatively continuous without outliers 
like the TGCCGC motif (Figure 5.3, red and green bars), which indicates that none of 
these motifs is truly characteristic of oocyte-methylated CpG islands (Table 5.1). 
The DNA sequences were then further expanded to include +/- 2kbp shores as 
defined in Irizarry et al (2009). Yet, while more motifs were identified, again, all but 
one contained TG dinucleotides, none contained CGs, and the E-value distribution was 
even more continuous than for +/- 1kbp shores (Table 5.1). 
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Figure 5.2: DREME results for the comparison of methylated CpG islands (988 
sequences) with un-methylated CpG islands (7,372), including +/-1kbp shores. Any 
overlapping sequences between the two sets were excluded and overlapping sequences 
within each set were merged. Other terms are analogous to those in Figure 4.1. 
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Figure 5.3: E-value distribution for DREME-reported motifs for three comparisons. 
The blue bars represent motifs that are enriched in methylated (988) relative to un-
methylated (7,372) CpG islands with +/-1kbp flanking sequences (Figure 5.2). The red 
and green bars represent the motifs enriched in PPM-DMRs (28) relative to methylated 
(1,013) and un-methylated (7,526) CpG islands, respectively. X-axis: E-value bins on a 
log10 scale, with text labels referring to the bin centres. Y-axis: number of motifs with an 
E-value in the respective bin. PPM-DMRs: primary permanent maternal-differentially 
methylated regions. Methy: methylated. Unmethy: un-methylated. 
 
In addition to the CpG island methylation state, other factors were introduced, 
hoping to enhance the motif search results. For instance, the CpG islands that do not 
overlap with oocyte transcripts were excluded. Then only methylated intragenic CpG 
islands were taken into consideration. And yet, none of these experiments revealed 
motifs anywhere near as characteristic as TGCCGC (Table 5.1). None of the motifs 
reported as statistically significant (E-value <= 0.05) stood out in terms of the E-value 
distribution, coverage or density. Other motif discovery tools that follow different 
underlying search algorithms, like MEME (Figure 5.4 and Table 5.2) and Scope 
(Carlson et al., 2007) were also used. Nevertheless, no significant distinctive motifs 
were detected in methylated CpG islands or their shores relative to un-methylated CpG 
islands. Scope results contained lots of CG-rich motifs and this was due to comparing 
CpG islands with the ‘default’ background that is composed of all mouse promoters. 
Because it was not trivial to customise Scope to use a proper background (un-
methylated CpG islands) Scope results were neglected. 
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Table 5.1: DREME experiments for testing the proposed model of a DNA methylation 
establishment signal (Figure 5.1). A discriminative search approach was used in which 
positive and negative sets of DNA sequences were provided. Significant motif means an 
E-value <= 0.05 (DREME default). The number between parentheses indicates the total 
number of sequences. P: positive, N: negative. Orders of magnitude (of statistical 
significance) = - log10 E-value. 
Experimental 
factors 
Positive set Negative set 
Number of 
significant 
motifs 
Top hit 
coverage 
Orders of 
magnitude 
Methylation 
State 
Methylated CpG 
islands (1013) 
Un-methylated 
CpG islands 
(7526) 
0 / / 
Methylated CpG 
islands +/- 1kbp 
(988) 
Un-methylated 
CpG islands +/- 
1kbp (7372) 
12: 
11-TG and 
0-CG motifs 
P: 56% 
N: 45% 
7, 6, 4, 3, 
3, 3, 2 
Methylated CpG 
islands +/- 2kbp 
(912) 
Un-methylated 
CpG islands +/- 
2kbp (7194) 
22: 
21-TG and 
0-CG motifs 
P: 60% 
N: 47% 
8, 7, 7, 6, 
6, 6, 5 
Methylation 
and 
Transcription 
State 
Methylated and 
transcribed CpG 
islands (799) 
Un-methylated 
and transcribed 
CpG islands 
(4931) 
0 / / 
Methylated and 
transcribed CpG 
islands +/- 1kbp 
(758) 
Un-methylated 
and transcribed 
CpG islands +/- 
1kbp (4850) 
19: 
19-TG and 
0-CG motifs 
P: 55% 
N: 41% 
9, 8, 7, 7, 
5, 5, 5 
Methylation, 
Transcription 
and Location 
Only “purely” 
intragenic 
labeled CpG 
islands were 
used 
Methylated, 
transcribed and 
intragenic CpG 
islands (463) 
Un-methylated, 
transcribed CpG 
islands (4931) 
0 / / 
Methylated, 
transcribed and 
intragenic CpG 
islands +/- 1kbp 
(434) 
Un-methylated, 
transcribed CpG 
islands +/- 1kbp 
(4856) 
16: 
14-TG and 
0-CG motifs 
P: 51% 
N: 35% 
6, 5, 7, 5, 
5, 5, 5 
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Figure 5.4: MEME results for discriminative and non-discriminative analyses. Left 
panel: MEME results for methylated, intragenic and transcribed CpG islands +/- 1kbp 
(434) relative to un-methylated and transcribed CpG islands +/- 1kbp (4,856). Right 
panel: the same positive data set without a negative set (non-discriminative comparison). 
The similarity between the two sets of motifs is presented in Table 5.2 below. MEME 
parameters were: minimum motif width: 5, maximum motif width: 25, maximum 
number of reported motifs: 20, motif distribution model: ZOOPS. A 1
st
 order 
background model (from the negative set) and a PSP file were also used in the 
discriminative analysis while only a 1
st
 order background model (from the negative set) 
was used for the non-discriminative analysis. 
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MEME results reported from the discriminative analysis (Figure 5.4, left panel) show 
significant motifs that cover a good portion (motif 3: 34% and motif 4: 41%) of the 
positive set (methylated, intragenic and transcribed CpG islands +/- 1kbp). However, 
before performing post identification analyses on any of the interesting (non-repetitive 
and high significant) motifs, particularly motifs 3 and 4, the analysis was repeated using 
the same parameter set except that no negative set was supplied (a non-discriminative 
search; Figure 5.4, right panel). The identified motifs in both comparisons were 
significantly similar (Figure 5.4 and Table 5.2). 
 
Table 5.2: Similarities between motifs that were identified by the discriminative and 
non-discriminative MEME analyses, respectively. 
Discriminative 
analysis 
Non-
discriminative 
analysis 
Discriminative 
analysis 
Non-discriminative 
analysis 
Motif 1 Motif 2 Motif 4 Motif 3 
Motif 2 Motif 1 
Motif 8 
(similar to 3) 
Motif 9 (RC) 
(similar to 4) 
Motif 3 Motif 4 (RC)   
 
The motifs that do not look like simple repeats (motif 3 and 4 from the discriminative 
analyses, Figure 5.4, left panel) were further investigated to determine its biological 
relevance. Overlapping these motifs with mouse chromosome 1 (Genome Reference 
Consortium Mouse Build 38) showed more than 70% co-localisation with mouse-
specific B1 and B2 retrotransposons. This indicates how sensitive MEME is towards 
repetitive elements as shown previously (Figure 3.1). Repeating the same comparisons 
after masking the repeats (Figure C.1) eliminate these motifs, as expected, and yet did 
not uncover any other significant motifs. 
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5.2 Promoters upstream of oocyte-methylated CpG islands 
lack characteristic DNA sequence motifs 
The search for sequence motifs in methylated CpG islands and their shores did not 
uncover a characteristic motif on par with TGCCGC in terms of absolute and relative, 
that is, relative to the other reported motifs, enrichment. However, a detailed study of 
the Gnas locus provided evidence that transcription through CpG islands is necessary to 
establish the DNA methylation marks in oocytes (Chotalia et al. 2009). Genomewide, 
there is a strong, positive association between CpG island methylation and a CpG island 
being intragenic relative to an oocyte-expressed transcript (Section 2.7 and Smallwood 
et al., 2011). The transcription has to be driven by oocyte-active promoters located 
upstream of the CpG islands. 
This idea moves the attention towards the upstream promoters of intragenic 
methylated CpG islands instead of the CpG islands themselves and their shores. And 
since transcription is necessary for methylation establishment at downstream CpG 
islands, the alternative hypothesis states that: transcription initiated from the upstream 
promoters of methylated CpG islands is driven by specific sequence motif(s) that may 
become a target for an oocyte transcription factor (Figure 5.5). 
 
 
Figure 5.5: Proposed model of DNA methylation establishment at intragenic, oocyte-
methylated CpG islands via a specific transcription factor binding site driving the 
upstream promoter. Without transcription, the CpG island remains un-methylated. 
Filled circles represent methylation, while empty circles indicate lack of methylation. 
CGI: CpG Island. TF: Transcription Factor. 
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The RNA-seq from two recent high throughout sequencing experiments of growing 
and fully grown oocytes (Smallwood et al., 2011; Kobayashi et al., 2012) were re-
analysed using the Tuxedo protocol as described in Trapnell et al., (2012). A ChIP-seq 
experiment for histone 3 lysine 4 tri-methylation (H3K4me3) in growing oocyte was 
also re-analysed to provide additional confirmation of the active state of promoters in 
oocyte (Smallwood et al., 2011). As mentioned previously, promoter regions were 
defined as +/- 1kbp around the TSS of the transcripts reconstructed from the merged set 
of all oocyte RNA-seq samples (Section 2.2). The TSS is defined as the start of the first 
exon of a reconstructed transcript. To be included in the analysis, a promoter region 
needed to overlap a CpG island and be H3K4me3-positive, to increase confidence in the 
region being an active promoter in oocyte. These criteria, while being stringent in order 
to reduce the number of false positives, resulted in enough promoter sequences for 
motif discovery (Table 5.3). 
To test the model proposed in Figure 5.5, that is, to detect DNA sequence motifs that 
are enriched in the upstream promoters of methylated CpG islands, the sequences of 
oocyte-active promoters located upstream of methylated intragenic CpG islands 
(OAPWMCGIs) were compared to oocyte-active promoters without methylated CpG 
islands downstream (OAPWoMCGIs). 
The results for comparing OAPWMCGIs with OAPWoMCGIs (+/- 1kbp from the 
TSS) using DREME did not uncover any significant motifs. Therefore, the motif search 
was extended to cover larger promoter regions, including sequence +/- 2, 4 and 5kbp 
from the TSS (Table 5.3 and Figure 5.6). 
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Table 5.3: Oocyte promoter set identification. The third column represents the number 
of promoters in each set after merging the overlapping regions and excluding the 
promoters that are common between the two sets. These numbers are for promoter 
regions of +/- 4kbp from the TSS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: DREME results for oocyte-active promoters with methylated CpG islands 
(OAPWMCGIs) versus oocyte-active promoters without methylated CpG islands 
(OAPWoMCGIs) comparison (promoter regions of +/- 4kbp from the TSS). 
   Promoter set      Condition 
Number of 
Promoters 
Oocyte Active Promoters With 
Methylated CpG islands 
downstream (OAPWMCGIs) 
 Each of these promoters contains an 
intragenic methylated CpG island in their 
gene body 
103 
Oocyte Active Promoters 
Without Methylated CpG 
islands downstream 
(OAPWoMCGIs) 
 Each of these promoters either has no CpG 
islands downstream or only has un-
methylated CpG islands downstream 
2,017 
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None of the reported motifs in OAPWMCGIs relative to OAPWoMCGIs were 
significant and characteristic, that is, were extremely significant relative to the other 
identified motifs (Table 5.4). The upstream promoters of PPM-DMRs were also 
collected and analysed, searching for any characteristic sequence motifs in these 
promoters in particular. No such motifs were identified (Table 5.4). 
 
 
Table 5.4: DREME experiments for testing the proposed model for DNA methylation 
establishment depending on a DNA sequence motif in the upstream promoters of 
methylated CpG islands (Figure 5.5). A discriminative search was performed with 
DREME. Significant motif means an E-value <= 0.05. The order of magnitude = - log10 
(E-value) 
Positive set Negative set 
Promoter region 
size in +/-kbp from 
TSS 
Number of 
significant 
motifs 
Order of 
Magnitude 
OAPWMCGIs OAPWoMCGIs 
1 0 / 
2 3 2, 2, 2 
4 
6 
(Figure 5.6) 
4, 3, 2, 2, 2, 
2 
5 8 
3, 2, 2, 2, 2, 
2, 2, 2 
PPM-DMRs OAPWMCGIs 
1 0 / 
2 0 / 
4 1 2 
5 0 / 
PPM-DMRs OAPWoMCGIs 
1 0 / 
2 0 / 
4 0 / 
5 0 / 
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5.3 Oocyte-specific transcription factors 
Having identified oocyte-active promoters motivated the analysis of oocyte-specific 
active promoters, irrespective of CpG island methylation, to identify DNA sequence 
motifs potentially recognised by oocyte-specific transcription factors. Oocyte-specific 
active promoters (OSAP) were defined as +/- 1kbp from the TSS of an oocyte-
expressed transcript, overlapping a CpG island and being H3K4me3-positive, while 
being at least 500bp distant from a reference (UCSC Known Genes) promoter on the 
same strand. Other oocyte-active promoters (OAP) that overlapped with or were within 
a distance of < 500bp from a reference promoter were not considered specific to oocytes. 
The discriminative motif search in OSAPs relative to OAPs uncovered 33 significant 
(E-value <= 0.05) motifs (Figure 5.7, and Figure C.5). None of these identified motifs 
were extreme outliers in terms of significance, yet the TOMTOM tool for comparing a 
motif with a database of known motifs was used to find known proteins with similar 
binding sites in the TRANSFAC mouse database (Wingender et al., 2000). 17 proteins 
were identified with a binding site that significantly (FDR < 5%) matched at least one 
identified motif and has a corresponding gene in mouse (Table 5.5). 
 
Table 5.5: TRANSFAC mouse proteins that have binding sites similar to the identified 
motifs in Figure 5.7. Similarity FDR threshold is <5%. Gene expression in oocytes was 
examined using the WAMIDEX web service (Schulz et al., 2008; if the gene was in the 
top 20
th
 percentile relative to other genes, then it is considered to be expressed in oocyte) 
Protein Name Mouse Gene Name Chromosome 
Expressed 
in oocyte 
AP2ALPHA Tfap2a (TF AP-2, alpha) chr13 No 
AP2GAMMA Tfap2c (TF AP-2, gamma) chr2 Yes 
AREB6 Zeb1 chr18 No 
CNOT3 Cnot3 chr7 Yes 
E2A Tcf3 (TF 3) chr10 No 
EKLF Eklf / klf1 (Erythroid krueppel-like TF) chr8 No 
FKLF Klf13 (Kruppel-like factor 13) chr7 GV, MII 
GKLF Klf4, (Kruppel-like factor 4) chr4 GV, MII 
HTF4 Tcf12 (TF 12) chr9 Yes 
MAZ Maz (Myc-associated zinc finger protein) chr7 MII 
MZF1 Mzf1 (Myeloid zinc finger 1) chr7 No 
NMYC Mycn (Neuroblastoma myc-related oncogene 1) chr12 No 
OBOX2 Obox2 (Oocyte specific homeobox 2) chr7 Yes 
PAX4 Pax4 (Paired box gene 4) chr6 No 
SP1 Sp1 chr15 Yes 
SP4 Sp4 chr12 No 
ZFP281 Zfp281 (Zinc finger protein 281) chr1 No 
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Figure 5.7: DREME results for the first 16 identified motifs in the oocyte specific 
active promoters (OSAP: 331 promoters) versus oocyte active promoters (OAP: 3,759 
promoters) comparison (promoter regions of +/- 2kbp from the TSS). 
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5.4 CpGs in oocyte-methylated CpG islands are not 
characteristically spaced 
Motif finding did not uncover any DNA sequence motifs that are characteristic of 
oocyte-methylated CpG islands, their shores or their upstream promoters. However, 
other DNA sequence features may play a role in the establishment of the DNA 
methylation at these regions. 
The DNA methyltransferases that are required for de novo DNA methylation in 
oocytes are Dnmt3a and Dnmt3L (Hata et al., 2002). They interact with each other by 
forming a tetrameric complex (Dnmt3L-Dnmt3a-Dnmt3a-Dnmt3L) with two active 
sites separated by one DNA helical turn, about 10bp, (Jia et al., 2007). Jia et al., (2007) 
observed, in vitro, that this complex preferentially methylates CpGs that are between 
eight to ten base pairs apart. Intriguingly, they also observed the same spacing pattern of 
CpG sites in 11 maternally imprinted murine DMRs but not at 10 randomly selected 
CpG islands from human chromosome 21. Based on these finding, Jia et al., (2007) 
suggest a Dnmt3a/L structure-based model for de novo DNA methylation specifically at 
DMRs in which CpG spacing is a key DNA sequence signal that guides this complex to 
its targets. 
In this section, CpG spacing and periodicity are analysed at PPM-DMRs, oocyte-
methylated and oocyte un-methylated CpG islands to determine whether they are part of 
the DNA sequence signal that attracts the methylation machinery to specifically PPM-
DMRs and/or oocyte-methylated CpG islands. In particular, the following hypothesis 
was tested: an 8-10bp CpG spacing is characteristic of PPM-DMRs and/or oocyte-
methylated CpG islands but not oocyte un-methylated CpG islands. 
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5.4.1 CpG pairs at 8-10bp distances in PPM-DMRs are as 
frequent as in oocyte un-methylated CpG islands 
Since CpG islands differ in length and CpG content, comparisons between CpG 
islands with respect to their distributions of pair-wise CpG distances requires the 
normalisation of observed frequencies by expected frequencies given the length and 
CpG content of an island. To date, there is no exact analytical solution to calculate 
the number of expected pairs of CpGs at a distance D in a sequence of length L 
containing N CpGs. A binomial distribution-based approximation gives good results 
for low CpG density regions. A binomial model permits sets of CpG positions within 
a sequence that are invalid in practise due to overlaps between CpGs. The number of 
invalid relative to valid sets is small for low CpG density regions. However, for 
regions with high CpG density, like CpG islands, the binomial approximations of 
expected frequencies deviate significantly from the actual expected values. For this 
reason, an empirical distribution of the expected number of CpG pairs at distances 
from 0 to 1000bp was generated for each CpG island from 1000 independent 
permutations of its nucleotides while maintaining the original frequencies of all 
dinucleotides (dinucleotide frequency-invariant DNA sequence shuffling; Altschul 
and Erikson, 1985). 
The CpG positions in each shuffled version of the sequence were recorded. From 
these positions, a pair-wise distance matrix was created. For each distance D from 0 
to 1000 or, if smaller, the length of the island L less two (the maximum distance 
between two CpGs in a sequence of length L is L-2), the number of CpG pairs was 
counted. For each distance D, the 1000 counts generated from the 1000 permutations 
of a sequence S form the empirical, expected distribution of the number of CpG pairs 
at distance D in S (Figure 5.8). 
Using the empirical distribution for S, the rank and corresponding empirical p-
value of the actually observed number of CpG pairs at distance D in S was 
determined. To test the significance of CpG pairs at distances between 8 and 10bp, 
the counts for these distances were added for each of the 1000 permutations of S as 
well as for the original sequence S. The empirical p-value for this range of distances 
was then determined as above (Figure 5.8). 
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Figure 5.8: The empirical, expected distribution of the number of CpG pairs and the 
calculation of the empirical p-value and observed/expected ratio at distance D in 
sequence S. The CpG counts for distances 8-10bp were added. 
 
Using a significance threshold of p < 0.05, the fraction of oocyte un-methylated 
CpG islands (~42%) that were significantly enriched with CpG pairs at distances 
between 8 and 10bp was larger than for PPM-DMRs (~36%) and oocyte-methylated 
CpG islands (~19%). In fact, for any significance threshold, the fraction of oocyte 
un-methylated CpG islands was always at least equal to and usually greater than the 
fraction of PPM-DMRs and oocyte-methylated CpG islands (Figure 5.9, top). 
Adding +/- 1kbp flanking sequence to the CpG islands markedly increased the 
fractions of enriched CpG islands for all three categories, but did not change the 
order among the categories (Figure 5.9, bottom). These results were recapitulated 
when approximate binomial models of the expected distributions were used, instead 
of the above empirical estimation of the expected distribution (Figure D.1). From 
above, CpGs at 8-10bp distances are enriched in PPM-DMRs, however to test if 
similar pattern is followed by other distances like, for example, 12-14bp, the 
empirical p-value for this range of distances was determined (Figure 5.10). 
Unexpectedly, the CpGs at 12-14bp distances were significantly depleted in PPM-
DMRs (only 3.4% of PPM-DMRs were significantly enriched with CpG pairs at 12-
14bp distances), while similar patterns were retained for oocyte-methylated and 
oocyte un-methylated CpG islands (Figure 5.10). 
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Figure 5.9: Cumulative empirical p-value distribution for CpG islands (top) and for 
CpG islands including the +/- 1kbp shores (bottom) for 8-10bp distances. X-axis: p-
value threshold for considering the observed number of CpG pairs at distances from 8 to 
10bp significant. Y-axis: cumulative relative frequency of CpG islands with p-values 
less than the threshold. The number between parentheses is the total number of 
sequences after merging overlapping sequences. The black dashed vertical line marks 
the significance threshold of p-value < 0.05. Two oocyte un-methylated CpG island 
sequences were excluded because they contain ambiguous nucleotide codes. 
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Figure 5.10: Cumulative empirical p-value distribution for CpG islands (top) and for 
CpG islands including the +/- 1kbp shores (bottom) for 12-14bp distances. Other terms 
are analogous to those in Figure 5.9. 
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5.4.2 A 9bp period in CpG spacing is present in 43% of 
PPM-DMRs 
Above, CpG pairs that are 8-10bp apart were shown to be enriched in both PPM-
DMRs and oocyte un-methylated CpG islands but not oocyte-methylated CpG 
islands. Below, whether other distances might distinguish CpG islands depending on 
their methylation state in oocytes is explored. From the permutation-generated 
expected distributions, the expected number of CpG pairs in sequence S at distance 
D, for each S and D, is derived by averaging the counts obtained from the 1000 
permutations of S (Figure 5.8). The expected number for S and D was used to 
normalised the number of actually observed CpG pairs at distance D in S, that is, 
observed over expected ratios (obs/exp) were generated (Figure 5.8). Finally, the 
obs/exp ratios for each distance D were averaged over all sequences in a CpG island 
category with L-2>=D where L is the length of the sequence, i.e., excluding 
sequences that are too short to contain CpG pairs at distance D. The obs/exp ratios 
were smoothed (twice) over a window of three distances for robustness. 
The obs/exp ratios for distances up to 200bp were generally greater for un-
methylated CpG islands than for methylated CpG islands (Figure 5.11). For 
methylated and un-methylated CpG islands, the obs/exp ratio did not show a periodic 
dependency on distance. The obs/exp ratio followed a global downward trend for all 
CpG island categories (Figure 5.11, bottom). For un-methylated CpG islands, the 
obs/exp ratio exhibited a slight peak centered at 6bp. There also was a peak in the 
case of methylated CpG islands, but centered at 8bp. In contrast, the obs/exp ratio for 
PPM-DMRs had clear peaks at distances 9, 18, 27 and 37bp, consistent with runs of 
up to five CpGs, each at a distance of between 8 and 9bp from the next, being 
enriched in specifically PPM-DMRs. 
Further analyses were performed to determine the origin of the peaks in the 
obs/exp ratio for PPM-DMRs (Figures 5.11). The obs/exp ratios were calculated and 
visualised for each PPM-DMR separately to see whether the previously observed 
peaks are a general pattern for all PPM-DMRs or a non-representative average due to 
chance and/or extreme cases (Figures D.2-5). Overall, the contribution of each PPM-
DMR to the obs/exp ratio pattern seems variable (Figure 5.12 and Table 5.6). 
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Figure 5.11: Average observed/expected ratio for distances up to 200bp per CpG island 
category. The top figure highlight the first 50bp distances, which contains the four 
enriched obs/exp peaks in PPM-DMRs (blue). Methylated CpG island group is shown 
in green, while the un-methylated group is in red. The black dashed horizontal line (at 
value 1) indicates no difference between the observed and the expected values. 
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Figure 5.12 
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Table 5.6: Summary of PPM-DMR obs/exp ratios (Figure 5.12). The columns indicate 
the enriched peaks in Figure 5.11. ‘Y’ indicates that the obs/exp ratio for a PPM-DMR 
is greater than the average obs/exp ratio. # represents the total number (out of 4) of 
peaks for which the PPM-DMR ratio is greater than the average. 
PPM-DMRs 9 18 27 37 # PPM-DMRs 9 18 27 37 # 
Ak008011  Y   1 Nespas_2795     0 
Cdh15     0 Nespas_463   Y Y 2 
Gnas-exon1a   Y  1 Nnat_239 Y Y Y Y 4 
Grb10 Y Y Y  3 Nnat_621     0 
Igf2r/Air Y   Y 2 Peg10     0 
Impact Y    1 Peg13 Y  Y Y 3 
Inpp5fv2 Y Y Y Y 4 Slc38a4 Y  Y Y 3 
Kcnq1  Y  Y 2 Snurf/Snrpn  Y  Y 2 
Mcts2     0 Socs5 Y Y  Y 3 
Mest_426 Y Y  Y 3 U2af1-rs1 Y Y Y Y 4 
Mest_452 Y Y Y Y 4 Zac1  Y Y  2 
Mest_742  Y Y  2 Zfp777   Y  1 
Nap1l5    Y 1 Zfp787     0 
Nespas_1348 Y    1 Zim2 Y Y Y  3 
 
 
The detailed look at the individual contributions of PPM-DMRs to the overall 
obs/exp ratio pattern (Figure 5.12 and Table 5.6) revealed that 13 PPM-DMRs 
contributed above average to each of the peaks/local maxima at 9, 18, 27 and 37bp. 
Six PPM-DMRs with obs/exp ratios greater than the average contain 0, 1, 2 or 3 
peaks, while only four PPM-DMRs (Inpp5fv2, Mest_452, Nnat_239 and U2af1-rs1) 
contain the 4 peaks. This distribution of PPM-DMRs can be modelled as a binomial 
distribution of p = 13/28, where p is the probability of success. However, the 
observed distribution is different than what is expected; there are more PPM-DMRs 
containing >= 3 peaks or <= 1 peak. The distribution also indicates that not all PPM-
DMRs contribute to the formation of these enriched peaks (36% of PPM-DMRs 
contain >= 3 peaks). 
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Excluding Inpp5fv2, Mest_452, Nnat_239 and U2af1-rs1 (that contain the four 
peaks) from the set of PPM-DMRs had no effect (very similar to the blue line in 
Figure 5.11) on the average obs/exp ratio (data not shown). Other PPM-DMRs 
therefore must also contribute to the average, seemingly 9bp-periodic obs/exp pattern, 
though individually, their obs/exp ratios have no periodic pattern or a pattern with a 
different period. 
To see whether there is a regular period in the spacing of CpGs in any of the three 
CpG island categories, auto-correlation coefficients (ACC) were computed (Figure 
5.13) from the (smoothed and de-trended) obs/exp ratios for distances between 5 and 
45bp and distances between 5+dD and 45+dD bp, for dD ranging from 0 to 40bp 
(Figure 5.13, top) and for distances between 5 and 105bp and distances between 
5+dD and 105+dD bp, for dD ranging from 0 to 100bp (Figure 5.13, bottom). The 
ACC plot for larger range of distances (200bp, Figure 5.13, bottom) becomes flatter 
due to the addition of more distances (beyond 40bp) that do not show any enrichment; 
i.e. the signals will be diluted. De-trending refers to the removal of the approximately 
linear, global downward trend in the obs/exp ratio seen in Figure 5.11 by replacing 
the obs/exp ratios with their residuals after linear regression. The global trend would 
otherwise distort the auto-correlation coefficients. 
Although the ACC for dD between 8 and 10bp for all CpG island categories were 
positive, they were small (< 0.2) (Figure 5.13). Overall, for dD > 10bp, the auto-
correlation coefficients, when they were positive, were also relatively small (< 0.4). 
PPM-DMRs exhibited multiple peaks at dD= 9, 17, 28 and 37, consistent with an 
average of 9.3bp period in CpG spacing (Figure 5.13, top). 
Similarly, the ACC for each PPM-DMR was calculated separately (Figures D.6-9 
and Table 5.7) to see if the majority of the PPM-DMRs exhibit a similar pattern to 
the overall average (Figure 5.13, top). Only 21% of PPM-DMRs contains >= 3 peaks, 
which suggest that these peaks are not a general pattern of PPM-DMRs  
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Figure 5.13: Auto-correlation coefficients derived from the smoothed and de-trended 
obs/exp ratios for each CpG island category. The ACC for distances up to 85bp shows 
four peaks (top) which become flatter when extending the distances up to 200bp 
(bottom). X-axis: base pair difference (dD) between the two distance ranges from whose 
obs/exp ratios the auto-correlation coefficient was computed. dD was varied from 0 to a 
maximum of 100bp. 
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Table 5.7: Summary of ACC for each PPM-DMR for distances up to 85bp. The 
columns indicate the dD at the enriched peaks in Figure 5.13. ‘Y’ indicates that the 
PPM-DMR has the peak in its ACC. # represents the total number (out of 4) of peaks. 
PPM-DMRs 9 17 28 37 # PPM-DMRs 9 17 28 37 # 
Ak008011 Y Y Y  3 Nespas_2795     0 
Cdh15  Y Y  2 Nespas_463   Y  1 
Gnas-exon1a   Y Y 2 Nnat_239 Y Y Y Y 4 
Grb10 Y  Y  2 Nnat_621     0 
Igf2r/Air Y Y  Y 3 Peg10     0 
Impact     0 Peg13   Y  1 
Inpp5fv2 Y    1 Slc38a4    Y 1 
Kcnq1ot1  Y   1 Snurf/Snrpn     0 
Mcts2    Y 1 Socs5     0 
Mest_426    Y 1 U2af1-rs1 Y Y Y Y 4 
Mest_452 Y Y Y Y 4 Zac1  Y Y  2 
Mest_742 Y  Y  2 Zfp777     0 
Nap1l5   Y  1 Zfp787   Y  1 
Nespas_1348   Y  1 Zim2 Y  Y Y 3 
 
 
 
Overall, CpG spacing was found to be variable across the different PPM-DMRs, 
irrespective of whether the obs/exp ratio or the auto-correlation coefficient was used 
to represent the data. This might be a consequence of having more than one dominant 
period in PPM-DMR sequences. Therefore, Fast Fourier transform (FFT) was 
applied on the smoothed and de-trended obs/exp ratios for distances from 5 to 68bp 
for each PPM-DMR (Figures D.10-13 and Table 5.8) and for the overall average 
(Figure 5.14). Fourier transform is used to decompose complex signals formed of 
multiple frequencies into simpler form that highlight these frequencies. 
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FFT of the average obs/exp ratio for all PPM-DMRs (Figure 5.14) shows two 
peaks one at 64bp (15.62Hz, sampling rate “1000” * [1/frequency]) and another one 
at 9.14bp (109.4Hz). The 64bp peak was neglected given the fact that the analysis 
was done for 64bp of data, specifically since the low frequencies change when up to 
128bp of data were used instead (data not shown), i.e., they are not robust. The FFT 
for each PPM-DMR (Table 5.8) was examined to see if it shows a frequency at 
109Hz with amplitude >= the amplitude of the 109Hz frequency in the average plot 
(Figure 5.14). 
 
 
Figure 5.14: Average frequency spectrum for the 28 PPM-DMRs with 1000 
sampling rate for the smoothed and de-trended obs/exp ratios for distances between 5 
to 68bp. The X-axis shows frequency in Hz (wave per second) and the Y-axis is the 
amplitude (power). Two frequencies are marked 15.62Hz and 109.4Hz. To convert 
frequency (Hz) into distance (bp) the following formula was used: distance (bp) = 
sampling rate * [1/frequency (Hz)]. 
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Table 5.8: Summary of PPM-DMRs frequency spectrum. ‘Y’ in the second column 
indicates that the PPM-DMR has a frequency at 109Hz. If yes, its amplitude is shown in 
the ‘Amplitude’ column. The ‘Y’ in the fourth column indicates that the PPM-DMR 
amplitude (for the 109Hz frequency) is >= the amplitude of the average frequency 
(blue). The second part of the table is a duplication of Table 5.6. Red represents PPM-
DMRs with no 109Hz frequency, while black represents those with 109Hz frequency 
but with lower amplitude than the average. 
PPM-DMRs 
Peak at 
9bp 
(109 Hz) 
Amplitude 
The Amplitude 
above the average 
amplitude (0.071) 
9 18 27 37 # 
Ak008011 Y 0.183 Y  Y   1 
Cdh15 / / /     0 
Gnas-exon1a Y 0.083 Y   Y  1 
Grb10 / / / Y Y Y  3 
Igf2r/Air Y 0.144 Y Y   Y 2 
Impact Y 0.078 Y Y    1 
Inpp5fv2 Y 0.104 Y Y Y Y Y 4 
Kcnq1 / / /  Y  Y 2 
Mcts2 / / /     0 
Mest_426 Y 0.181 Y Y Y  Y 3 
Mest_452 Y 0.538 Y Y Y Y Y 4 
Mest_742 Y 0.057 N  Y Y  2 
Nap1l5 Y 0.105 Y    Y 1 
Nespas_1348 Y 0.166 Y Y    1 
Nespas_2795 / / /     0 
Nespas_463 / / /   Y Y 2 
Nnat_239 / / / Y Y Y Y 4 
Nnat_621 / / /     0 
Peg10 / / /     0 
Peg13 Y 0.117 Y Y  Y Y 3 
Slc38a4 / / / Y  Y Y 3 
Snurf/Snrpn / / /  Y  Y 2 
Socs5 / / / Y Y  Y 3 
U2af1-rs1 Y 0.349 Y Y Y Y Y 4 
Zac1 / / /  Y Y  2 
Zfp777 / / /   Y  1 
Zfp787 Y 0.056 N     0 
Zim2 Y 0.201 Y Y Y Y  3 
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There is no strong correspondence between the peaks in the obs/exp (second part 
of Table 5.8) and the frequencies. Nnat_239, for example, contains the four peaks but 
the fast Fourier transformation does not show a peak at 109Hz frequency, it shows a 
frequency at ~ 220Hz (4.5bp) instead (Figure D.12). This is due to smoothing (low-
pass filtering) the ratios before applying FFT, which has the effect of removing high 
periods (like 9bp), therefore the low periods (like 4.5bp) pass. The 9bp period is a 
multiple of the 4.5bp; this is why the obs/exp ratio shows the four peaks. 12 PPM-
DMRs (Table 5.8, blue) have this frequency with amplitude >= the average 
amplitude (0.071), while 14 do not. Unexpectedly, excluding these 12 PPM-DMRs 
had little effect on the average obs/exp ratio, only the peak at 27bp becomes flatter 
(Figure 5.15). The same minor effect was shown even after, also, excluding 
Mest_742 and Zfp787 (Table 5.8, black) PPM-DMRs with 109Hz frequency but with 
amplitude less than the average (data is not shown). However, applying FFT on the 
obs/exp ratios after excluding these 12 PPM-DMRs eliminates the frequency at 
109Hz and highlights one higher and two other lower frequencies (Figure 5.16). 
 
 
Figure 5.15: Average obs/exp ratio for all 28 PPM-DMRs (blue line) versus PPM-
DMRs excluding the 12 that contain a 109Hz frequency with amplitude >= the average 
amplitude (red dashed line). 
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Figure 5.16: Average frequency spectrum after excluding the 12 PPM-DMRs that 
contain a 109Hz frequency with amplitude >= the average amplitude. Other identified 
frequencies are highlighted. Other terms are analogous to those in Figure 5.14. 
 
 
 
The observed/expected and the correlation coefficient for CpG islands with +/- 
1kbp flanking sequences show analogous pattern to the CpG island (Figure D.14). 
Similarly, the contribution of individual PPM-DMR sequences with shores is 
analogous to those without (Figure D.15).  
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5.5 Summary and Discussion 
Two DNA sequence motif-based models (Figures 5.1 and 5.5) of DNA methylation 
establishment at CpG islands during oogenesis were tested. The results indicate that 
neither oocyte-methylated CpG islands nor the promoters upstream of intragenic 
oocyte-methylated CpG islands contain a characteristic DNA sequence motif like 
TGCCGC, the recognition site for Zfp57/Kap1, is for PPM-DMRs. In particular, the 
core sequences of oocyte-methylated CpG islands did not contain any significantly 
enriched motifs (Table 5.1). Only when the CpG island shores were included, did the 
motif search identify significantly enriched motifs. However, there was no characteristic 
motif that stood apart in terms of the magnitude of statistical significance. The 
significantly enriched motifs in oocyte-methylated CpG islands identified by DREME 
are rich in TpG dinucleotides and devoid of CpGs (Figure 5.2 and Table 5.1). In 
addition to none of the motifs being characteristic, the lack of CpGs further reduces the 
likelihood that they are a recognition signal for the de novo DNA methylation 
machinery. The enrichment with TpGs on the other hand is consistent with the high 
mutation rate of methylated CpGs due to deamination (Hess et al., 1994), which via 
uracil leads to CpG to TpG substitutions. Given that oocyte-methylated CpG islands 
reside in a germ line, CpG to TpG substitutions are expected to spread and be fixed in 
the population over time. The identified motifs therefore are more likely traces of the 
consequence of accidental deamination over time than recognition sites.  
MEME motif finding tool was also used in an attempt to identify long significant 
motifs. The results for MEME discriminative analysis is similar to non-discriminative 
analysis (Figure 5.4) and most of identified motifs co-localise with mouse-specific B1 
and B2 retrotransposons (the DNA methylation establishment signal, if any exist, need 
not be specific to one mammalian species, but rather a general signal), and hence, when 
masking the repeats most of these motifs disappear. Yet, TOMTOM was used to identify 
similar known protein binding sites to MEME motif 3 and 4 in Figure 5.4 left panel. 
TOMTOM results (Figures C.2-4) are summarised in Table C.1. The notable hits are 
Esr1/2 and Esrrb which are expressed in oocyte. Esr1 is an activator transcription factor 
that is essential for reproductive development. 
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Not finding any significant motifs that support DNA sequence motif-based models 
for DNA methylation establishment moves the attention to other sequence-based 
features. CpG spacing was suggested as a signal that guides Dnmt3a/L complex to its 
targets therefore CpG spacing at different distances was examined. Figures 5.9 and 5.11 
show that un-methylated CpG islands have more CpGs overall (and at distances 8-10bp 
in particular) than methylated CpG islands, which was unexpected. Nevertheless, taking 
the structure of Dnmt3a/L tetramer and the deamination process into consideration 
makes the pattern seen in these figures more acceptable. The structure of Dnmt3a/L 
tetramer with two active sites separated by about 8-10bp allows the complex to 
methylated CpGs, at methylated CpG islands, that are separated by the same distance in 
one binding event. Furthermore, since methylated CpGs are more susceptible to 
deamination (Hess et al., 1994), methylated CpG islands are depleted with CpGs at 
these distances relative to un-methylated CpG islands as a consequence of being 
methylated by a complex with such a structure. This explanation is supported by the 
TG-rich motifs identified in methylated relative to un-methylated CpG islands (Figure 
5.2 and Table 5.1). 
Similar to oocyte un-methylated CpG islands, PPM-DMRs are also enriched in CpG 
pairs that are 8-10bp apart; however, CpGs at another short range of distances (12-14bp) 
are significantly depleted in PPM-DMRs opposite to the oocyte un-methylated CpG 
islands, which indicate that 8-10bp distances are special in PPM-DMRs. 
Adding CpG island shores to the CpG island sequences not only significantly 
increases the difference between methylated and un-methylated CpG islands it also 
increases the overall percentage of sequences with significant p-values (Table 5.9). This 
raises interesting questions related to the sequence content of the shores and the reason 
for their enrichment with CpG pairs at 8-10 distances. 
The authors in (Jia et al., 2007) observed an 8-10bp period in the spacing of CpGs 
specific to 11 maternally imprinted murine DMRs (Figure 4.b from Jia et al., 2007) 
relative to 10 CpG islands randomly select from human chromosome 21 (Figure 4.c 
from Jia et al., 2007). They essentially compared CpG islands with shores (the set of 
DMRs that was used) with just CpG island sequences. Following the same criteria, 
PPM-DMRs and methylated CpG islands both with +/- 1kbp flanking sequences were 
compared to un-methylated CpG islands without any additional sequences (Figure 5.17), 
which will inflate the periodicity seen in PPM-DMRs about 2-fold. 
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Table 5.9: Percentage of CpG island sequences with a significantly (p < 0.05) greater 
than expected number of pairs of CpGs 8-10bp apart. 
CpG island group 
Percentage of CpG 
island sequences 
Percentage of CpG island 
sequences including +/- 1kbp 
shores 
PPM-DMRs 36% 87% 
Methylated CpG islands 19% 56% 
Un-methylated CpG islands 43% 88% 
 
 
 
Figure 5.17: Cumulative empirical p-value distribution for a mix between CpG islands 
(un-methylated, red) and CpG islands with shores (PPM-DMRs, blue and methylated, 
green). Other terms are analogous to those in Figure 5.9. 
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The peaks shown in the average obs/exp ratio (Figure 5.11) that run up to five CpGs 
separated by a 8-9bp suggest a pattern of a degenerated sequence motif with the form of 
(CGN8CGN8CGN8CGN9CG). Such a motif, if exists, will not be identified by 
traditional motif finding tools. Nevertheless, if it exists, it is only presents in less than 
the half of the PPM-DMRs; therefore it is not a characteristic feature of the majority of 
these sequences. 
Analysing the average observed/expected ratio for CpG pairs at distances up to 
200bp uncover four peaks separated by 8-9bp period (9, 18, 27 and 37bp; Figure 5.11, 
blue line). These peaks are enriched in four PPM-DMRs (Inpp5fv2, Mest_452, 
Nnat_239 and U2af1-rs1, Table 5.6), however, excluding them did not change the 
overall average, which indicates that other PPM-DMRs contribute to the average pattern. 
Next, the auto-correlation coefficients were calculated at PPM-DMR sequences, 
individually and overall, to see if there is a regular period in the spacing of CpGs 
(Figure 5.13 and Table 5.7). Nevertheless, despite how the data were represented 
(obs/exp ratio or ACC) CpG spacing was found to be variable across the different PPM-
DMRs, probably due to having more than one dominant period (frequency). This lead to 
exploring the different periods (frequencies) in each PPM-DMRs using fast Fourier 
transform. 12 PPM-DMRs contain a frequency at 109Hz (~9bp period) with 
amplitude >= the average amplitude (Figure 5.14 and Table 5.8). Calculating the 
average obs/exp ratios after excluding these 12 PPM-DMRs had minor effect on the 
original pattern (Figure 5.15), however, the frequency spectrum for the set of PPM-
DMRs excluding these sequences removes the frequency at 109Hz (Figure 5.16). This 
suggests that the peaks seems to be enriched in the average obs/exp ratio are due to 
overlying of different frequencies enriched in different PPM-DMRs. Furthermore, 
although the 9bp period is present at significant proportion of PPM-DMRs (43%) it is 
not a general pattern of the majority of them. 
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6. Chapter 6: CpG island Protection from de novo DNA 
Methylation during Oogenesis 
 
An interesting, yet open, question is whether the DNA sequence plays a role in 
protecting the majority of CpG islands from acquiring DNA methylation during 
methylation establishment in germ line and pre-implantation embryos. Previous studies 
have proposed different mechanisms through which the DNA sequence of un-
methylated CpG islands can be resistant to genomewide changes during oogenesis and 
early embryogenesis. For instance, Bird (2002) suggested transcription initiation as a 
necessary process for maintaining the un-methylated state of CpG island promoters. On 
the other hand, Takeshima et al., (2009) and Deaton and Bird (2011) reported that the 
presence of specific signals, such as: RNA polymerase II, H3K4me3 and Cfp1 are 
associated with DNA methylation resistance. 
According to the proposed mechanism of methylation establishment in the oocyte 
(Chotalia et al., 2009), a CpG island needs to be in an active gene body (intragenic) to 
gain methylation. However, a set of around 250 intragenic CpG islands maintain their 
default un-methylated state. 
This set of CpG islands motivated the search for a 'protection signal' in their DNA 
sequence that may attract specific proteins, which in turn may protect these regions 
from acquiring DNA methylation. This chapter investigates the possibility of having a 
TGCCGC-like motif in the DNA sequences of this distinct set of CpG islands.  
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6.1 A CG-rich sequence motif is a DNA characteristic feature 
of un-methylated CpG islands in the oocyte 
As discussed in chapter 4, the Zfp57/Kap1 consensus binding site was used as a 
positive control to enable the selection of a motif finding tool that can identify short 
enriched motifs. The DREME discriminative motif search could successfully detect 
TGCCGC in a small set of sequences. The aim here is to identify DNA sequence motifs 
with similar characteristics to TGCCGC in terms of the E-value distribution, coverage 
and/or density that are specifically enriched in un-methylated CpG islands. 
The DNA sequence of about 250 intragenic un-methylated CpG islands was analysed 
using DREME. Among 118 statistically significant (E-value <= 0.05) identified motifs, 
a single hepta-nucleotide motif with 2-3 consecutive CpGs was reported as 
exceptionally significant (Figures 6.1 and 6.2), analogous to TGCCGC. However, 
unlike TGCCGC, the motif is characterised by a high coverage of the positive sequence 
set (un-methylated CpG islands) rather than a particularly high density (Figures 6.3 and 
6.4). 
Since this motif contains ‘repetitive’ CGs, the same motif analysis was applied on 
the sequences after masking the repeats using the data in the UCSC repeat masker track. 
Repeat masking did not qualitatively change the results (Figure 6.5). A CG-rich motif 
with a core sequence (CGCGC) identical to the original motif was identified as 
significantly enriched (both versions of the motif are variable in their first and/or last 
positions), and it again constituted an extreme outlier with respect to the E-value 
distribution of all significantly enriched motifs. This shows that the enrichment of the 
CG-rich motif is not due to repetitive elements in the un-methylated CpG islands. 
Furthermore, the coverage and density of this motif across the different groups of 
CpG islands indicate that the motif is associated with the methylation state of the CpG 
islands rather than their transcript-relative location (Figures 6.3 and 6.4).  A question 
that remains, given the high CpG content of the motif, is whether this association can be 
explained by the overall higher CpG density of un-methylated CpG islands. 
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Figure 6.1: Motifs reported by DREME as the most significantly enriched in the set of 
intragenic un-methylated CpG islands (259) compared to the set of intragenic 
methylated CpG islands (545). The CG-rich motif (MCGCGCS; the first motif) is the 
most significant motif with an extremely small E-value relative to the other reported 
motifs (Figure 6.2). 
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Figure 6.2: Similarity between the E-value distributions resulting from the de novo 
motif searches that identified the CG-rich and TGCCGC motifs. The blue bars represent 
the E-value distribution of the identified motifs when comparing un-methylated with 
methylated CpG islands. The CG-rich motif is the short bar in the bottom-left corner, 
reported as nine orders of magnitude more significant than any of the other identified 
motifs. Red and green bars refer to the distribution of E-values for TGCCGC among 
other identified motifs in two comparisons: PPM-DMRs with other oocyte-methylated 
(red) and un-methylated (green) CpG islands. Similarly, TGCCGC was six to eight 
orders of magnitude more significant than any of the other reported motifs. 
 
 
 
Figure 6.3: Coverage statistic for the CG-rich motif per CpG island category (x-axis). 
The y-axis represents the percentage of CpG islands containing at least one occurrence 
of the motif. The number between parentheses shows the total number of sequences in 
each CpG island group. TMI: transcribed methylated intragenic CpG islands. TUMI: 
transcribed un-methylated intragenic CpG islands. 
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 Figure 6.4: Density of the CG-rich motif per CpG island category (x-axis). The 
primary y-axis (left) represents the absolute number of motif occurrences per 1Kbp, 
while the secondary y-axis shows the number of motif occurrences per 1Kbp relative to 
the whole mouse genome (NCBI build 37). Other terms are analogous to those in Figure 
6.3. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5: DREME-reported motifs for intragenic un-methylated CpG islands 
compared to intragenic methylated CpG islands after masking the repeats. Similar to 
Figure 6.1, the CG-rich motif (the first motif) is the most significant identified motif. 
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6.2 The CG-rich motif is not a consequence of the relatively 
high CpG density of un-methylated CpG islands 
The main sequence characteristic of CpG islands is a high CpG density relative to 
other regions in the genome. This likely explains the generally much higher density of 
the CG-rich motif in CpG islands relative to the whole genome (Figure 6.4, secondary 
y-axis). However, oocyte-methylated CpG islands are relatively CpG-deficient (Figure 
6.6), presumably due to the high rate of conversion of methylated CpGs to TpGs by 
deamination (Hess et al., 1994). This may explain the over-representation of the CG-
rich motif in specifically un-methylated CpG island sequences. Overall, CpG density 
and the CG-rich motif density show a similar pattern across different CpG island groups 
(Figures 6.4 versus 6.6) 
 
 
Figure 6.6: Density of the CpG per CpG island category. Overall density pattern is 
similar to the CG-rich motif density pattern. Other terms are similar to Figure 6.4.  
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If the CG-rich motif is a consequence of the high CpG density of un-methylated CpG 
islands then the expectation is that shuffling of their sequences, while preserving di-
nucleotide frequencies, will not significantly alter the density and/or coverage of the 
motif. Each sequence of the 7,526 sequences of un-methylated CpG islands was 
shuffled once using the Altschul-Erikson algorithm that maintains all dinucleotide 
frequencies (Altschul and Erikson., 1985). Two un-methylated CpG island sequences 
were excluded before shuffling because they contain ambiguous nucleotide codes. 
After shuffling, the total number of motif occurrences in un-methylated CpG island 
sequences was reduced by 45% (from 20,927 to 11,625). Moreover, the distribution of 
the number of motif occurrences per un-methylated CpG island sequence is different 
from the distribution that is expected to occur by chance, i.e., when the sequences have 
been shuffled (Figure 6.7). 
 In particular, comparing the coverage and density of the CG-rich motif between the 
original and the shuffled sequences revealed a significant reduction of both in the 
shuffled sequences, despite the identical CpG density of both sets (Figure 6.8). 
Therefore, high CpG density in un-methylated CpG islands can be ruled out as the cause 
of the enrichment of un-methylated CpG islands with the CG-rich motif. 
Figure 6.7: Relative distribution of the number of occurrences (x-axis) of the CG-rich 
motif in un-methylated CpG islands (dark blue) and in sequence-shuffled un-methylated 
CpG islands with identical CpG densities (pink). The number between parentheses 
shows the total number of sequences. 
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Figure 6.8: Coverage (left) and density per 1Kbp (right) of the CG-rich motif in un-
methylated versus un-methylated but sequence-shuffled CpG islands. The y-axis in the 
coverage figure represents the absolute percentage of CpG islands containing at least 
one occurrence of this motif. The y-axis in the density figure represents the number of 
motif occurrences per 1Kbp. The difference between un-methylated and shuffled un-
methylated CpG islands in both figures is significant (p < 2.2 e-16; Fisher’s exact test).  
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6.3 The CG-rich motif is not a consequence of locally high 
CpG density in un-methylated CpG islands 
Despite the fact that the CG-rich motif contains 2-3 consecutive CpGs, its 
enrichment in un-methylated CpG islands cannot be explained by their relatively high 
overall CpG density. However, the CpG density within an island is not typically 
uniform. Hence, the occurrence of the motif still may primarily be due to high CpG 
density, but limited to the immediate vicinity of the motif occurrence. To investigate 
this possibility, the CpG density in the +/- 10bp regions surrounding the motif 
occurrences was examined in the original as well as the shuffled un-methylated CpG 
islands. The CpGs in motifs occurring in the examined regions were masked, that is, 
they were excluded from the CpG counts of the regions. 
The distribution of the number of motif occurrences as a function of the number of 
CpGs in their flanking regions was compared between the original and the shuffled un-
methylated CpG island sequences (Figure 6.9A). There are 8,755 extra motif 
occurrences in the original relative to the shuffled sequences (Figure 6.9B). Of those, 
644 have fewer CpGs in their flanking regions than expected by chance, i.e., fewer than 
the average of the (null) distribution for the shuffled sequences (Figure 6.9C). They in 
particular cannot be explained by locally high CpG density. In addition, most of the 
extra occurrences (8,317) in the original sequences have a local CpG content within the 
95% confidence interval of the expected value (average of the null distribution) (Figure 
6.9D). Only 5% (436) of the extra motif occurrences in the original un-methylated 
sequences have a significantly greater than expected local CpG density (Figure 6.9E). 
Overall, the difference between the means of the two distributions corresponds to 
less than one CpG (Figure 80F). In conclusion, apart from a small fraction of the motif 
occurrences, the local CpG density cannot explain the enrichment of un-methylated 
CpG islands with the CG-rich motif. 
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Figure 6.9:  Number of motif occurrences as a function of the number of CpGs in the 
+/- 10bp flanking region of the motif (excluding CpGs in other motif occurrences) for 
the original (blue) and the shuffled (red) un-methylated sequences. The x-axis 
represents the number of CpGs in the flanking region and the y-axis represents the 
number of motif occurrences. The left vertical blue line marks the average of the 
original set of sequences, while the left red line marks the average for the shuffled set, 
i.e., the value expected by chance. The shorter lines to the right mark the upper bound 
of the 95% confidence intervals for the two distributions. 
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6.4 The CG-rich motif is a potential binding site for the 
E2F1/2 transcription factor 
The CG-rich motif is significantly enriched in un-methylated CpG islands, and most 
occurrences are not the result of high global or local CpG density. The association of 
the motif with a lack of DNA methylation therefore does not seem to have a trivial 
explanation, but may reflect a role in protecting these CpG islands from acquiring 
methylation during oogenesis, potentially via recognition and binding by a specific 
protein or protein complex. Using TOMTOM, a protein with a significantly similar 
binding site called RSC3/RSC30 (yeast-specific proteins; Badis et al., 2008) was 
identified (Figure 6.10). Other less significant TOMTOM hits are shown in Figure 6.11 
and Table 6.1. 
 
Figure 6.10: TOMTOM top and most significant hits (RSC3/RSC30) for the CG-rich 
motif. The TOMTOM tool provides three significance measurements, the raw p-value, 
the E-value and the q-value (false discovery rate). The name of the matching protein 
and other summary information is presented in the left panel, while motif logos are 
shown on the right. The top motif logo is the target motif while the bottom is the query 
motif (MCGCGCS). 
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Three members of E2F family (E2F1/2/3) are among TOMTOM hits for the CG-rich 
motif (Figure 6.11). Although individually they are less significant than RSC3/RSC30, 
the fact that they are all of the same mammalian gene family and were matched in two 
distinct databases (Jaspar Core 2009 and Uniprobe) increase their significance. 
 
 
Figure 6.11: Other, less significant TOMTOM hits. Three E2F proteins are reported: 
E2F1/2/3. They all are transcriptional activators, in addition to Zfp161. The databases 
that contain the MCGCGCS-matching motifs are Jaspar Core 2009 (E2F1) and Mouse 
Uniprobe (E2F2/3). 
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Table 6.1: Known protein binding sites that are similar to the CG-rich motif. Gene 
expression in oocytes was examined using the WAMIDEX web service (Schulz et al., 
2008; if the gene was in the top 20
th
 percentile relative to other genes, then it is 
considered to be expressed in oocyte). Tissue specificity was determined using BioGPS 
(http://biogps.org , Wu et al., 2009). E2F1/2 are expressed and specific to oocytes which 
make them potential binding proteins. 
Protein Chromosome 
Expressed in oocyte 
(WAMIDEX) 
Oocyte-specific (BioGPS) 
E2F1 chr2 Yes, all stages 
Highly and specifically 
expressed in oocyte and 
fertilised egg 
E2F2 chr4 Yes, in primordial, GV and MII 
Highly and specifically 
expressed in oocyte and 
fertilised egg 
E2F3 chr13 No Not specific 
Zfp161 chr17 Yes, in GV and MII No entry 
 
A recent ChIP-seq experiment in a MCF-7 human breast cancer cell line described a 
CG-rich motif with a CGCGC core as the consensus binding site for E2F1 (Figure 6.12, 
Cao et al., 2011), which is significantly similar to the identified MCGCGCS motif in 
un-methylated CpG islands (Figure 6.1). The DREME-reported motif after repeat-
masking of the input sequences was an altered version of the motif but with an identical 
CGCGC core (Figure 6.5). Furthermore, changing the positive sequence set of un-
methylated CpG islands to those CpG islands that are purely intragenic has the same 
effect. This indicates that the bases flanking the CGCGC core are variable.  
 
 
 
 
Figure 6.12: The consensus binding site for E2F1 identified by a ChIP-seq experiment 
in a human breast cancer cell line (Cao et al., 2011).  
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6.5 The CG-rich motif acts independently of transcriptional 
activation at un-methylated CpG islands 
Having discovered that the CG-rich motif is a potential binding site for E2F1/2, 
reported to be an activator of transcription, raises the question of whether the motif 
enrichment in un-methylated CpG islands merely reflects that most of them are active 
promoters. The odds (the ratio of the probability that an event will occur to the 
probability that the event will not occur) of being an un-methylated versus a methylated 
CpG island while not being promoter-associated and not containing the CG-rich motif is 
1.6 (Table 6.2, Case 1). Having the CG-rich motif increases the odds to 7.8 (Table 6.2, 
Case 2). Similarly, being promoter-associated increases the odds to a similar ratio of 7.0 
(Table 6.2, Case 3). The odds roughly quadruple for CpG islands having both features, 
suggesting that each of the two factors is significantly and independently associated 
with lack of methylation (Table 6.2, Case 4). 
 
Table 6.2: Three-way contingency table of CpG island counts for three factors: 
methylation state, CG-rich motif occurrence and promoter-association (PA). The last 
column shows the odds of being un-methylated. Presence/absence of a feature is 
encoded as 1/0. 
         Factors Methylated 
Un-methylated state odds 
(counts for 0 / counts for 1)  
PA CG-rich motif 0 1 
Case 1 0 0 831 514 
1.616731518 
Case 2 0 1 2118 272 
7.786764706 
Case 3 1 0 873 124 
7.040322581 
Case 4 1 1 3704 131 
28.27480916 
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To gain more insight into these results, the effects of having the CG-rich motif and/or 
being promoter-associated on predicting the methylation state of the CpG islands was 
analysed further using logistic-linear regression. Logistic-linear regression was used to 
model the categorical response variable, methylation state, in terms of linear 
combinations of the two categorical factors, CG-rich motif occurrence and promoter-
association. Five models were fitted to the data (summarised in Table 6.3). The main 
aim was to find out if the addition of the CG-rich motif factor to the model significantly 
improves the fit of the model, expressed as the residual deviance of the fitted model. In 
addition, the predictive values of the two factors were compared and tested for a 
significant interaction between them (Table 6.4 and section 6.8). 
 
Table 6.3: Logistic-linear regression models with two factors and one response. 
Response Model Description 
Methylation 
State (M) 
/ Null model 
PA Being promoter-associated 
Motif Having the CG-rich motif 
PA + Motif 
Being promoter-associated and having the CG-rich 
motif 
PA + Motif + 
PA : Motif 
Being promoter-associated, having the CG-rich motif 
and their interaction 
 
Analysing the reduction of deviance when comparing M ~ PA and M ~ PA + Motif + 
PA:Motif models using ANOVA in R shows that there is a significant (p = 0; Chi-square 
test of 498.57 reduction in model deviance with two degrees of freedom) additional 
predictive value with respect to the methylation state (Table 6.4, Test 1). To test whether 
this additional effect is due to the motif itself, M ~ PA and M ~ PA + Motif models were 
compared and the results shows a similar significant reduction in model deviance (Table 
6.4, Test 2). 
  
164 
 
The addition of the interaction term to the model did not significantly reduce model 
deviance, indicating that the two factors are independent (Table 6.4, Test 3). A direct 
comparison of M ~ PA and M ~ Motif models with the null model indicates that motif 
occurrence explains the methylation state significantly better than promoter association 
(p = 0; Chi-square test of 149.33 difference in deviance reduction with 0 degrees of 
freedom; Table 6.4, Tests 4 and 5).  
 
Table 6.4: Test models to find whether or not the motif and being PA are independent 
factors. Df: Degrees of freedom. 
 First model Second model 
Reduction in 
deviance 
Df 
Chi-square 
p-value 
Test 1 M ~ PA 
M ~ PA + Motif + 
PA:Motif 
498.57 2 0 
Test 2 M ~ PA M ~ PA + Motif 497.07 1 0 
Test 3 M ~ PA + Motif 
M ~ PA + Motif + 
PA:Motif 
1.4956 1 0.2213 
Test 4 M ~ PA M ~ 1 498.13 1 0 
Test 5 M ~ Motif M ~ 1 647.46 1 0 
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6.6 The contribution of R-loop formation potential to 
protection from DNA methylation 
Other DNA sequence signals might play a role in protecting the majority of CpG 
islands from obtaining methylation in the oocyte. R-loops are three-stranded structures 
formed through the association of a single RNA strand with the DNA template strand 
(Aguilera and Garcia-Muse, 2012). Ginno et al. (2012) suggested that R-loop formation 
is a distinctive feature of un-methylated (promoter) CpG islands and that they protect 
them from acquiring methylation (in human ES cells). Their finding raises the question 
of whether R-loop formation is a characteristic feature of un-methylated CpG islands in 
mouse oocytes also. R-loop formation requires transcription and preferentially occurs in 
G-skewed regions, i.e., where the transcribed strand contains more Gs than Cs (Figure 
6.13). 
 
 
Figure 6.13: R-loop formation. (A) Transcription (black arrow) through G-skewed 
region (green), leads to the formation of an R-loop structure (red). (B) Transcription 
through C-skewed region (blue) typically does not form R-loops. 
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The classifier used by the Chedin group (Ginno et al., 2012) to predict sites with R-
loop formation potential is a hidden Markov model (HMM) with four states 
representing distinct classes of regions in terms of sequence composition: 
 Genomic state: represents an average sequence composition. 
 GC state: a GC-rich state devoid of GC-Skew. 
 G-skew state: G-skewed state. 
 C-skew state: C-skewed state. 
 
The model was trained on empirical data that contain verified R-loop forming 
regions in the human and mouse Snrpn and mouse Arin genes. The trained model is not 
in the public domain and so, the model predictions are not reproducible. Therefore, a 
naïve approach was followed to classify CpG islands into either G-skewed or C-skewed 
based on whether Gs or Cs were more frequent in the sequence of the transcribed strand. 
Comparing this naïve classifier with Chedin's classification (Table S1, first sheet, named 
“All GC skewed regions”) results in more than 99% concordance, with only 126 
misclassifications out of 16,951. In addition, there are 12 regions with equal frequencies 
of Cs and Gs that were not classified by the naïve approach. The fact that 6 of these 
were classified as G-skewed by Chedin implies that the HMM classifier takes into 
account other, additional sequence features, but they seem to play a minor role. 
After validating the accuracy of the naïve approach, it was applied to CpG islands. 
Transcription through G-skewed regions is positively correlated with the formation of 
R-loop structures (Figure 6.13). Thus, CpG islands that are transcribed from the forward 
strand and show a G-skew and CpG islands that are transcribed from the reverse strand 
and show a C-skew were considered to have the potential for R-loop formation. To add 
the strand information (direction of transcription) to the CpG islands used in Smallwood 
et al. (2011), they were overlapped with the oocyte transcripts reconstructed from all 
mRNA-seq samples (merged data set). CpG islands that overlapped with more than one 
transcript on different strands were neglected. 
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The frequency of having R-loop formation potential first was determined for 
promoter and intragenic CpG islands (Figure 6.14, green doughnut). The result shows a 
much smaller difference (67% of promoter-associated and 54% of intragenic CpG 
islands have R-loop formation potential) in comparison with the ~50% difference 
presented in Figure 6.A in Ginno et al. (2012). However, the difference is still 
significant (p < 2.2 e-16; Fisher exact test). The paper also proposed that R-loop 
formation potential can be used as a predictor of the un-methylated state of CpG islands 
in human ESCs. To test this hypothesis for mouse oocytes, the frequency of R-loop 
potential for oocyte-methylated and un-methylated CpG islands was calculated. 
Although there is only a ~16% difference in frequency between the two groups, the 
difference is significant (p < 1 e-15; Fisher exact test; Figure 6.14, blue doughnut). 
Figure 6.14: R-loop formation potential in relation to CpG island methylation state 
(blue), oocyte transcript-relative location (green) and their combination (red). The sub-
figure titles contain the CpG island group names, the total number of sequences, 
whether they are the outer or inner circle. Many CpG islands were excluded from this 
analysis since either they do not overlap a transcript (no strand information), have 
ambiguous strand information or they contain an equal number of Cs and Gs. 
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Furthermore, when CpG island methylation state and transcript-relative location (un-
methylated promoter versus methylated intragenic CpG islands; Figure 6.14, red 
doughnut) were combined, the difference remained small (20%) yet significant (p < 1 e-
13). 
Interestingly, the outer circles in the three analyses (blue, green and red) always show 
the same frequencies: 67% with R-loop formation potential versus 33% without R-loop 
potential. Moreover, the differences between the three analyses for the inner circle are 
small. These results indicate that R-loop potential is equally associated with CpG island 
methylation state and transcript-relative location, which is expected given the high 
correlation between these two features (Figure 2.19). However, the association, while 
significant, is much less pronounced than that reported for human ES cells (Ginno et al. 
2012). 
Splitting the CpG islands into distinct classes depending on their methylation state 
and relative location to the 5’-end, and then analyse the percentage of CpG islands 
having R-loop potential and compare it to the percentage of those with no R-loop 
potential (Figure 6.15) shows a minor shift, yet to the right direction, consistent with the 
R-loop being positively, yet insignificantly, correlated with un-methylated CpG islands. 
 
 
Figure 6.15: R-loop formation potential in distinct CpG island groups. The percentages 
of methylated CpG islands within each category are shown. 
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6.7 Cfp1 ChIP-seq analysis 
CXXC finger protein 1 (Cfp1), also known as CpG binding protein (Cgbp), binds 
specifically to un-methylated CpGs, which suggests a role in regulating the expression 
of genes with CpG island promoters (Voo et al., 2000; Lee et al., 2001). Cfp1 is part of 
the mammalian Set1 H3K4 methyltransferase and is required for mammalian 
embryogenesis, normal cytosine methylation and cellular differentiation (Lee and 
Skalnik, 2005). Thomson et al. (2010) report a tight association between Cfp1 binding 
and H3K4me3 at un-methylated CpG islands in mouse whole brain. Moreover, they 
show that insertion of an artificial, un-methylated and promoter-free CpG-rich sequence 
into the genome of mouse ESCs is sufficient to recruit Cfp1 and to generate an 
H3K4me3 signal, despite the absence of RNA polymerase II. 
Cfp1 ChIP-seq data (Thomson et al., 2010) were analysed to investigate if Cfp1 
binding and the presence of the CG-rich motif (MCGCGCS) at un-methylated CpG 
islands are associated. The authors did not include input DNA control samples in their 
experiments. Therefore, the input samples for a CTCF ChIP-seq experiment in the same 
tissue (whole mouse brain) were used instead (Prickett et al., 2013). The sequence reads 
for the input samples were trimmed to be equal in length to the immunoprecipitated (IP) 
samples (Table 6.5). Figure 6.16 shows the work flow diagram for analysing the Cfp1 
ChIP-seq data. Although only a single end of the DNA fragments in the samples were 
sequenced, duplicates (distinct reads generating identical alignments) were removed 
since the duplication level was low in three samples and the fourth, input sample, while 
having a high duplication level, still yielded double the number of reads compared to 
the IP samples. 
 
Table 6.5: Mouse whole brain Cfp1 samples. IP: Cfp1 immunoprecipitation. BxC, CxB: 
inter-subspecies crosses between C57/Bl6 (Mus mus domesticus) and Mus mus 
castaneous mice. 
Experiment Samples 
Total number 
of sequences 
Sequence 
length 
Trimmed 
bases 
Duplication 
level 
Thomson et 
al., 2010 
IP1, Cfp1 15,402,359 37 / 25.06 % 
IP2, Cfp1 15,927,537 37 / 25.69 % 
Prickett et 
al., 2013 
Input1, BxC CTCF 33,786,908 76 38 – 76 75.64 % 
Input2, CxB CTCF 32, 960,735 76 38 - 76 21.99 % 
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Figure 6.16: Cfp1 ChIP-seq analysis work flow diagram. Starting from the raw read 
data (two IP samples and two inputs) several pre-processing steps were then applied to 
align the reads (with Novoalign), sort the alignments (with Picard tools), filter the 
alignments (with samtools) and to remove duplicate reads (with Picard tools). Trimming 
of read was an additional step only applied to the input samples to achieve identical 
lengths of input and IP reads. The selected minimum mapping quality was 10 (<=10% 
probability of a chance alignment). The numbers 1 and 2 indicate the two peak calling 
tools that were used, USeq and MACS. The diagram is colour-coded depending on the 
tools used. Tool names along with utilised functions are shown. 
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Cfp1 peaks were identified using two peak calling tools, USeq (Nix et al., 2008) and 
MACS (Zhang et al., 2008). The ‘ChIP-seq’ function of USeq identified 8,586 peaks. 
Since MACS cannot handle replicate samples, the two replicates for each of the IP and 
input conditions were merged. The main parameters for MACS are a p-value threshold, 
chosen to be 1.0 e-5, and fold enrichment lower and upper limits (set to 10- and 30-fold). 
With the parameter values, MACS identified 27,286 peaks and estimated the fragment 
size to be 168bp (Figure 6.17). 
 
Figure 6.17: MACS fragment size estimation from a random sample of 1,000 peaks. d 
is the distance between the modes of the forward (red) and the reverse (blue) strand read 
depth distribution. Reads are enriched in a characteristic bimodal pattern centred on the 
true binding site (black). Half the estimated fragment size (d/2) is used to shift read 
alignments in the 3’ direction, i.e., towards the true binding site, to generate a unimodal 
pattern centred on the binding site. The x-axis represents the distance from the central 
base of the true binding site. The y-axis shows the relative sequence depth. 
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 USeq reports enriched regions as well as their most enriched sub-regions (~ 25bp 
best sub-windows, BSWs), while MACS reports enriched regions and identifies their 
summits. MACS summits were expanded by +/- 40bp of flanking sequence. Then they 
were filtered by keeping only the peaks with FDR < 1% and fold enrichment > 2. To 
increase the confidence, the remaining 10,504 MACS summits were further filtered, 
using Galaxy, by removing the summits that do not overlap any of the USeq peaks. The 
2,338 high confidence summits were then used for a de novo motif search with the goal 
to identify a consensus recognition site for Cfp1 (Figures 6.18 and 6.19). 
 
Figure 6.18: Work flow diagram for filtering MACS summits. Pink cylinders indicate 
MACS summits while the blue cylinder represents the USeq best sub window (BSW). 
Intermediate processes are represented in light blue. The diagram is colour-coded 
depending on the tools used. 
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Figure 6.19: DREME results on the 2,338 high confidence (called by MACS at FDR< 
1%, and supported by USeq) Cfp1 binding sites. 
 
 
DREME did not identify any highly significant motifs. All but one of the identified, 
nominally significant motifs did not contain CpGs. Given that Cfp1 is known to 
preferentially bind CpG-rich regions, i.e., CpG islands, the lack of a CpG-containing, 
significantly enriched motif at Cfp1 binding sites suggests that Cfp1 does not recognise 
a DNA sequence motif apart from the CpG dinucleotide, consistent with what has been 
reported by Thomson et al. (2010). 
To annotate the CpG islands with whether or not they are Cfp1-positive, the 
identified whole peaks of USeq (8,586 in total) and the filtered whole peaks of MACS 
(10,504 in total) were combined to increase coverage and then overlapped with the CpG 
islands (Figure 6.20). A high degree of co-localisation between Cfp1 peaks and CpG 
islands was observed, confirming previous reports (Thomson et al., 2010): 81% of Cfp1 
peaks overlap CpG islands while half the CpG islands overlap with a Cfp1 peak. 
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Figure 6.20: Work flow diagram for annotating the CpG islands with Cfp1 signal. 
11,264 out of 13,848 (81 %) Cfp1 peaks overlap with CpG islands. Nearly half (48%) 
of the CpG islands overlap with Cfp1 peaks. Other annotations are similar to Figure 
6.18. 
 
 
The Cfp1 ChIP-seq data did not yield a DNA sequence motif that is specifically 
recognised by Cfp1. Nevertheless, analysing the association between Cfp1 binding sites 
and the identified CG-rich motif in un-methylated CpG islands shows that 72% of un-
methylated CpG islands that contain the CG-rich motif also overlap a Cfp1 peak 
suggesting that these two factors may interact. 
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6.8 Predictive power, correlations and interactions of factors 
associated with un-methylated CpG islands 
Thus far, different factors that had been reported to be associated with un-methylated 
CpG islands were explored. Some of these factors may interact and/or correlate with 
each other, while others do not. Their power in predicting the methylation state of CpG 
islands differ; for instance, the CG-rich motif is a better predictor of the CpG island 
methylation state than ‘being promoter-associated’ (Table 6.4, Tests 4 and 5). Using 
logistic-linear regression, the predictive power of the CpG island methylation state, and 
the two-way interactions / correlations between these different factors were analysed 
(Figures 6.21 and Tables E1-3). 
The interaction network (Figure 6.21) clearly states that there is no significant 
interaction between the CG-rich motif and either H3K4me3 or PA (p = 0.4 and 0.2 
respectively, Table E.1), which supports the idea that this motif may play a different role 
than transcription initiation at un-methylated CpG islands. This role may have 
something to do with the interaction with Cfp1 as a protection signal. Also, a significant 
triangular interaction between PA, Cfp1 and R-loop is shown, indicating that these 
factors have more effect on predicting the methylation state when present together. 
All the factors are negatively correlated with methylated CpG islands (Table E.3). 
The correlation between PA and R-loop provides a good sanity check, since the R-loop 
‘potential’ is transcription-dependent (section 6.6). The values of the correlation 
coefficients are all < 0.5, which indicates that none of these factors are truly redundant 
and they all contribute to the prediction of the CpG island methylation state (Figure 
6.21). 
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Figure 6.21: Pair-wise significant interaction/correlation network of methylation-free 
associated factors and their relative ranking in predicting the methylation state. The 
numbers from 1 to 5 indicates the rank of the factors based on their reduction in 
deviance compared to the null model (which represents their power in predicting CpG 
islands methylation free state, 1 is the highest, Table E.2). The interactions between the 
factors are represented by two heads black lines accompanied with their corrected Chi-
square p-value, (significant threshold < 0.05; full list of pair-wise interactions is 
presented in Table E.1). The correlations are represented by grey lines accompanied 
with their coefficients. Only the significant (with coefficients >= the coefficient of the 
respective factor with the methylation state; except for the R-loop; Table E.3) 
correlations are shown (Full list is presented in Table E.3). 
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6.9 Summary and Discussion 
During DNA methylation establishment in oogenesis most of the CpGs in the 
genome acquire methylation except the CpGs in most CpG islands, including a set of 
~250 intragenic CpG islands that ought to be methylated given the model of 
transcription-induced methylation (Figure 5.5). This exception raises the question of 
whether CpG islands are actively protected from de novo methylation in the oocyte. 
This chapter analysed the DNA sequence of the above 250 CpG islands, searching for 
distinctive DNA sequence motifs. 
De novo motif finding using DREME uncovered a CpG-rich motif that is not part of 
a repetitive sequence element that successfully discriminates a large proportion of CpG 
islands according to their methylation state (Figures 6.1 and 6.5). Its E-value among 
other identified motifs as well as its coverage statistics are similar to the Zfp57/Kap1 
motif (Figures 6.2 and 6.3). Although the density statistics of the CG-rich motif (Figure 
6.4) are overall similar to those for CpGs (Figure 6.6), the motif is not a byproduct of 
high global or local CpG density in un-methylated CpG island (Figures 6.7 and 6.8). 
Only 5% of motif occurrences in un-methylated CpG islands can be explained by high 
CpG density (Figure 6.9). 
Using TOMTOM and depending on data in the Jaspar and Uniprobe motif databases, 
and the results of a ChIP-seq experiment (Figure 6.11 and Cao et al., 2011), the E2F1 
(highly and specifically expressed in oocyte) transcription factor was identified as a 
candidate DNA-binding protein that recognises the CG-rich motif. Although TOMTOM 
result suggests another two members of the E2F family (E2F2 and E2F3) as potential 
binding proteins, only the former is highly and specifically expressed in oocyte and can 
potentially also be a candidate protein that recognises the CG-rich motif (Table 6.1). 
Since Zfp161 is only expressed in GV and MII oocyte stages (after DNA methylation 
establishment) it is less likely to be a candidate binding protein (Table 6.1). 
Although the CG-rich motif may represent a potential binding site for the 
transcription activator E2F1/2, it is significantly associated with un-methylated CpG 
islands independently of promoter activity. In fact the most significant TOMTOM hits 
(Figure 6.10) were related to RSC3 and RSC30. 
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Remodel the Structure of the Chromatin (RSC) is a nuclear, yeast-specific and 
abundant protein complex. Members of RSC complex are encoded by essential genes 
and are involved in mitotic processes and cell cycle control (Cairns, 1998; Angus-Hill et 
al., 2001). It plays a critical role in maintaining nucleosome free regions as well as 
transcript abundance at yeast promoters (Badis et al., 2008). Although its two 
components RSC3 and RSC30 have similar amino acid sequences, they perform distinct 
cellular functions. In addition, they interact physically by forming an RSC3/RSC30 
heteromeric complex (Angus-Hill et al., 2001). In yeast, it is ~10-fold more abundant 
than the SWI/SNF chromatin remodelling complex, which is functionally conserved in 
mammals (Sudarsanam et al., 2000). 
The SWI/SNF chromatin-remodelling complex modulates the structure of 
nucleosomes at (yeast) promoters to either activate or repress transcription (Sudarsanam 
et al., 2000). However, whole-genome gene expression analyses of SWI/SNF mutant 
show that it is not an essential protein complex, regulating only ~200 genes in yeast 
(Sudarsanam et al., 2000). BAF (BRG1 associated factors) is the mammalian gene sub-
family that shows similar structural and functional activities to the yeast components of 
SWI/SNF (Wang et al., 1996). 
SWI/SNF subunits differ in their structure, but the majority is capable of binding 
DNA via DNA-binding domains, particularly ARID (AT-rich interaction) domains. 
However, their binding may lack DNA sequence specificity (reviewed in Mohrmann 
and Verrijzer, 2005; Euskirchen et al., 2012). Two ARID-containing subunits 
(ARID1A/B) have roles in controlling cell cycle-dependent gene activity. While 
ARID1A has been shown to be involved in gene repression, ARID1B, on the other hand, 
is associated with gene activation (Nagl et al., 2007). 
One of the mechanisms for SWI/SNF recruitment to DNA is via interactions with 
transcription factors (Neely et al., 2002; Kwon and Wagner, 2007; Euskirchen et al., 
2012). The E2F transcription factor family in particular has been shown to mediate 
SWI/SNF regulation of gene expression in mouse, via ARID1A interaction with E2F4/5 
as well as HDACs (histone de-acetyltransferases) to inhibit gene activity, and via 
ARID1B interactions with E2F1/2/3 and HATs (histone acetyltransferases) to activate 
transcription (Blais and Dynlacht, 2007; Nagl et al., 2007). 
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E2F1 is a member of the E2F gene family with seven other members (reviewed in 
Dimova and Dyson, 2005). It is a transcription factor essential in postnatal development, 
cellular proliferation and other cellular and organismal functions (Wu et al., 2001; Tsai 
et al., 2008). Many in vitro studies suggest protein-protein interaction as a possible 
mechanism for E2F1 recruitment to the genome (summarised in Cao et al., 2011). One 
of these interactions is with SP1 (Shin et al., 1996). Taking all together, E2F1/2 might 
represent good protein(s) binding candidate(s) involved in protecting the CpG islands 
from de novo methylation during oogenesis. 
Although an appealing notion, R-loop formation potential, as determined by the 
naïve G/C-skew classifier, is a poor predictor of the methylation state of a CpG islands 
in mouse oocytes. R-loop formation potential also does not appear to be as predictive of 
the human CpG island methylation state as the Chedin paper suggests at first sight, 
given that most of the observed difference in R-loop potential between methylated and 
un-methylated CpG islands (Ginno et al., 2012, Figure 6.B) can be accounted for by 
whether a CpG island is associated with a promoter or is intragenic (Ginno et al., 2012, 
Figure 6.A). Classifying the CpG islands into separate groups depending on their 
methylation state as well as their location relative to the 5’ end, suggests that R-loop 
formation potential alone, is a weak predictor of CpG island methylation state in mouse 
oocyte unless it is combined with transcription (Figure 6.15). 
There are a few possible reasons why the results for mouse and particularly mouse 
oocytes differ from the Chedin paper. Mouse CpG islands are overall smaller and less 
CpG-dense than human CpG islands, which may have an impact on the sequence 
analysis. However, the G/C-skew metric (that is followed in this study) is independent 
of CpG density so that only the size difference remains. Furthermore, the HMM 
employed by Chedin may classify CpG islands not just based on G/C-skew but also 
other sequence features. However, the concordance between the naïve classification and 
the published results for human is very high so that whatever other sequence features 
are taken into account by the HMM seem to only have an effect on the classification of 
a few CpG islands that are borderline in terms of G/C-skew. Finally and perhaps most 
likely, oocytes, as opposed to ES cells, may employ a completely different mechanism 
for protecting CpG islands from methylation. R-loops are supposed to inhibit Dnmt3b, 
which is not involved in oocyte-methylation (Chedin et al., 2002). 
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Thomson et al., (2010) proposed binding of Cfp1 as a mechanism for the protection 
of CpG islands from gaining DNA methylation. Cfp1 recognises un-methylated CpG 
islands without any apparent additional sequence specificity (DREME results in Figure 
6.19 and Thomson et al., 2010). Since during oogenesis and before methylation 
establishment all CpG islands are un-methylated, Cfp1, if present at that stage in 
oogenesis, is expected to occupy all CpG islands. Therefore, Cfp1 on its own is an 
unlikely candidate for the protection of a specific subset of CpG islands in the oocyte. 
However, the logistic-linear regression analysis results suggest a significant positive 
interaction between the CG-rich motif and Cfp1 binding (Figure 6.21), suggesting that 
the respective protein complexes (SWI/SNF and Set1/MLL HMT; Figure 6.22) may 
interact. 
Pair-wise interactions (using logistic-linear regression) between the different factors, 
reported to be associated with un-methylated CpG islands uncover other significant (p < 
0.05; Chi-square test) interactions; Rloop with being PA & with Cfp1, and being PA 
with Cfp1. However, there is no interaction between being PA and H3k4me3, which 
was unexpected. One explanation would be related to the relatively high correlation 
between these two factors, which indicates that they are dependent and therefore their 
interaction to predict CpG islands methylation state is insignificant (Figures 6.21). On 
the other hand the absence of significant interaction between the motif and being PA 
indicates that the motif may indeed paly a different role than initiating transcription 
from these regions. 
These results suggest a model centred at the CG-rich motif, potentially recognised by 
E2F1/2, and mediating between the Set1/MLL histone methyltransferase and SWI/SNF 
chromatin remodelling protein complexes (Figure 6.22). The interactions between the 
different components are empirically supported (see discussion above), which is also 
reflected in the interaction network generated by STRING web service (Figure 6.23, 
http://string-db.org/, Franceschini et al., 2013). 
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Figure 6.22: The proposed model of methylation-free state at oocyte un-methylated 
CpG islands. Different components/factors from two protein complexes interact to 
protect the un-methylated CpG islands from de novo methylation. Arid1b is highly and 
specifically expressed in oocyte (BioGPS; http://biogps.org, Wu et al., 2009). 
 
 
Figure 6.23: Protein-protein interaction network between selected components of 
SWI/SNF chromatin remodelling and Set1/MLL HMT complexes. The edges between 
the proteins refer to empirical evidence for the association (the wider the edge the 
stronger the evidence). Figure was generated by STRING protein-protein interaction 
tool (http://string-db.org/, Franceschini et al., 2013). 
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7. Chapter 7: Concluding Remarks 
 
This study investigates the role of the DNA sequence in hosting specific 
characteristics essential in establishing the methylation marks during oogenesis, in 
maintaining the germ line acquired DNA methylation of oocyte-specifically methylated 
regions post fertilisation as well as in protecting the majority of CpG islands from de 
novo methylation during oogenesis. 
The mere presence of Zfp57/Kap1 recognition site (TGCCGC) could not distinguish 
PPM-DMRs from other CpG islands, however, multiple motif occurrences (density) is 
shown to be an indispensable discriminative feature at specifically the PPM-DMRs. 
Furthermore, the absence of another TGCCGC-like significant motif reduces the 
possibility of having another DNA-binding protein (complex), like Zfp57/Kap1, 
however it does not provide evidence that Zfp57/Kap1 is the solo player in maintaining 
the DNA methylation at PPM-DMRs. The analyses of methylation patterns at distinct 
stages (oocyte, blastocyst, E8.5 embryo; data not shown) shows that not all CpG islands 
lose their DNA methylation at the same degree after fertilisation, a few regions maintain 
their methylation till the blastocyst stage, and very few of those preserve it post-
implantation (PPM-DMRs). Other proteins like Dppa3 (PGC7/Stella, Sato et al., 2002; 
Payer et al., 2003; Nakamura et al., 2007) that is highly and specifically expressed in 
PGCs, during oogenesis and after fertilisation till the blastocyst stage, were proposed to 
protect against DNA de-methylation in early embryogenesis, however, whether its 
mechanism is through direct DNA-interaction or via other DNA-binding proteins (like, 
for example, Zfp57/Kap1) is remain undetermined. 
The DNA sequence of oocyte-methylated CpG islands does not harbor any 
TGCCGC-like motif relative to oocyte un-methylated CpG islands. However, CpG 
spacing was proposed as a triggering signal for the methylation machinery. The 8-10bp 
CpG distance is enriched in PPM-DMRs as well as oocyte un-methylated but not 
oocyte-methylated CpG islands; which makes it less likely to be an establishment signal. 
Nevertheless, the CpG pairs at 8-10bp distance seem to be special in specifically PPM-
DMRs compared to other short distances (12-14bp). This raises a general question 
related to the importance of this contrast in CpG spacing at PPM-DMRs. 
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In addition, the shores, in all CpG island categories, are significantly more enriched 
in CpG pairs at 8-10bp distance than the islands themselves, which is, by itself, another 
interesting observation. 
Furthermore, no CpG periodicity was found in either oocyte-methylated or oocyte 
un-methylated CpG islands. On the other hand, a 9bp period in CpG spacing is present, 
but only in 43% of PPM-DMRs, that is, it is not a general feature of all PPM-DMRs. It 
is not necessary that these observations be associated with DNA methylation 
establishment, there are other genomic features that are associated with periodicity and 
nucleotide spacing like, for example, nucleosome positioning. Taking all together, not 
finding a characteristic DNA-based feature for the majority of PPM-DMRs, or oocyte-
methylated CpG islands (or both) supports a sequence-independent (and transcription-
driven) model of de novo DNA methylation establishment during oogenesis, supported 
by the high correlation between gene body CpG island methylation and transcription 
initiated from upstream promoters. 
On the contrary, the DNA sequence of oocyte un-methylated CpG islands is 
significantly enriched with a CG-rich motif that is independent of the relatively high 
CpG density at these CpG islands. This motif is highly similar to the recognition site of 
E2F1/2, DNA-binding protein(s) involved in chromatin remodelling that is highly and 
specifically expressed in oocytes. Logistic-linear regression analysis indicates that this 
motif acts independently of transcriptional activation at un-methylated CpG islands, 
which suggests it to be, with the interactions with other components, a model for active 
protection against de novo methylation at un-methylated CpG islands during oogenesis. 
In summary, the DNA sequence seems to be important for the protection of CpG 
islands from DNA methylation during oogenesis, and for the DNA methylation 
maintenance at PPM-DMRs, but not for the establishment of DNA methylation at CpG 
islands in the oocyte. 
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Appendices 
 
Appendix A: Samples and tools used in the study 
 
Table A.1: Different (mouse) samples analysed/used in this study. (ENA: European 
Nucleotide Archive, CEO: Gene Expression Omnibus, DDBJ: DRA000484 (DDBJ)) 
Samples Experiments Reference Accession Number 
Oocyte 
ChIP-seq Smallwood et al., 2011 ERP000689 (ENA) 
RRBS-seq Smallwood et al., 2011 ERP000689 (ENA) 
BS-seq Kobayashi et al., 2012 DRA000484 (DDBJ) 
mRNA-seq 
Smallwood et al., 2011 
Kobayashi et al., 2012 
ERP000689 (ENA) 
DRA000484 (DDBJ) 
Sperm 
RRBS-seq Smallwood et al., 2011 ERP000689 (ENA) 
BS-seq Kobayashi et al., 2012 DRA000484 (DDBJ) 
Blastocyst 
RRBS-seq Smallwood et al., 2011 ERP000689 (ENA) 
BS-seq Kobayashi et al., 2012 DRA000484 (DDBJ) 
ESCs BS-seq Kobayashi et al., 2012 DRA000484 (DDBJ) 
Adult Liver MeDIP-seq Proudhon et al., 2012 GSE32687 (GEO) 
Embryo MeDIP-seq Proudhon et al., 2012 GSE32687 (GEO) 
Brain ChIP-seq 
Thomson et al., 2010 
Prickett et al., 2013 
GSE18578 (GEO) 
GSE35140 (GEO) 
 
 
Table A.2: The tools and their versions that were used to analyse the mRNA-seq data. 
Tool Version Tool Version 
Bowtie 1 SAM tools 0.1.18 
Cufflinks 2.0.1 TopHat 2.0.4 
HTSeq 0.5.4 Picard tools 1.68 
Novocraft 2.08.01   
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Appendix B: Database schema diagrams 
 
 
 
 
Figure B.1: CpG islands and Zfp57 / TGCCGC class diagram. 
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Figure B.2: CpG islands methylation state class diagram. 
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Figure B.3: mRNA-transcripts class diagram. 
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Figure B.4: UCSC reference genes class diagram. 
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Figure B.5: H3K4me3 ChIP-seq class diagram. 
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Figure B.6: Annotation summary class diagram. 
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Figure B.7: Oocyte promoters class diagram.  
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Appendix C: A Search for a DNA methylation establishment 
signal: TOMTOM and DREME results 
 
 
Figure C.1: MEME results for discriminative and non-discriminative analyses after 
masking the repeats while searching for an establishment signal. Other terms are 
analogous to those in Figure 5.4. 
  
  
213 
 
 
 
Figure C.2: TOMTO hits for motif 3 reported in discriminative MEME analysis 
comparing methylated, transcribed and intragenic CpG islands versus un-methylated 
and transcribed CpG islands (Figure 5.4, left panel). 
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Figure C.3: TOMTO hits for motif 4 reported in discriminative MEME analysis 
comparing methylated, transcribed and intragenic CpG islands versus un-methylated 
and transcribed CpG islands (Figure 5.4, left panel). (Part 1) 
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Figure C.4: TOMTO hits for motif 4 reported in discriminative MEME analysis 
comparing methylated, transcribed and intragenic CpG islands versus un-methylated 
and transcribed CpG islands (Figure 5.4, left panel). (Part 2) 
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Table C.1: Known protein binding sites that are similar to MEME-identified motifs 3 
and 4 from Figure 5.4, left panel. Gene expression in oocytes was examined using the 
WAMIDEX web service (Schulz et al., 2008; if the gene was in the top 20
th
 percentile 
relative to other genes, then it is considered to be expressed in oocyte). SKN7 has no 
mouse counterpart and SWI5 was not found in the WAMIDEX database. 
MEME 
Motif 
TOMTOM 
Match 
Mouse Gene Name Chromosome 
Expressed 
in oocyte 
Motif 3 
Ace2 
Angiotensin I converting 
Enzyme-2 
chrX No 
Swi5 
SWI5 recombination repair 
homolog (yeast) 
chr2 
Not in 
WAMIDEX 
Nkx3-1 
NK-3 transcription factor, locus-
1 (Drosophila) 
chr14 No 
Motif 4 
Esr1 Estrogen receptor-1 chr10 Yes 
Esr2 Estrogen receptor-2 chr12 Yes 
Hic1 Hypermethylated in cancer-1 chr11 No 
Skn7 / / / 
Ace2 
Angiotensin I converting 
Enzyme-2 
chrX No 
Esrrb Estrogen related receptor beta chr12 Yes 
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Figure C.5: DREME results for the identified motifs (motif 17-33) in OSAP versus 
OAP comparison with +/- 2kbp flanking sequences. 
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Appendix D: Periodicity in CpG spacing 
 
 
 
Figure D.1: Cumulative binomial p-value distribution for CpG islands (top) and for 
CpG islands including the +/- 1kbp shores (bottom) for 8-10bp distances. 
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Figure D.2: Observed/expected ratio for distances up to 50bp for AK008011, Cdh15, 
Gnas-exon1a, Grb10, Igf2r/Air, Impact, Inpp5f and Kcnq1ot1 PPM-DMRs. 
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Figure D.3: Observed/expected ratio for distances up to 50bp for Mcts2, Mest_426, 
Mest_452, Mest_742, Nap1l5, Nespas_463, Nespas_1348 and Nespas_2795 PPM-
DMRs. 
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Figure D.4: Observed/expected ratio for distances up to 50bp for Nnat_239, Nnat_621, 
Peg10, Peg13, Slc38a4, Snrpn/Snurf, Socs5 and U2af1-rs1 PPM-DMRs. 
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Figure D.5: Observed/expected ratio for distances up to 50bp for Zac1, Zfp777, Zfp787, 
and Zim2 PPM-DMRs. 
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Figure D.6: Auto-correlation coefficients for distances up to 85bp derived from the 
smoothed and de-trended obs/exp ratios for AK008011, Cdh15, Gnas-exon1a, Grb10, 
Igf2r/Air, Impact, Inpp5f and Kcnq1ot1 PPM-DMRs. 
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Figure D.7: Auto-correlation coefficients for distances up to 85bp derived from the 
smoothed and de-trended obs/exp ratios for Mcts2, Mest_426, Mest_452, Mest_742, 
Nap1l5, Nespas_463, Nespas_1348 and Nespas_2795 PPM-DMRs. 
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Figure D.8: Auto-correlation coefficients for distances up to 85bp derived from the 
smoothed and de-trended obs/exp ratios for Nnat_239, Nnat_621, Peg10, Peg13, 
Slc38a4, Snrpn/Snurf, Socs5 and U2af1-rs1 PPM-DMRs. 
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Figure D.9: Auto-correlation coefficients for distances up to 85bp derived from the 
smoothed and de-trended obs/exp ratios for Zac1, Zfp777, Zfp787 and Zim2 PPM-
DMRs. 
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Figure D.10: Frequency spectrum for AK008011, Cdh15, Gnas-exon1a, Grb10, 
Igf2r/Air, Impact, Inpp5f and Kcnq1ot1 PPM-DMRs. 
  
228 
 
 
 
Figure D.11: Frequency spectrum for Mcts2, Mest_426, Mest_452, Mest_742, Nap1l5, 
Nespas_463, Nespas_1348 and Nespas_2795 PPM-DMRs. 
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Figure D.12: Frequency spectrum for Nnat_239, Nnat_621, Peg10, Peg13, Slc38a4, 
Snrpn/Snurf, Socs5 and U2af1-rs1 PPM-DMRs. 
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Figure D.13: Frequency spectrum for Zac1, Zfp777, Zfp787 and Zim2 PPM-DMRs. 
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Figure D.14: Average observed/expected ratio for distances up to 200bp and the auto-
correlation coefficient derived from the smoothed and de-trended obs/exp ratios for 
each CpG island category with +/- 1kbp flanking sequences. 
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Appendix E: Factors pair-wise interactions and predictive 
power 
 
Table E.1: Full list of pair-wise interactions between methylation-free associated 
factors. Df: Degrees of freedom. The raw p-values can be corrected by multiplying by 
10 (total number of tests). 
First model Second model 
Reduction in 
deviance 
Df 
Raw Chi-
square 
p-value 
PA + Motif PA + Motif + PA:Motif 1.4956 1 0.2213 
PA + Rloop PA + Rloop + PA: Rloop 165.2 1 0 
PA + H3K4me3 
PA + H3K4me3+ PA: 
H3K4me3 
1.1127 1 0.29 
PA + Cfp1 PA + Cfp1+ PA: Cfp1 24.719 1 6.632e-7 
Motif + Rloop 
Motif + Rloop + Motif: 
Rloop 
4.8503 1 0.0276 
Motif + 
H3K4me3 
Motif + H3K4me3+ Motif: 
H3K4me3 
0.63687 1 0.4248465 
Motif + Cfp1 Motif + Cfp1+ Motif: Cfp1 13.503 1 0.000238 
H3K4me3+ 
Rloop 
H3K4me3+ Rloop + 
H3K4me3: Rloop 
7.0307 1 0.008012 
H3K4me3+ Cfp1 
H3K4me3+ Cfp1+ 
H3K4me3: Cfp1 
0.66337 1 0.4153 
Rloop + Cfp1 Rloop + Cfp1+ Rloop: Cfp1 41.638 1 1.098e-10 
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Table E.2: Interactions between methylation-free associated factors and the null model 
for predicting CpG islands methylation state. Other terms are analogous to those in 
Table E.1. 
First model 
Second 
model 
Reduction in 
deviance 
Df 
Raw Chi-square 
p-value 
M ~ H3K4me3 M ~ 1 851.57 1 0 
M ~ Motif M ~ 1 647.46 1 0 
M ~ Cfp1 M ~ 1 583.73 1 0 
M ~ PA M ~ 1 498.13 1 0 
M ~ Rloop M ~ 1 4.7133 1 0.029930 
 
 
 
Table E.3: Pair-wise Pearson correlation coefficients between the methylation-free 
associated factors in addition to the methylation state. 
 PA 
Methylation 
State 
CG-rich 
motif 
Cfp1 R-loop H3K4me3 
PA 1 -0.24 0.17 0.45 0.49 0.31 
Methylation 
State 
 1 -0.29 -0.27 -0.02 -0.29 
CG-rich 
motif 
  1 0.21 0.05 0.13 
Cfp1    1 0.24 0.22 
R-loop     1 0.14 
H3K4me3      1 
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SUMMARY
Identifying loci with parental differences in DNA
methylation is key to unraveling parent-of-origin
phenotypes. By conducting a MeDIP-Seq screen
in maternal-methylation free postimplantation
mouse embryos (Dnmt3L-/+), we demonstrate that
maternal-specific methylation exists very scarcely
at midgestation. We reveal two forms of oocyte-
specific methylation inheritance: limited to preim-
plantation, or with longer duration, i.e. maternally
imprinted loci. Transient and imprinted maternal
germline DMRs (gDMRs) are indistinguishable in
gametes and preimplantation embryos, however,
de novo methylation of paternal alleles at implanta-
tion delineates their fates and acts as amajor leveling
factor of parent-inherited differences. We charac-
terize two new imprinted gDMRs, at the Cdh15 and
AK008011 loci, with tissue-specific imprinting loss,
again by paternal methylation gain. Protection
against demethylation after fertilization has been
emphasized as instrumental in maintaining parent-
of-origin methylation inherited from the gametes.
Here we provide evidence that protection against
de novo methylation acts as an equal major pivot,
at implantation and throughout life.
INTRODUCTION
Fertilization ensures the propagation of genetic and epigenetic
information from one generation to the next. In mammals, epige-
netic and long-lasting effects inherited in a parent-of-origin
manner are known as genomic imprinting (Barlow, 2011). The
main epigenetic mark that ensures their transmission and effects
is DNA methylation. Methylation marks at imprinted loci are
established in a sex-specific manner during gametogenesis, at
genomic loci referred to as germline differentially methylated
regions (gDMRs). After fertilization, these gDMRs act in cis to
control the monoallelic and parent-specific expression of a
subset of genes, the imprinted genes. Germline DMRs can affect
imprinted expression in a variety of ways, including promoter
control of protein-coding and noncoding RNAs, regulation of
transcription elongation, and long distance insulator activities.
The allelic differences of gDMRs also include a typical chromatin
signature, consisting of both repressive and permissive histone
marks (McEwen and Ferguson-Smith, 2010). Disruption of im-
printed expression upon genetic deletion of a gDMR is ultimate
proof that it functions as an imprinting control region (ICR).
To date, around 120 imprinted genes have been identified in
mouse and human. They are under the control of 20 identified
gDMRs/ICRs, 17 of which aremethylated in the oocyte (maternal
gDMRs), and only three in sperm (paternal gDMRs). Parental
ICRs are also sexually dimorphic in terms of CpG content and
genomic localization: maternal ICRs are CpG island (CGI)
promoters, while paternal ICRs are relatively CpG poor and inter-
genic. Evolutionary reasons for these discrepancies may be
linked to the different developmental kinetics of male and female
gametogenesis (Bourc’his and Bestor, 2006; Schulz et al., 2010).
Importantly, maternal ICRs have a dominant role in early devel-
opment, regulating biological pathways related to the establish-
ment of the feto-maternal interface (Schulz et al., 2010).
It is becoming increasingly clear that the acquisition of sex-
specific methylation patterns extends beyond imprinted regions
in gametes (Kobayashi et al., 2012a; Smallwood et al., 2011;
Smith et al., 2012). CpG islands are more prone to being methyl-
ated in the oocyte than in sperm and globally, about a thousand
CGIs may be specifically methylated in the oocyte genome,
exceeding the number of known maternal ICRs by far. Imprinted
and nonimprinted methylation is likely to be established in the
same way in the oocyte, under the control of the de novo DNA
methyltransferase DNMT3A and its cofactor DNMT3L, and in
a transcription-dependentmanner (Bourc’his et al., 2001; Chota-
lia et al., 2009; Kaneda et al., 2004; Kobayashi et al., 2012a;
Smallwood et al., 2011).
Instead of specific targeting mechanisms for their establish-
ment in gametes, what truly distinguishes ICRs from the rest of
the genome is their treatment after fertilization, in the wake of
the extensive methylation changes inherent to early mammalian
development. Before implantation, methylated alleles of ICRs
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are resistant to the genome-wide erasure of gametic methylation
that coincides with the acquisition of embryonic pluripotency.
Specific trans acting factors have been identified as critical in
maintaining ICR methylation during this period, such as binding
of the KRAB (Kru¨ppel-associated box-containing) zinc finger
protein system, which involves Zfp57 and the heterochromatin
inducer KAP1/TRIM28 (Li et al., 2008; Mackay et al., 2008; Quen-
neville et al., 2011; Zuo et al., 2012). Following this critical period,
parental differences in ICR methylation are thought to persist
throughout life, with no stage- and tissue-specificity, although
this aspect of imprinting has not been fully addressed.
To gain insight into the extent of gametic methylation inheri-
tance, we performed a genome-wide screen for gDMRs in
the mouse postimplantation embryo. Considering their larger
number, we specifically looked for maternally transmitted
gDMRs, by comparative methylation profiling of wild-type
embryos and embryos lacking oocyte-inherited methylation,
using MeDIP-Seq (Methylated DNA Immunoprecipitation fol-
lowed by high throughput sequencing). We exploited the well-
characterizedDnmt3Lmutant system, in which postimplantation
Dnmt3L-/+ embryos generated by fertilization of Dnmt3L/
oocytes completely lack maternal imprints, while methylation
patterns at paternal ICRs and repeats are unaltered (Bourc’his
et al., 2001; Schulz et al., 2010).
Our approach proved to be highly sensitive and efficient at
identifying regions of oocyte-inherited methylation. We found
all 17 known maternal gDMRs/ICRs and less than thirty new
candidates, revealing that loci that maintain maternal-specific
methylation are rare in the postimplantation embryo. We charac-
terized two new maternally imprinted gDMRs, located within the
Cdh15 gene and at the promoter of AK008011, a retroposed
pseudogene. Further analyses enabled us to demonstrate that
inherited maternal gDMRs can exist in a permanent or transient
state after fertilization, and that avoidance of de novo methyla-
tion during embryo or tissue differentiation plays a key role in
the permanency of parent-of-origin methylation inherited from
the gametes.
RESULTS
A Genome-wide Screen for Regions of Oocyte-Inherited
Methylation by MeDIP-Seq
We generated DNAmethylation profiles by MeDIP-Seq for pools
of 8.5 dpc (days post coı¨tum) embryos of either a wild-type or
Dnmt3L-/+ genotype. For each pool, two independent MeDIP
preparations were sequenced. We obtained 41 M and 32.7 M
distinct and uniquely alignable reads for wild-type and
Dnmt3L-/+ embryos, respectively (Supplemental Information).
For a 1000 bp sliding window size and a permissive false
discovery rate (FDR) threshold of < 50%, 398 differentially meth-
ylated regions (DMRs) were identified genome-wide, 163 of
which were hypomethylated and 235 hypermethylated in
Dnmt3L-/+ embryos (Table S1). This suggests that overall,
wild-type andDnmt3L-/+ postimplantation embryos have similar
methylation profiles and differ only at a small set of discrete loci.
The relatively small number of DMRs between wild-type and
Dnmt3L-/+ embryos was not due to a lack of sensitivity of our
MeDIP-Seq approach, as all of the 17 known maternal ICRs
were identified at an FDR threshold of only 5%. Furthermore,
when ranked by confidence score (10log10 of FDR), the top
13 ranks were occupied by known maternal ICRs (Figure 1A).
The highest level of significance was obtained for the Peg13
ICR (FDR < 1027), then for the KvDMR ICR (FDR < 1025), which
regulates the promoter of the Kcnq1ot1 noncoding RNA, and the
lowest for the Peg10/Sgce ICR (FDR < 0.04) (Figures 1B, S1A,
and S1B). Of note, the Peg3 and Snrpn ICRs, which are prone
to regaining methylation in some Dnmt3L-/+ progeny (Arnaud
et al., 2006), were identified as highly significant hypomethylated
DMRs (FDR < 0.02) (Figures S1C and S1D).
Unexpectedly, our screen uncovered hypermethylated DMRs,
which gain methylation in Dnmt3L-/+ embryos. Among them, we
found known secondary imprinted DMRs, which acquire methyl-
ation in somatic tissues as a consequence of maternal ICR
control. For example, the Gnas locus contains two maternal
ICRs, encompassing the Gnas ex1A (FDR < 1018) and the
Nespas promoters (FDR < 1020) (Figure 1C). Paternal Nespas
transcription induces the paternal methylation in cis of a
secondary, somatically acquired DMR at the Nesp promoter. In
the absence of maternal germline methylation, Nespas expres-
sion becomes biallelic and Nesp methylation occurs on both
alleles (Liu et al., 2005). Our MeDIP-Seq approach unambigu-
ously detected hypermethylation at the Nesp secondary DMR
in Dnmt3L-/+ embryos (FDR < 0.02) (Figure 1C). Our MeDIP-
Seq screen alsoproved to be highly specific: the three genetically
confirmed paternal ICRs (H19-Igf2, Dlk1-Gtl2 and Rasgrf1) that
acquire methylation in the male germline were not identified as
DMRs (Figure S2A). In addition, sequences that acquire methyl-
ation specifically in the embryo, such as CGI promoters of germ-
line expressed genes (Borgel et al., 2010), also showed similar
profilesbetweenwild-typeandDnmt3L-/+embryos (FigureS2B).
In summary, evidence from knownpositive and negative controls
demonstrates that our MeDIP-Seq screen accurately identified
regions of oocyte-dependent methylation in the embryo.
To prioritize our candidate DMRs, we applied certain strin-
gency filters, based on systematic genomic features of known
maternal ICRs. Sequences that acquire methylation in oocytes
tend to be CG-rich and among them, maternal ICRs have an
observed to expected CpG ratio > 0.5 (Schulz et al., 2010). Given
this fact and due to the functional link between CG density
and DNA methylation-mediated transcriptional control (Weber
et al., 2007), we excluded DMR candidates that contained fewer
than 10 CpGs and that had a ratio of < 0.213 (the median across
all identified DMRs). Additionally, we found that all known
maternal ICRs and their associated secondary somatic DMRs
have < 25% repeat sequence content. Given this relatively
repeat-free nature and the difficulty of accurately assigning the
genomic origin of short sequencing reads that originate from
repeats, we further excluded candidates with a repeat content
> 25%. These filters reduced the DMR number to 96, 47 hypo-
methylated and 49 hypermethylated, which showed a dispersed
distribution throughout the mouse genome (Figure 1D).
Improved Definition of Known Imprinted Loci
and Identification of New gDMRs
We first used our MeDIP-Seq data to improve the genetic map of
germline or secondary DMRs for known imprinted loci that have
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not been fully documented. Two hypomethylated DMRs coin-
cided with the promoters of the Slc38a4 (FDR < 0.5) and
Peg12 (FDR < 0.05) genes (Figures S1E and S1F), and were
confirmed to be hypomethylated in Dnmt3L-/+ embryos by
MSRE-qPCR assays (Methylation-Sensitive Restriction Enzyme
coupled with quantitative PCR) (Figure 1E). Paternal-specific
expression and maternal-specific methylation had been previ-
ously reported at these loci in somatic tissues (Kobayashi
et al., 2002; Smith et al., 2003). Reduced-Representation
Bisulfite Sequencing (RRBS) confirmed here that the Slc38a4
DMR is indeed methylated in oocyte and hypomethylated in
sperm and can be categorized as a genuinematernal gDMR (Fig-
ure S3A). However, the Peg12 DMR was unmethylated in both
oocyte and sperm, suggesting that it is not a gDMR. Our
screen also led to a reassessment of the imprinted Gpr1-Zdbf2
locus, which was originally characterized as a fourth imprinted
region controlled by paternal methylation (Hiura et al., 2010;
Kobayashi et al., 2009). We identified two hypermethylated
Figure 1. MeDIP-Seq Screen for the Identification of Oocyte-Dependent DMRs, Using 8.5 dpc WT and Dnmt3L-/+ Embryos
(A) DMRs with an FDR of up to 5% are ranked from top to bottom in order of statistical significance (10log10(FDR)). The 17 knownmaternal ICRs are labeled with
red asterisks. NG means ‘‘no gene,’’ according to UCSC annotation.
(B) MeDIP-Seq profile of theKcnq1ot1 locus controlled by KvDMR, a knownmaternal ICR (red). The tracks depict theMeDIP-Seq profiles of 8.5 dpcWT embryos
andDnmt3L-/+ embryos, which are highly similar except for a the hypomethylated KvDMR (purple). Genes are oriented 50 to 30, and the y axis scale expresses the
number of fragments per million mapped fragments.
(C) MeDIP-Seq profile of the Gnas locus, controlled by two known maternal ICRs, which are hypomethylated (purple). This locus also contains a secondary
somatic DMR, hypermethylated (yellow) in Dnmt3L-/+ embryos.
(D) Mouse karyotype with the positions of 47 hypomethylated and 48 hypermethylated candidate DMRs in Dnmt3L-/+ embryos, and the previously known ICRs.
(E) MSRE-qPCR validation of methylation. Error bars show the standard devitation from three independent digestions.
(F) Transcript position of 28 hypomethylated DMRs, which represent new potential maternal gDMRs.
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DMRs (FDR < 0.01 and 0.07), which overlap with two originally
described paternal gDMRs (DMR2 and DMR3) (Figures 1A and
S1G). However, as discussed earlier, paternal gDMRs, such as
the H19-Igf2 DMR, are unaltered in our screen. The methylation
status of theGpr1-Zdbf2DMRs inDnmt3L-/+ embryos is instead
reminiscent of a secondary, somatic DMR similar to the Nesp
DMR, as validated by MSRE-qPCR (Figure 1E) and bisulfite
sequencing (data not shown), and was recently independently
confirmed (Kobayashi et al., 2012b).
In our search for additional novel maternal gDMRs, we
focused on 28 hypomethylated, single-copy and relatively
CpG-rich candidate DMRs (Table 1), which importantly do not
belong to known imprinted regions. All but three of the candidate
gDMRs were within a transcription unit, among which ten were
located to an annotated promoter, six overlapped with the last
exon/30 UTR, and nine were within a gene body (Table S1 and
Figure 1F). Contrary to known maternal ICRs, all of which coin-
cide with promoter-associated CGIs, only nine out of 28 candi-
dates overlapped with a CGI and only five of those were associ-
ated with an annotated promoter. To evaluate which candidate
gDMRs may constitute regions of bona fide oocyte-specific
methylation, we interrogated publically available CGI methyla-
tion data in the mouse oocyte (Kobayashi et al., 2012a): all but
two CGI candidates from our screen were found methylated.
We further integrated MeDIP-Seq data from mouse C57Bl6/J
sperm (Table 1), and found only one of the candidates to be
methylated in sperm, confirming that sequences methylated in
the oocyte are usually not methylated in sperm (Kobayashi
et al., 2012a; Smallwood et al., 2011; Smith et al., 2012). As an
indication of long-term maintenance of maternal-specific meth-
ylation, we integrated MeDIP-Seq data from fetal 17.5 dpc
hybrid mouse liver from C57Bl6/J and PWD/PhJ strain crosses.
In these samples, parental allele-specific sequencing reads
were counted at known SNPs between the parental strains
Table 1. Maternal gDMR Candidates: Hypomethylated, Single-Copy, and Relatively CpG-Rich DMRs
Chr Start End Closest Transcript CGI CpG Content Sperm Methylationa Liver Methylationb
8 125387861 125390344 Cdh15 CGI21235 0.37 5.1 0.1334
6 47974007 47975979 Zfp777 CGI17361 0.56 5.3 0.6911
13 54209856 54211139 Sfxn1 0.25 0.9 0.5000
17 87524084 87525819 Socs5 CGI9617 0.43 3.4 0.0020
7 86519538 86521097 Rlbp1 0.23 0.9 0.1334
7 6083480 6084890 Zfp787 CGI18282 0.64 4.7 0.6964
7 24992450 24993377 Zfp111 CGI18528 0.45 2.7 0.7500
15 76010966 76012080 Plec1 CGI7215 0.68 1.5 1.0000
11 102057005 102057998 Hdac5 0.30 1.2 0.0078
13 60557950 60559042 0.24 1.1 1.0000
16 20530221 20531293 Dvl3 CGI8073 0.27 1.9 0.3438
4 150993001 150994022 Camta1 0.33 2.6 1.0000
4 53727006 53728024 Fcmd CGI14304 0.89 3.5 0.8750
15 102047274 102048271 Itgb7 0.26 1.3 0.7500
5 106629403 106630408 nenese 0.66 4.7 0.3125
10 122303419 122304463 Ppm1h 0.26 1.4 0.0384
7 148034494 148035458 Odf3 0.26 1.0 1.0000
7 147267611 147268611 Drd1ip CGI19894 0.34 2.2 1.0000
15 11250512 11251415 Adamts12 0.29 1.4 1.0000
13 66815007 66816022 2410141K09Rik 0.57 2.9 1.0000
14 122056331 122057326 Dock9 0.32 0.8 1.0000
8 12262778 12263827 0.21 1.1 1.0000
12 118489501 118490705 Ptprn2 0.30 1.3 0.5000
19 45385459 45386455 sneefar 0.27 0.8 0.7734
6 125660898 125661895 Tmem16b CGI18014 0.28 1.0 1.0000
11 115748842 115749776 Myo15b 0.22 1.2 0.5000
10 74869979 74870980 Upb1 0.28 2.2 1.0000
13 96588183 96589194 Iqgap2 0.27 0.8 0.1938
Information shown: genomic coordinates of the DMR as determined by USeq, closest transcript (RefSeq), CGI reference number (Illingworth et al.,
2010), observed/expected CpG ratio, methylation status in sperm, and evidence for maternal methylation in hybrid fetal liver.
alog2 of fold-change relative to wildtype embryos: negative values are indicative of sperm hypomethylation.
bone-tailed binomial test p values: entries with p > 0.2 are indicative of low degree of evidence for maternal-specificmethylation; italics highlight entries
where the test was underpowered.
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(Supplemental Information). For six candidate gDMRs, we found
evidence for maternal-specific methylation maintenance (bino-
mial p < 0.2) (Table 1). Of note, the lack of evidence for
maternal-specific methylation from liver was mostly due to
a paucity of SNPs (7/28 DMRs) or low read depth over an existing
SNP (14/28 DMRs). Using bisulfite sequencing, we further as-
sessed four of these candidates. None of these showed
maternal-specificmethylation in fetal liver (Figure S4), confirming
that very few new maternal gDMRs persisting after implantation
are left to be uncovered.
Figure 2. Identification and Methylation
Analysis of the Cdh15 DMR
(A) MeDIP-Seq profile of the Cdh15 locus. Genes
are oriented 50 to 30. The MeDIP-Seq tracks
show an intragenic CGI with hypomethylation in
Dnmt3L-/+ embryos and sperm compared to WT
embryos (thick part of purple bar: highest statis-
tical confidence).
(B) Developmental analysis of Cdh15 DMR meth-
ylation by bisulfite sequencing. Red and blue lines
delineate maternal and paternal alleles.
(C) Maternal-specific methylation is maintained in
various hybrid adult tissues.
(D) The parental specificity of the DMR is lost in
cortex, cerebellum and ES cells, by methylation
acquisition on paternal alleles (blue). Black circle:
methylated CpG, white circle: unmethylated
CpG, dash: absent CpG corresponding to strain-
specific SNPs or, rarely, sequencing errors.
Mouse strains: B = C57Bl6/J, C = CAST/Ei, 129 =
129 Sv.
We went on to study four candidate
maternal gDMRs in more detail, chosen
for their high level of significance in our
screen and their association with a CGI,
a systematic feature of currently known
maternal ICRs. Importantly, MSRE-
qPCR and bisulfite sequencing confimed
their hypomethylation in 8.5 dpc
Dnmt3L-/+ embryos and in sperm (Fig-
ure 1E and data not shown). Three are
located in gene bodies toward the 30
end of the respective canonical RefSeq
transcript (Cdh15, Zfp777 and Zfp787).
The fourth candidate overlaps with the
promoter of AK008011, a mono-exonic
retrogene.
The Cdh15 DMR Controls the
Paternal- and Tissue-Specific
Expression of an Intragenic
Transcript
The Cdh15 DMR (ranked 14th; FDR <
0.02) spans exons 10 to 12 of the Cdh15
gene (Figures 1A and 2A), which maps
to distal chromosome 8 (8qE2) and
encodes the M-cadherin protein, a cell-
adhesion protein linked to muscle and
cerebellum (Padilla et al., 1998; Rose et al., 1995). By bisulfite
sequencing of exon 11, we showed that this DMR fulfills the three
developmental criteria of a maternally imprinted gDMR (Figures
2B and S3B): (1) methylation acquisition in the oocyte but not
in sperm, (2) maintenance of maternally methylated alleles prior
to implantation, as revealed by the lack of methylated alleles in
maternal-imprint free Dnmt3L-/+ blastocysts compared to
wild-type blastocysts, and (3) protection of the paternally unme-
thylated alleles after implantation, as shown in 9.5 dpc embryos
derived from C57Bl6/J and CAST/Ei strains. Moreover, we
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demonstrated that the maternal allele is unable to regain methyl-
ation in Dnmt3L-/+ postimplantation embryos, confirming the
obligate passage through the female germline to imprint this
locus.
In adult tissues and cells derived from C57Bl6/J by CAST/Ei or
129 Sv by CAST/Ei crosses, the methylated status of maternal
alleles was consistently maintained. In quadriceps, tail and
hypothalamus, methylation differences between parental alleles
were highly significant (Fisher’s exact p < 1011), although a
minority of paternal alleles tended to regain methylation in quad-
riceps (Figure 2C). MeDIPSeq analysis of fetal hybrid liver DNA
also showed higher methylation of maternal compared to
Figure 3. Chromatin and Expression Anal-
ysis at the Cdh15 Locus
(A and B) In MEFs, the Cdh15 DMR (A) globally
maintains maternal-specific DNA methylation, (B)
shows combined enrichment of permissive and
repressive histone marks. Relative enrichments
were calculated from ChIP-qPCR experiments as
Input %, and normalized to Tbx15 promoter for
H3K4me2, and to IAP 50LTR for H4K20me3 and
H3K9me2. Error bars show the standard deviation
from three biological replicates.
(C) Permissive and repressive marks show oppo-
site allelic enrichment by ChIP-pyrosequencing,
on reciprocal BxC and CxB MEFs. Genomic
DNA (gDNA) was used to exclude assay-specific
biases.
(D) RT-qPCR assay shows equal measurement of
expression upstream (exon 1) and downstream
(exons 12–13) of the DMR in quadriceps and
cerebellum. A 10-fold higher expression is de-
tected downstream in the hypothalamus.
(E) Northern blot analysis identifies a full 3 kb
transcript in cerebellum, a shorter 1–1.5 kb tran-
script in adult hypothalamus, and both forms in
neonatal brain.
(F) RT-PCR sequencing tracks of the allelic
expression status of the main and short Cdh15
transcripts. SNP nucleotides (red) are indicated in
the B then C order.
paternal alleles (binomial p = 0.133)
(Table 1). However, in ES cells, adult
cortex and cerebellum, parental speci-
ficity was lost due to acquisition of meth-
ylation on the paternal alleles (Figure 2D).
The intragenic Cdh15 DMR is therefore
conserved during adulthood, but in
a tissue-specific manner.
We next investigated the chromatin
state of the Cdh15 DMR by immuno-
precipitation (ChIP). We measured the
quantity and allelic specificity of three
marks associated with imprinted DMRs
(H3K4me2, H3K9me2 and H4K20me3),
in MEFs (mouse embryonic fibroblasts),
which globally maintain maternal-specific
DNA methylation (Figure 3A). The Cdh15
DMR was found enriched in repressive
H3K9me2 and H4K20me3, at a level similar to the typical
maternal ICR KvDMR (Figure 3B). Permissive H3K4me2 marks
were also found at this locus. We assayed the allele-specificity
of these marks by pyrosequencing, exploiting SNPs between
the C57Bl6/J and CAST/Ei strains (Figure 3C). H3K4me2 was
associated with the paternal allele, while H4K20me3 was en-
riched on the maternal allele. In contrast to KvDMR, for which
H3K9me2 is maternally enriched, this mark was equally distrib-
uted on both parental alleles at the Cdh15 DMR. This shows
that the Cdh15 DMR harbors opposite allelic states of histone
modifications in MEFs, with respect to H3K4 and H4K20
methylation.
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Cdh15 is highly expressed in satellite cells of skeletal muscles
and granular cells of the cerebellum (Cornelison and Wold,
1997; Rose et al., 1995). Moreover, evidence for paternal-
specific expression was recently reported in adult hypothal-
amus (Gregg et al., 2010). By using quantitative RT-PCR, we
readily detected Cdh15 expression in quadriceps, cerebellum
and hypothalamus, with the strongest detection in cerebellum
(Figure 3D). Expression measurements were equal upstream
and downstream of the DMR (exon 1 versus exons 12–13) for
the quadriceps and the cerebellum, suggesting the existence
of a transcript elongating from the 50 canonical promoter
throughout the coding unit. However, in the hypothalamus,
10-fold greater expression was measured downstream of the
DMR, suggesting the existence of a transcript originating
intragenically. Northern blot analysis confirmed the production
of a single full-length transcript in the cerebellum, around the
expected 3 kb size, while the hypothalamus specifically ex-
pressed a shorter version of Cdh15, which could be detected
with a probe spanning exons 9–14 (Figure 3E), but not exons
5–9 (data not shown). Both transcripts were present in neonatal
brains.
The allelic status of Cdh15 expression was determined in
reciprocal BxC and CxB crosses: while biallelic expression
was found upstream and downstream of the DMR in quadriceps
and cerebellum, only paternal expression of the short Cdh15
transcript was detected in hypothalamus (Figure 3F). In neonatal
brains, a switch from biallelic to monoallelic expression was
observed at the DMR. Further allelic mapping by RT-PCR
revealed that the short paternal transcript originates between
exons 9 and 10, 50 of the Cdh15 DMR, a region that showed
maternal-specific methylation in neonatal brain (Figures S5A
and S5B). The Cdh15 DMR probably corresponds to an intra-
genic promoter, specifically active in brain cell-types detectable
at birth and in the hypothalamus at adulthood. Its differential
methylation correlates with differential allelic transcription in
these cell types.
The Cdh15 DMR defines chromosome 8 as a new chromo-
some harboring an imprinted locus. To determine the extent
of Cdh15 DMR control, we measured the allelic expression of
the three closest neighboring genes (Acsf3, AK040202 and
Ankrd11), by an RT-PCR pyrosequencing-based approach. We
did not detect imprinted expression for these genes, in a bank
of reciprocal hybrid tissues including embryonic, fetal, neonate
and adult stages (Figure S6). It is therefore highly probable that
the Cdh15 DMR does not control an imprinted cluster.
Of clinical interest, the human CDH15 gene has been associ-
ated with intellectual disability (Bhalla et al., 2008). The CDH15
gene has a similar genomic organization to its mouse homolog,
notably with an intragenic CGI spanning exons 9 to 12. We
analyzed the imprinted status of this locus in human fetal liver,
a tissue we find to maintain maternal-specific methylation in
mouse. Unexpectedly, the 50 part of the CGI was completely
methylated, while the 30 part that includes the region homolo-
gous to the sequence we analyzed in mouse was completely
unmethylated (Figure S5C). Lack of methylation was confirmed
in lymphocyte and placental DNA (data not shown). Our study
does not support a conservation of imprinting for the CDH15
locus in humans but rather points to a bipartite CGI.
The AK008011 DMR Is a Tissue-Specific Imprinted
gDMR at a Mouse Pseudogene
The second DMR we focused on maps to a CGI located 50 of
AK008011, an intronless gene (Figure 4A). It was likely generated
via the retrotransposition of a Coro1c mRNA (Coronin, Actin
binding protein 1c located on chromosome 5) to a region
1.5 kb downstream of Nhlrc1 on chromosome 13qA5, an event
that occurred specifically in the mouse lineage (Kent et al.,
2003). We uncovered this small DMR through a 500 bp sliding
window analysis (FDR < 0.35) (Table S1), while no DMR was
identified at the Coro1c locus. Bisulfite-based methylation
analysis revealed 1) methylation acquisition in oocyte but not in
sperm, 2) protection of maternally methylated alleles prior to
implantation and 3) protection of paternally unmethylated alleles
after implantation (Figure 4B). This locus therefore behaves as
a typical maternal imprinted gDMR during the critical window
around fertilization and implantation. However, in adult life, this
gDMRbecomes tissue-specific.Whilematernal-specificmethyl-
ation is properly maintained in tail and fibroblasts (Figure 4C), the
quadriceps, cortex and liver show dense methylation (over 60%)
of both paternal and maternal alleles (Figure 4D). This finding
again questions the view of the permanency of imprinted gDMRs
throughout life.
In an attempt to investigate the impact of this gDMR on allelic
expression, we designed primers that specifically distinguish
AK008011 from Coro1c mRNA. However, we could not detect
expression in tissues where the gDMR is conserved. The high
rate of nucleotide divergence between mouse strains suggests
a low selective pressure on this gene, which may be a pseudo-
gene: 40 SNPs are referenced at AK008011, including 9 nonsy-
nonymous ones, versus 6 synonymous changes at the tran-
scribed region of Coro1c (MGI and dbSNP build 128). Further
examination of the closest gene, Nhlrc1, did not reveal a bias
in parental expression in any tissue from our hybrid bank (data
not shown), suggesting that the AK008011 gDMR does not
have long-range imprinting effects.
Zfp777 and Zfp787 DMRs Are Transient Maternal
gDMRs
The last two hypomethylated DMRs we validated (FDR < 2%)
map to CGIs located in the last exon of the Zfp777 (6qB2.3)
and Zfp787 (7qA1) genes, which encode zinc finger proteins
(Figures 5A and S7A). As is typical for maternal gDMRs, we
found methylation acquisition specifically in the oocyte, and
protection of maternally methylated alleles prior to implantation
(Figures 5B, S3B, and S7B). However, paternal alleles of these
DMRs undergo de novo methylation at implantation, so that
both parental alleles displayed similar levels of methylation at
9.5 dpc as well as in 17.5 dpc fetal liver (Table 1). Contrary to
imprinting-associated gDMRs, which show lifelong parental
differences at least in some tissues, these DMRsmay be catego-
rized as transient gDMRs. Interestingly, in Dnmt3L-/+ embryos,
paternal and maternal alleles were equally methylated at
9.5 dpc, suggesting no differential treatment of the two alleles
(Figures 5B and S7B). The global methylation per parental allele
was slightly lower than age-matched wild-type embryos, likely
as a consequence of a postimplantation developmental delay
(Bourc’his et al., 2001). Examination of various normal adult
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tissues by bisulfite sequencing confirmed complete methylation
later in life (Figures 5C and S7C). Further analysis of the last exon
of ZNF777 in human postimplantation tissues confirmed the
existence of methylated alleles only (data not shown).
The observation of parent-specific marks at the blastocyst
stage prompted us to analyze the allelic methylation of these
transient gDMRs in ES cells. Bisulfite analysis showed that ES
cells do not reproduce the parental methylation differences of
their biological progenitors; the Zfp777 DMR was biallelically
methylated, while the Zfp787 DMR was biallelically hypomethy-
Figure 4. Identification and Methylation
Analysis of the AK008011 DMR
(A) MeDIP-Seq profile of the AK008011 locus.
(B) Developmental analysis of DNA methylation of
this locus by bisulfite sequencing.
(C) Maternal-specific methylation is maintained in
tail and MEFs.
(D) The parental specificity is lost in liver, quadri-
ceps and cortex, by methylation acquisition on
paternal alleles (blue).
lated (Figures 5D and S7C). This was
observed in ES cells that were isolated
and grown in conditions optimal for
‘‘ground-state’’ pluripotency cells (2i
medium) (Nichols et al., 2009), and in ES
cells cultured in classical medium (data
not shown). Similar to previous findings
(Borgel et al., 2010; Dean et al., 1998),
our results demonstrate that ES cells do
not necessarily maintain the allelic status
of sequences that are differentially meth-
ylated in the blastocyst, and specifically,
may not be a suitable cellular model for
studying transient gDMRs.
When allelic expression patterns were
measured in hybrid reciprocal tissues,
we found no parental bias in Zfp777 and
Zfp787 expression, even in the preim-
plantation blastocyst, where parental
methylation differences still exist (Figures
5E and S7D). Our results suggest that the
methylation located in the 30 end of the
Zfp777 and Zfp787 genes may not func-
tionally impinge on their expression.
DISCUSSION
In mammals, the oocyte and sperm
genomes harbor distinct methylation
patterns, as a result of different kinetics
and constraints exerted on gamete
production in the two sexes. The inheri-
tance of parent-specific methylation at
fertilization provides the opportunity
for differential allelic regulation in the
progeny, with genomic imprinting as the
most durable form of parent-specific regulation of gene expres-
sion. Our present work demonstrates that the total number of
maternal germline DMRs persisting throughout development
and adulthood is very limited, in line with current estimates for
the number of known ICRs. From this study, it can be concluded
that genomic imprinting is an unusual form of regulation in
mammals.
Recent genome-wide studies have highlighted preimplanta-
tion demethylation as a major determinant of gametic methyla-
tion clearance (Borgel et al., 2010; Kobayashi et al., 2012a;
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Smallwood et al., 2011). We reveal here that de novomethylation
plays an equally important role in leveling parental methylation
differences inherited from the gametes (Figure 6). Zfp777
and Zfp787 DMRs lose their maternal specificity early, by
paternal methylation acquisition at implantation. Cdh15 and
AK008011DMRs are protected at implantation, but nevertheless
gain paternal methylation later, during tissue differentiation.
The permanency and universality of imprinted gDMRs was
a commonly held notion in genomic imprinting. The tissue-spec-
ificity of Cdh15 and AK008011 gDMRs revisits this notion and
highlights the limitation of studies performed on a specific adult
tissue for identifying new imprinted gDMRs. In this regard,
a recent genome-wide screen performed on adult mouse cortex
uncovered nine candidate regions of parent-of-origin methyla-
tion (Xie et al., 2012), of which only two candidates overlapped
Figure 5. Identification and Methylation
Analysis of the Zfp777 DMR
(A) MeDIP-Seq profile of the Zfp777 locus.
(B) Contrary to imprinted gDMRs, DNA methyla-
tion is gained on paternal alleles at implantation
and parental alleles exhibit similar methylation
levels both in WT and Dnmt3L-/+ 9.5 dpc
embryos.
(C) Adult tissues show a fully methylated pattern.
(D) Parental alleles are similarly methylated in ES
cells.
(E) RT-PCR pyrosequencing analysis of a SNP
located in the 30UTR shows biallelic expression of
Zfp777 in hybrid blastocysts at 3.5 dpc.
with our unfiltered candidate list
(AK008011 and Casc1). Interestingly,
loss of parent-specific marks by de novo
methylation may not be restricted to the
new imprinted loci we describe: indeed,
at traditionally known ICRs, loss of differ-
ential methylation has been sporadically
reported in normal adult cells, occurring
by methylation gain, rather than loss
(Fang et al., 2012; Ferro´n et al., 2011).
Our work increases the number of
known imprinted gDMRs to 23, including
two new loci to be referenced. While the
Cdh15 DMR is associated with parent-
specific expression, the AK008011 DMR
may not be functional, showing that im-
printed gDMRs may not necessarily be
selected for a role in gene regulation.
Previous studies hadalluded to apossible
imprinted status of Cdh15. Analysis of
chromosome 8 duplications led to the
characterization of a region of complete
maternal methylation and intermediate
paternal methylation in embryos and
neonates (Kelsey et al., 1999). While no
parent-specific Cdh15 expression was
found in embryos, a recent analysis re-
ported paternal-specific expression of
three SNPs confined to exons 12 to 14, in adult hypothalamus
(Gregg et al., 2010). Our study resolves the modus operandi of
this locus, by the identification of a maternal gDMR that maps
to Cdh15 exons 10–12, which is maintained in a tissue-specific
manner and controls the paternal expression of a short alterna-
tive transcript in neonatal brain and adult hypothalamus. The
Cdh15 DMR may be a docking site for transcription factors ex-
pressed in specific brain cell types, whose binding/activity is
impaired by maternal DNA methylation.
Cdh15/M-cadherin is an adhesion protein that mediates
cell-to-cell interactions. Homozygous Cdh15 null mice are
viable, and show no apparent defects in skeletal muscle and
cerebellum, likely due to compensation from other cadherins
(Hollnagel et al., 2002). Moreover, there is no evidence of
parent-of-origin effects in these mutant mice. However, the
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corresponding deletion targets exons 1 to 4, and therefore,
should not impair the production of the short imprinted Cdh15
transcript. Interestingly, a similar 50 truncated form of cadherin
with altered adhesion activity has been described in specific
neurons of the chick embryo (Shirabe et al., 2005). Provided
that the short imprinted Cdh15 transcript is translated, it may
likewise exert specific functions in mammalian hypothalamic
cells, related to cell communication, polarization and shaping.
By identifying both imprinted and transient gDMRs, our screen
highlights that these two types of gDMRs are indistinguishable in
gametes and early embryos (Figure 6). Recruitment of KAP1
through Zfp57 binding was shown to be required for the mainte-
nance of methylated alleles of ICRs (Li et al., 2008; Mackay et al.,
2008; Quenneville et al., 2011; Zuo et al., 2012). By in silico anal-
ysis we found that all thematernal gDMRswe validated (Slc38a4,
Cdh15, AK008011, Zfp777 and Zfp787) contain some hexanu-
cleotide motifs for Zfp57 binding (Table S1). Moreover, Zfp57
and KAP1 are enriched at these sites in published ES cell
ChIP-Seq data (Table S1) (Quenneville et al., 2011). Our study
therefore shows that the presence of Zfp57 motifs cannot be
used as a hallmark of genomic imprinting, as it is also found at
transient gDMRs. However, it is likely to specify all genomic
sequences that maintain gametic methylation during preimplan-
tation development. Interestingly, four Zfp57 binding motifs
exist at the intragenic CGI of the human CDH15 locus. While
we found no evidence of imprinting, we cannot exclude that
this locus is a true maternal gDMR in human, either transient or
tissue-specific.
Methylation gain at implantation is what discriminates tran-
sient from lifelong imprinted gDMRs. The former are permissive,
while the latter are refractory to this process. Zfp777, Zfp787,
andCdh15DMRsare all intragenic sequences, forwhich a strong
positive correlation has been reported between DNAmethylation
and transcriptional read through from the host gene (Ball et al.,
2009; Chotalia et al., 2009). Paternal de novomethylation at tran-
sient Zfp777 and Zfp787 gDMRs may therefore be facilitated
by ongoing transcription from these genes at implantation.
Conversely, at the imprinted Cdh15 gDMR, low levels of tran-
scription from the main upstream promoter, local enrichment in
H3K4 methylation and transcription factor occupancy may
protect from de novo methylation (Lienert et al., 2011; Ooi
et al., 2007). The same rules would apply later during life with
tissue formation. The DMR is conserved in tissues where it
acts as an active promoter for the short paternal Cdh15 tran-
script (hypothalamus and neonatal brain), and is potentially pro-
tected by transcription factors and/or H3K4memarks. However,
in tissues where the short transcript is not expressed, different
methylation states are observed and seem to correlate with the
expression status of the long canonical Cdh15 transcript.
Our screen designed at 8.5 dpc was effective at identifying
tissue-specific imprinted gDMRs, because it was performed at
a time when they are still universal. It also identified transient
gDMRs during their remethylation process. Although the tran-
sient gDMRs we found do not seem to affect expression,
presumably because of their 30 position, other transient gDMRs
may regulate the transcriptome of the peri-implantation embryo.
Notably, the parental specificity of these methylated sequences
should be lost upon somatic nuclear transfer, resulting in two
methylated alleles instead of one during preimplantation devel-
opment. Furthermore, as for imprinted gDMRs, transient gDMRs
may be sensitive to assisted reproductive technologies,
involving stimulation of oocyte production and preimplantation
embryo culture.
EXPERIMENTAL PROCEDURES
MeDIP-Seq
MeDIP-Seq was performed on three pooled litters with the Dnmt3L+/+ (WT) or
Dnmt3L-/+ genotype. All MeDIP and sequencing library preparations were
performed in parallel. Additionally, MeDIP-Seq was performed on three inde-
pendent C57Bl6/J sperm samples and twelve pools of three livers each of
17.5 dpc fetal hybrid C57Bl6/J and PWD/PhJ mice. MeDIP enrichment and
preparation of paired-end sequencing libraries were then performed as
described (Down et al., 2008), using monoclonal anti-5-methylcytosine
antibody (Eurogentech) and magnetic anti-mouse beads (Dynabeads) for
immunoprecipitation. All libraries were sequenced using an Illumina GA2x
instrument.
DNA Methylation Analyses
For MSRE-qPCR, the methylation-dependent restriction enzyme McrBC was
used, and methylation percentages were calculated according to (Oakes
et al., 2009). Values represent the average of three independent digestion
experiments, performed on DNA from 8.5 dpc litters of eight embryos. For
bisulfite conversion, DNA was treated with the EpiTect kit (QIAGEN). BiQ
Analyzer software was used for sequence alignments (Bock et al., 2005) and
cloneswith identical patterns of conversionwere removed from the final pileup.
ACCESSION NUMBERS
Raw MeDIP-Seq read and alignment data are available from GEO with acces-
sion GSE32687.
Figure 6. Different Fates of Oocyte-Inherited Methylation
(A and B) Maternal alleles (red line) of (A) imprinted and (B) transient gDMRs
acquire methylation in oocytes and are protected against genome-wide (gray
line) demethylation during preimplantation development. These two types of
gDMRs contain Zfp57 binding sites and physically interact with Zfp57/KAP1.
However, while unmethylated paternal alleles (blue line) of imprinted gDMRs
are protected against de novo methylation at implantation, transient gDMRs
are permissive to this process. Imprinted gDMRs can also gain methylation on
paternal alleles later during life, in a tissue-specific manner (dotted blue line).
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